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A fosfatidilserina (PS) é um fosfolípido que se encontra em todas as células de 
mamíferos e desempenha um papel importante em processos biológicos, tais 
como, a coagulação sanguínea e a apoptose. A externalização da PS em 
células apoptóticas é reconhecida pelos recetores dos macrófagos, sendo uma 
via de sinalização essencial para a eliminação destas células. Nos últimos 
anos, tem sido proposto que a externalização da PS pode estar associada 
oxidação, e que a PS oxidada (oxPS) parece ser mais facilmente reconhecida 
pelos macrófagos do que a PS não oxidada. No entanto as modificações 
geradas pela oxidação da PS, assim como os seus efeitos biológicos são 
ainda pouco conhecidas. A PS, tal como outros fosfolípidos, pode ser 
facilmente oxidada em especial quando tem na sua composição ácidos gordos 
polinsaturados. Por outro lado, o grupo amina livre do aminoácido serina do 
grupo polar da PS pode sofrer glicação por reação com o grupo carbonilo da 
glucose, aumentando assim a sua suscetibilidade à oxidação. O principal 
objetivo deste trabalho foi caracterizar e identificar produtos de oxidação e 
glicação de PS e desta forma contribuir para a compreensão do seu papel 
biológico especialmente na resposta imune e inflamatória. 
Para alcançar o objetivo proposto, procedeu-se à oxidação da PS. Para este 
fim, foram selecionados compostos modelo de PS com diferentes composições 
de ácidos gordos: 1-palmitoil-2-oleoil-sn-glicero-3-fosfo-L-serina (POPS); 1,2-
dipalmitoil-sn-glicero-3-fosfo-L-serina (DPPS); 1-palmitoil-2-linoleoil-sn-glicero-
3-fosfo-L-serina (PLPS) e 1-palmitoil-2-araquidonoil-sn-glicero-3-fosfo-L-serina 
(PAPS). De modo a completar o estudo procedeu-se também à oxidação da 
PAPS e POPS glicadas. As reações de oxidação foram realizadas em 
sistemas modelo usando diferentes reagentes oxidantes: HO• e dicloridrato de 
2,2’-azo-bis- (2-amidinopropano) (AAPH). A caracterização estrutural 
detalhada dos produtos obtidos nas diversas reações foi realizada por 
espectrometria de massa (MS) com ionização por electrospray (ESI) ESI-MS e 
por espectrometria se massa tandem (MS/MS) acoplada a técnicas de 
separação como cromatografia de camada fina (TLC) (off-line TLC-MS) e 
cromatografia líquida (LC) (on line LC-MS). 
Os resultados obtidos neste trabalho permitiram identificação dos vários 
produtos de oxidação de PS e PS glicada, observando-se modificações na 
cadeia acilo insaturada. Observaram-se também produtos de oxidação 
formados devido a alterações estruturais no grupo polar com formação de 
produtos com terminais: acetamida, hidroperoxiacetaldeido e ácido acético 
(ácido glicerofosfoacetico, GPAA). A caracterização por MS/MS permitiu 
identificar as vias de fragmentação específicas de cada tipo de produto de 
oxidação. Com base nas vias de fragmentação identificadas anteriormente, foi 
realizada uma análise de lipidómica direcionada “targeted lipidomic” para 
detetar os produtos resultantes da oxidação do grupo polar da PS em 
queratinócitos HaCaT tratados com AAPH, como estímulo de stress oxidativo. 
 
  
  
 
 
 
 
 
 
 
 
 
 
  
  
 
 
Com esta abordagem direcionada foi possível detetar derivados GPAA nos 
extratos lipídicos obtidos destas células HaCaT, confirmando a possibilidade 
de oxidação de cabeça de PS em sistemas biológicos. Os estudos de oxidação 
de PS glicadas mostraram que as PS glicadas oxidam mais facilmente que as 
suas congéneres não glicadas. Durante a oxidação de PS glicada, além da 
oxidação nas cadeias acilo foram identificadas novos produtos de oxidação 
devido a degradação oxidativa na molécula de glucose ligada á PS, 
identificados como PS-AGES (do inglês, PS- Advanced glycation end 
products). 
Com o objetivo de investigar o efeito da radiação UVA na membrana 
fosfolipídica e, em particular, no perfil de fosfatidilserinas, foi realizado um 
estudo com linhas celulares de melanoma (SK-MEL-28). Após a exposição à 
radiação UVA das linhas SK-MEL-28, os extratos lipídicos foram analisados 
por LC-MS e MS/MS e GC-MS. Os resultados não revelaram diferenças 
significativas no teor de PS após a exposição. A nível molecular, apenas a PS 
(18:0/18:1) diminuiu no momento da irradiação, sugerindo algum dano 
oxidativo, mas que foi revertido nos tempos seguintes. As mudanças mais 
significativas no teor de fosfolípidos ocorreram nas classes da fosfatidilcolina e 
fosfatidilinositol, observando-se um aumento da concentração relativa de 
ácidos gordos monoinsaturados (MUFA). As alterações observadas nos lípidos 
parecem estar relacionadas com a lipogénese e com desenvolvimento e 
progressão do cancro. Curiosamente, apesar do UVA estar associado ao dano 
oxidativo, não foi possível observar neste estudo a presença fosfolípidos 
oxidados. Para o estudo das propriedades anti- e pró-inflamatórias da PLPS 
oxidada (oxPLPS) e PLPS não oxidados foi avaliada a produção de óxido 
nítrico (NO) por macrófagos na presença e na ausência do estímulo 
inflamatório, o lipopolissacarídeo (LPS). Os resultados obtidos mostraram que 
não houve alteração na produção de NO em macrófagos estimulados com PS 
e oxPS na ausência de LPS. Por outro lado observou-se que no caso de 
macrófagos estimulados com LPS, o oxPLPS inibiu significativamente a 
produção de NO induzida por LPS, enquanto que o PLPS não mostrou 
qualquer efeito significativo. A nível molecular, observou-se que a diminuição 
de NO foi mediada pela inibição da fosforilação da c-Jun-N-terminal quinase 
(JNK) e na translocação nuclear do p65 NF-kB. Em geral estes dados sugerem 
que oxPLPS, mas não PLPS, reduz a sinalização pró-inflamatória em 
macrófagos, contribuindo para a contenção de inflamação durante apoptose 
celular.  
Os resultados obtidos nesta dissertação fornecem nova informação sobre as 
modificações da PS, facilitando a sua identificação em amostras complexas, 
nomeadamente em condições fisiopatológicas e também, informação que 
permite uma melhor compreensão sobre o papel da oxPS e PS na resposta 
inflamatória, no processo de apoptose e em outras funções biológicas. 
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abstract 
 
Phosphatidylserine (PS) is a member of the class of phospholipids, and is 
distributed among all cells of mammalians, playing important roles in diverse 
biological processes, including blood clotting and apoptosis. When 
externalized, PS is a ligand that is recognized on apoptotic cells. It has been 
considered that before externalization PS is oxidized and oxPS enhance the 
recognition by macrophages receptors, however the knowledge about oxidation 
of PS is still limited. PS, like others phospholipids, has two fatty acyl chains and 
one polar head group, in this case is the amino acid serine. The modifications 
in PS structure can occur by oxidation of the unsaturated fatty acyl chains and 
by glycation of the polar head group, due to free amine group, thus increasing 
the susceptibility to oxidative events. The main goal of this work was to 
characterize and identify oxidized and glycoxidized PS, contributing to the 
knowledge of the biological role of oxidation products of PS, as well as of 
glycated PS, in immune and inflammatory processes. 
To achieve this goal, PS standards (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
L-serine (POPS), 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS), 1-
palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS) and 1-palmitoyl-2-
arachidonoyl-sn-glycero-3-phospho-L-serine (PAPS)) and glycated PS (PAPS 
and POPS) were induced to oxidize in model systems, using different oxidant 
reagents: HO• and 2,2'-azobis-2-methyl-propanimidamide dihydrochloride 
(AAPH) . The detailed structural characterization of the oxidative products was 
performed by ESI-MS and MS/MS coupled to separation techniques such as off 
line TLC-MS and on line LC-MS, in order to obtained better characterization of 
the larger number of PS and glycated PS oxidation products.  
The results obtained in this work allowed to identify several oxidation products 
of PS and glycated PS with modifications in unsaturated fatty acyl chain. Also, 
oxidation products formed due to structural changes in the serine polar head 
with formation of terminal acetamide, terminal hydroperoxyacetaldehyde.and 
terminal acetic acid (glycerophosphacetic acid, GPAA) were identified.  The 
mass spectrometric specific fragmentation pathway of each type of oxidation 
product was determined using different mass spectrometry approaches. Based 
on the identified fragmentation pathways, targeted lipidomic analysis was 
performed to detect oxidation products modified in serine polar head in HaCaT 
cell line treated with AAPH. The GPAA was detected in HaCaT cells treated 
with AAPH to induce oxidative stress, thus confirming that modifications in PS 
polar head is possible to occur in biological systems. Furthermore, it was found 
that glycated PS species are more prone to oxidative modifications when 
compared with non glycated PS. During oxidation of glycated PS, besides the 
oxidation in acyl chains, new oxidation products due to oxidation of the glucose 
moiety were identified, including PS advanced glycation end products (PS-
AGES). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
To investigate if UVA oxidative stress exerted changes in the lipidome of 
melanoma cell lines, particularly in PS profile, a lipidomic analysis was 
performed. The lipid profile was obtained using HILIC-LC-MS and GC-MS 
analysis of the total lipid extracts obtained from human melanoma cell line (SK-
MEL-28) after UVA irradiation at 0, 2 and 24 hours. The results did not showed 
significant differences in PS content. At molecular level, only PS (18:0:18:1) 
decreased at the moment of irradiation. The most significant changes in 
phospholipids content occurred in phosphatidylcholines (PC) and 
phosphatidylinositol (PI) classes, with an increase of mono-unsaturated fatty 
acid (MUFA), similarly as observed for the fatty acid analysis. Overall, these 
data indicate that the observed membrane lipid changes associated with 
lipogenesis after UVA exposure may be correlated with malignant 
transformations associated with cancer development and progression. Despite 
of UVA radiation is associated with oxidative damage, in this work was not 
possible observe oxidation phospholipids. 
The anti/pro-inflammatory properties of the oxidized PLPS (oxPLPS) versus 
non-oxidized PLPS were tested on LPS stimulated RAW 264.7 macrophages. 
The modulation of intracellular signaling pathways such as NF-kB and MAPK 
cascades by oxPLPS and PS was also examined in this study. The results 
obtained from evaluation of anti/pro-inflammatory properties showed that 
neither PLPS or oxPLPS species activated the macrophages. Moreover only 
oxidized PLS were found to significantly inhibit NO production and iNOS and 
il1β gene transcription induced by LPS. The analysis at molecular level showed 
that this was the result of the attenuation of LPS-induced c-Jun-N-terminal 
kinase (JNK) and p65 NF-kB nuclear translocation. Overall these data suggest 
that oxPLPS, but not native PLPS, mitigates pro-inflammatory signaling in 
macrophages, contributing to containment of inflammation during apoptotic cell 
engulfment. 
The results obtained in this work provides new information on the modifications 
of PS, facilitating the identification of oxidized species in complex samples, 
namely under physiopathologic conditions and also contributes to a better 
understanding of the role of oxPS and PS in the inflammatory response, in the 
apoptotic process and other biological functions 
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1.1 Introduction to phospholipids structure and functions 
Lipids are one of the most important group of biomolecules that embrace structurally 
quite heterogeneous molecules. The structural diversity of the lipid species is side by side 
with their different roles in living systems. In fact, lipids can fulfill a variety of biological 
functions, such as energy source (e.g. triglycerides and fatty acids), constituents of cell 
membranes and subcellular compartments (e.g. mitochondria) or as bioactive molecules 
with important role in several signaling events (e.g. phosphatidic acid, sphingosine-1-
phosphate, ceramides) [1,2,3,4]. To understand these diversified structures and functions, a 
new omics field has emerged. In fact, lipidomics became during the last decade a growing 
research discipline, positioned between proteomics and metabolomics, aiming at the global 
characterization of lipids and lipids metabolites and their functions in biological systems 
[5,6]. 
Among lipids, the phospholipids (PL) are a major class present in high abundance in 
all organisms, from the arcobacter to plants and humans. These hydrophobic molecules 
have a diversity of functions: building blocks of cell membranes, compartmentalization of 
the cytoplasm, storage of proteins involved in cell signaling, intercellular adhesion and 
cytoskeleton support [7]. They also serve as a precursor for lipid’s biologically active 
mediators [8]. The major groups of PLs are glycerophospholipids and sphingolipids. 
The glycerophospholipids are the most abundant PLs; they have a key role in energy 
storage as well as in cell structure, since they are the main components of cell membrane. 
They are also involved in cell signaling, cell proliferation and may serve as potential 
biomarkers for several diseases. Glycerophospholipids usually consist of a glycerol 
molecule linked to two fatty acids and a phosphate group that can bind a polar molecule by 
an ester bond. This portion of the PL molecule is called the head group of the PL, as is the 
base to define several classes of PLs [9] (Figure 1).  
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Figure 1: Structure of glycerophospholipids. Typical glycerophospholipids consist of two fatty acyl 
chains, a glycerol backbone, and a phosphophodiester linked to a head group. The most common 
phospholipid classes are: Phosphatidylcholine (PC); phosphatidylethanolamine (PE), 
phosphatidylinositol (PI); phosphatidylserine (PS); phosphatidylglycerol (PG); phosphatidic acid 
(PA). 
The composition of the head group of glycerophospholipids is primordial in dividing 
the PL in distinct classes. For example, if the head group is a serine, then the PL belongs to 
the phosphatidylserines (PS) class. Other classes include phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylglycerols (PG) and phosphatidylinositols (PI) 
(Figure 1). When the phosphate group is not substituted the PL class is called PA. All these 
classes paring with Cardiolipin (CL) are the main classes of polar PLs. The cardiolipin is 
an odd PL, since it is a dimeric PL that presents two phosphatidic acids linked together 
through an additional glycerol molecule and thus bearing four fatty acyl chains. 
Glycerophospholipids are a group of biomolecules that is abundant in cells, presenting 
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very diverse in structural forms. This structural variety is due to the presence of different 
combinations of lipids that vary according to the composition of the polar head group and 
also with different combination of fatty acyl chains that can have linked to the glycerol 
fatty acids. The fatty acyl chains that bind to the glycerol backbone encompass variation in 
their length, degree of unsaturation of acyl chains and in the positions of the glycerol 
backbone (sn-1 and sn-2 positions) [10]. In mammalian tissues it is possible to find 
between 30-60 different fatty acids, that can have chain length between 12-26 carbons and 
can be saturated or unsaturated, with up to 6 double bonds, and the double bonds can be 
located in different positions. In general, the saturated fatty acids are attached to glycerol at 
sn-1 position while unsaturated fatty acids are at sn-2 position. The sn-2 fatty acids are 
usually attached through an acyl bond, however the sn-1 fatty chain can be either acyl, 
alkyl ether or alkyl-1’-enyl ether linked, called respectively diacyl, plasmanyl and 
plasmenyl (also called plasmalogen) PLs [11]. The possibility of different combination of 
polar head, fatty acyl structure and position, makes several combinations possible. It is 
estimated that glycerophospholipids comprise around 600 detectable molecular species, but 
theoretical has been estimated to be in order of ~10000 glycerophospholipids (as reviewed 
in [12]. 
Each tissue, type of cell or biofluid has specific combinations of PL classes and a 
proper fatty acyl distribution [13]. PC is the most abundant class comprising around 50% 
of total PL classes in almost all tissues and cells [14]. PE is the second most abundant PL, 
but the percentage is very diverse among tissues; For example, in the brain it represents 
around 45% and in the liver around 20% of the total of PLs. PE is also present in higher 
proportions in mitochondria than in other organelles [15]. PI is present in all tissues, but in 
the brain is present with more abundance than in other tissues (~10%) [16]. CL has been 
found to be present exclusively in mitochondria membrane, representing 15% of total PL 
content in this organelle [17]. Lipids in plasma membranes of eukaryotic cells are 
asymmetrically distributed between the inner and outer membrane leaflet. PC and 
sphingomyelin (SM) are primarily located on the external leaflet, while PS, PE, and PI are 
concentrated in the internal leaflet. This odd distribution is crucial for cell homeostasis and 
it is maintained and regulated by numerous enzymes and proteins [18]. It is assumed that 
the temporal and spatial distribution of different classes of lipids in the cytoplasmic 
membranes and organelles has an important biological significance. The disturbance of 
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lipid distribution have been thoroughly investigated and are the topic of many areas of 
biomedical research, mainly due to their correlation with several pathological conditions 
such as cancer, diabetes or atherosclerosis. The deviation in the distribution and 
concentration of lipid molecules are associated with the development of diseases and 
suggest that these biomolecules can be biomarkers for diversified pathologies [19]. As an 
example, a panel of PC has recently been used as signaling molecules for Alzheimer 
disease [20,21]. 
One of the causes that can affect lipid homeostasis and distribution is the induced 
modifications associated with oxidative injure. Under oxidative conditions, PLs are very 
prone to suffer oxidative modifications mainly due to the presence of unsaturated fatty 
acids in their structure. Oxidation of PLs causes changes in their structure, resulting in a 
vast number of structurally different oxidation products. In biological systems, these 
changes may occur through radical reactions involving non-enzymatic (•OOH, •OH, Fe2+, 
Cu+, radiation) or enzymatic systems, leading to a diversity of oxidation products. 
Depending on the predominating oxidative process, different PLs oxidation products can 
be formed. Oxidized PLs can acquire novel biological activities, which are distinct from 
the non-oxidized PLs. These oxidized PLs have been described to participate in several 
biological processes such as the immune response, inflammation, apoptosis and age-related 
diseases, but little is known about the relationship between specific oxidation products and 
distinct biological effects. These biological effects have been described both in vitro and in 
vivo, and may have deleterious effects, as for example exhibiting potent pro-inflammatory 
activities, or beneficial and protective effects, for example the ones with anti-inflammatory 
properties [22]. These oxidative modifications have been extensively studied for the PC, 
since it is the most abundant class of PL. Several studies suggested that oxidized PC are 
important mediators in inflammation and are assumed that they are involved in LDL 
oxidation and the process of atherosclerosis formation by the uptake of oxidized LDL 
[22,23].  
Aminophospholipids, namely PS and PE, can also be modified by glycation and 
glycated PE have been identified in plasma, LDL and erythrocytes of diabetic patients with 
hyperglycemia [24,25,26,27,28,29]. In fact, amino PLs have a primary amine and are a 
target of modifications such as glycation, which contributes to increased oxidative stress. 
Recently, in attempt to explain the high plasma levels of PC hydroperoxides (PC-OOH) in 
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patients with type 2 diabetes, Suzuki et al correlated the presence of Amadori-PE with PC-
OOH, relating the involvement of lipid glycation and lipid oxidation in the development of 
diabetes [30]. Although glycated PE has already been detected in vivo, the glycated 
derivatives PS were only produced in laboratory using in model conditions that mimic 
hyperglycemia. Thus, PS glycation in vivo was just hypothesized and most probably has 
never been identified because PS exist in very low abundance in plasma and the 
correspondent glycated derivatives, should be very difficult to detect.  
Oxidized PS (oxPS) has already been detect in some tissues and has been correlated 
with important regulatory functions. PS have been correlated with CL oxidation in a 
process that seems to be essential in apoptotic, during controlled cell death [31]. Oxidized 
CL in mitochondria is proposed to facilitate the release of cytochrome c into the cytosol, 
that may further contribute to the formation of oxPS, culminating in its externalization to 
the outside of the plasma membrane [31]. PS itself has significant roles in several 
biological processes, which is outweighed by its physiological importance. These 
importance is attributable to its unique physical and biochemical properties, as we will 
explain in detail in the following sections. 
 
1.2 Phosphatidylserine: structure and localization 
Phosphatidylserine (PS) was first isolated in 1941 by Folch and coworkers from brain 
lipid extracts [32]. In 1948 they proposed the chemical structure of PS [32,33], but the 
exact structure was describe later by Baer and Maurukas in 1955 [34]. As described earlier, 
PS contains two acyl chains at the sn-1 and sn-2 positions of the glycerol moiety, and 
attached to position sn-3 the phosphate group linked to the amino acid serine, the polar 
head of the class of lipids. PS is dissimilar from other PLs by the polar head group 
features, being considered an anionic PL (Figure 2), while PC and PE are zwitterionic PLs. 
PS, like the other PLs, is found in nature in the form of salt. 
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Figure 2: Structure of phosphatidylserine. Note that at physiological pH the head-group bears one 
net negative charge, thus being called anionic phospholipid. 
 
PS is found preferentially in the inner leaflet of the plasma membrane and in 
endocytic membranes [35]. When present in relatively high amounts in membrane, there is 
an accumulation of negative charges, allowing the binding of polycationic proteins. This 
effect may be important in movement and recruitment of proteins at the cellular level. [36].  
The maintenance of PS in this specific location and thus maintaining the membrane 
lipid asymmetry is mediated by the interplay of different transporters, including 
aminophospholipid translocases (APT) or ‘‘flippase’’, which transports PS and PE from 
the outer leaflet to the inner leaflet and ‘‘floppases’’ that transport lipids in the opposite 
direction, from inside to outside [18] (Figure 3). The transbilayer movement of PS in 
plasma membrane may also be mediated by Ca2+-dependent scramblase-1 (PLSCR1), 
which can random distribute PS across membrane bilayers [37]. 
Flippase Floppase Scramblase
ATP ADPATPADP
PS PE PC/SM PI
Extracellular
leaflet
Cytosolic
leaflet
 
Figure 3: Asymmetric membrane regulated by aminophospholipid translocases. Adapted from 
Pennings [18]. 
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PS is present in biological membranes in various relative abundances when considered 
other membrane lipids or protein content. The plasma membrane is, of the biological 
membranes, the most enriched in PS, followed by early endosomes, while mitochondria 
membranes contain the lowest mole fraction of PS [38]. PS is also present in higher 
proportions in brain and central nervous system, representing about 15% of total PL pool 
in human brain [39]. Other tissues usually contain a smaller amount of PS; in rat liver, for 
example, the PS content is around 3% [40,41]. 
 
PS molecular species present in the cell membranes consist of many different 
molecular species because of the combination of several fatty acids bonded at the sn-1 and 
sn-2 position of glycerol moiety. Although the acyl chains in PS vary among cell types and 
organelles, the saturated fatty acids of 16 and 18 or more carbons are generally attached to 
the sn-1 position, whereas unsaturated and mostly polyunsaturated fatty acids are generally 
found at the sn-2 position. The most abundant PS molecular specie contains at sn-1 
position almost exclusively stearic acid (FA 18:0) and docosahexaenoic acid (FA 22:6) at 
sn-2 position (PS-18:0/22:6). The FA 22:6 accounts for more than 36% of the fatty acyl 
species of PS in brain. This is probably related to the fact that FA 22:6 is essential for the 
normal development and functioning of the nervous system [42,43]. 
 
1.3 Biosynthesis of phosphatidylserine 
In mammalian cells, PS is synthesized by calcium dependent reaction in which the 
polar head group of an existing PL is replaced by L-serine (Figure 4) [44,45]. In 
prokaryotes and yeast, PS is synthesized by conjugation of serine to CDP-diacylglycerol. 
The CDP-diacylglycerol pathway for PS synthesis has not been detected in mammalian 
cells [38,45,46]. 
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Figure 4: Phosphatidylserine (PS) synthesis and metabolism in mammalian cells. (PS) is 
synthetized by replacement of the choline group of PC by serine in a reaction catalyzed by PSS1. 
The PSS2 is responsible for the replacement of ethanolamine group of PE by serine [36]. 
Synthesis of PS occurs in the endoplasmic reticulum (ER), mediated by two base-
exchange enzymes, PS synthase-1 (PSS1) and PS synthase-2 (PSS2), that exchange 
choline and ethanolamine head groups of PC and PE respectively for serine [36,38,44,46]. 
The brain, testis and kidney are the tissues that have higher capacity to synthesize PS. 
Studies in brain suggested PC-(18:0/22:6) molecular specie is the preferred substrate for 
PS synthesis [41]. Although PC-(16:0:22:6) molecular specie is present in large amount is 
not utilized efficiently by PSS1 [41]. In the other hand, recent studies demonstrate that 
PSS2 utilizes PE containing FA16:0 and FA18:0 at sn-1 position equally well. However 
PSS2 prefers PE with FA22:6 in the sn-2 position to either FA20:4 or FA18:1 [47]. Thus, 
both PSS1 and PSS2 contribute to the higher amount of PS containing FA22:6 in the Brain 
[41]. 
  
1.4 Functions of phosphatidylserine 
Although PS is only a quantitatively minor PL in most biological membranes, it is 
required for specific functions in addition to its assumed structural role in membranes. PS 
play important roles in diverse biological processes with emphasis in blood clotting and 
apoptosis. The involvement of this aminophospholipid in signaling pathways is correlated 
with the asymmetric transbilayer distribution. Externalization of PS occurs in apoptotic 
cells, being an important signal in apoptosis and an important modulator of the immune 
response. PS asymmetry has been associated with clinical situations where apoptosis plays 
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a relevant role, like in cancer, chronic autoimmunity, and infections. PS participate both in 
intracellular and extracellular cellular functions, as we will describe latter. 
 
1.4.1 Intracellular functions of PS 
Among intracellular function of PS, a key function is of being the precursor of PE, via 
the mitochondrial enzyme PS decarboxylase (Figure 4) [36,44]. PS is involved in signaling 
pathways such as Raf1 kinase, neutral sphingomyelinase and protein kinase C pathways 
and in localizing intracellular proteins to cytosolic membrane leaflets [36,44]. PS also 
promotes Ca2+-induced membrane fusion events such occur during exocytosis [48,49,50]. 
PS has also important roles in maintaining brain and central nervous system 
homeostasis. PS plays an important role in neuronal modulation and excitability, signal 
transduction and neurotransmitter activity. It is well known its effect in the improvement in 
the NA+/K+-ATPase activity, and its effects in memory recovery [51]. This PL has shown 
to provide many benefits in physical and mental performances, being recognized to 
improve the cerebral function, including attention and memory, especially in elderly 
people [51,52], thus being used as a nutritional supplement. Alteration in PS profile and in 
PS structure (e.g. due to oxidation) have been considered as important players in the 
pathological process in several brain diseases, including depression, neurodegenerative 
diseases, aging and many other neuronal disorders [53,54]. 
Some studies reported other important roles of PS since it increases procollagen 
synthesis and inhibits metalloproteinase-1 induction in both UV-irradiated skin and 
intrinsically aged skin in vivo [55,56]. Due to these beneficial effects in skin, PS is also 
being considered as having therapeutical benefits in the treatment of a variety of cutaneous 
disorders. 
 
1.4.2 Extracellular functions of PS  
PS is normally localized in membrane leaflets that face the cytosol, however, in 
certain physiologically relevant circumstances, PS redistribution from the inner to the outer 
surface of the plasma membrane of mammalian cells can occur. This redistribution to the 
outer surface may initiate and participate in humoral and cellular processes [57]. Cell 
surface localization of PS has been found in erythrocytes and platelets from patients with 
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diabetes mellitus [58,59,60], aging erythrocytes [61], activated platelets, activated 
macrophages, undifferentiated tumor cells and apoptotic cells [48] and also in tumor cells 
[62]. The PS externalization can play a different roles. For example, this process is 
important in the activation of platelets, which is critical for the efficient propagation and 
control of coagulation and thrombosis. In erythrocytes and other cells is also an important 
and necessary signal for apoptotic cell removal by phagocytes [63,64]. 
Translocation of PS to the cell surface has also been shown to occur independently of 
the apoptotic process in the case of tumor cells. In fact, several studies indicated that 
malignant cells showed surface exposure of PS, such as in the case of leukemia and 
neuroblastoma cells [65], malignant melanoma [62,66,67] and gastric carcinoma [68], as 
well as in surface of endothelial cells in tumor blood vessels [69]. In all of these cases no 
apoptotic events occurred. Tumor cells, although exposing PS, seems to find a way around 
apoptosis and prevent the recognition by macrophages [70,71]. The investigators believed 
that PS could serve as uniform marker of tumor cells and metastases as well as a target for 
a novel therapeutic approaches based on membrane-active peptides, since positively 
charged peptides specifically interact with negative charge of PS on their target cell 
membrane [62,65,72]. However, the real role of PS in tumor cell surface are far from being 
completely elucidated. In the next section, we will describe in detail the functions of PS in 
clotting and apoptosis. 
 
PS in blood clotting  
PS is a key signal in the coagulation cascade [57,73]. In normal blood circulation, the 
coagulation factors in plasma do not contact with PS, since PS is absent from the surface 
blood cells and endothelial cells that line the vessel wall. When activated, blood platelets 
expose PS on their outer surface. The exposure of extracellular PS triggers the activation of 
several clotting factors, notably factors V, VIII, X, and prothrombin [57,74,75,76,77,78]. 
The recruitment of these proteins to the surface of platelets is mediated by specialized 
recognition modules, such as discoidin-type C2 or gamma-carboxyglutamic acid domains 
that bind PS with a high degree of selectivity and stereospecificity. The tenase and 
prothrombinase complexes that promote coagulation become fully active only after binding 
PS on the surface of activated platelets [57,76]. 
General Introduction 
29 
In blood platelets from diabetic patients, a 3-7 times enhanced capacity to catalyze 
prothrombinase activity has been observed [79], which is most likely due to increased 
surface exposure of PS. Erythrocytes and platelets from patients with diabetes mellitus 
have been found to exhibit a partial collapse of membrane asymmetry with increased 
surface exposure of PS [58,59,60]. These observations suggest that in diabetic conditions, 
besides a partial loss of PL asymmetry, these events also reflect a destabilization of the 
erythrocyte membranes [48]. 
 
PS in apoptotic cell removal by phagocytes 
During apoptosis the asymmetric transbilayer distribution of PS is lost, bringing PS to 
the surface where it acts as a signal for engulfment by phagocytes [48,80,81,82,83]. 
Several studies showed that apoptotic cells are recognized and phagocytized by 
macrophages through a PS-dependent mechanism, suggesting that externalization of PS is 
the “eat-me” signal that macrophages recognize to initiate the clearance of apoptotic cells 
[48,84,85,86].  
Kagan and colleagues attempted to explain the proper context by which PS is 
recognized as an “eat-me” signal. These investigators pointed out that fatty acyl oxidation 
of PS are a prerequisite for PS externalization and recognition as an apoptotic signal 
[87,88]. APT is responsible for the maintenance of PS in the inner leaflet of the plasma 
membrane [89,90] and the mechanisms for PS exposure on surface of apoptotic cells 
appears to involve the down-regulation of APT [91,92]. Earlier, it was established that 
apoptosis and PS externalization were associated with reactive oxygen species (ROS) 
generation [93,94]. Thus, appearance of PS in outer monolayer of the plasma membrane 
can be related to its oxidation in membrane of apoptotic cells, and that oxPS may fail to be 
recognized by APT, preventing its translocation to the inner leaflet of plasma membrane 
[95,96]. Kagan and co-workers proposed that oxidation of PS preceded its externalization 
during apoptosis [95,97,98,99,100,101] and they found that recognition of the cells with 
externalized PS was strongly facilitated when oxPS was also present on the surface of 
target cells [98]. They also, demonstrated that oxPS exist both within and on the surface of 
apoptotic cells [102]. In Figure 5 it is illustrated the participation of oxPS in its 
externalization and recognition and engulfment of apoptotic cells.  
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Figure 5: Proposed model by Tyurina et al. for participation of oxidized PS in the engulfment of 
apoptotic cells. Extracted from [103]. 
More recently, Greenberg et al. [104] demonstrated macrophage recognition of 
apoptotic cells via CD36 (scavenger receptor in the recognition of apoptotic cells). CD36 
receptors are activated by oxPS, particularly the short chain oxidation products of PS and, 
to a lesser extent, oxidized PC, but not non-oxidized PS molecular species. 
Apoptosis or programmed cell death is a physiological process for orderly removal of 
dead cells in a controlled process where apoptotic cells are rapidly recognized and 
engulfed by phagocytes (e.g. macrophages), resulting in inhibiting inflammatory response 
and being an important step in the resolution of inflammation [105,106]. Phagocytic 
clearance of apoptotic cells is characterized by the active production of anti-inflammatory 
cytokines, such as transforming growth factor β (TGF-β) and interleukin 10 (IL-10), and 
down-modulation of the pro-inflammatory cytokines tumor necrosis factor α (TNF-α) and 
IL-12 that promote an immunosuppressive environment in tissues which is very important 
for the resolution of inflammation [105,106,107]. Several studies showed that PS 
suppresses the formation and release of pro-inflammatory mediators and induces 
production and release of anti-inflammatory cytokines ((TGF-β) and IL-10) from 
macrophages [84,85,106]. Activated phagocytes also regulate inflammation by generating 
reactive nitrogen and oxygen such as NO and superoxide. Studies demonstrated that PS 
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liposomes strongly reduced the LPS-induced release of NO in microglial cultures from 
neonatal rat brain [108,109] and in apoptotic PC12 cells [110]. 
Initially, externalization of non-modified PS has been considered the “eat me” signal 
for apoptotic cell, while nowadays both non modified PS and oxPS are considered active 
players in this process, in spite of the increasing recognition of the importance of oxPS in 
this signaling event. The recognition of externalized PS has occurs, most probably through 
Annexin V due to capacity of PS to bid to protein membranes [111]. The annexins have the 
biological property of binding to PLs in Ca2+-dependent way [111]. It is a natural ligand 
for PS, since annexin V preferentially binds to negative charged PLs. This enables the 
detection of phosphatidylserine exposure on the membrane by flow cytometry analysis 
using the binding of fluorescein isothiocyanatelabeled annexin V [112]. The interaction 
between annexin V and PS only occurs when PS is in the leaflet of the membrane [113]. 
OxPS preserves the negative charge of the polar head, maintaining the availability to bind 
annexin V. Thus Annexin V does not allow to differentiate oxPS from the native PS. 
Consequently, more efforts are needed to develop specific methods that allows the 
distinction among PS and oxPS in cell surface and their specific biological roles. 
1.5 Modifications in phosphatidylserine structure 
As referred, all PLs, including PS, can be modified under oxidative conditions. This 
process can lead to important modifications of their structure and thus, in their properties, 
preventing or modified their role in cells. In addition, modification of PS can impair 
asymmetry of lipid membrane, which can induce the collapse of the lipid membrane. The 
modifications of PS via oxidation are possible due to the presence of the unsaturated fatty 
acyl chain. In these conditions, oxPS, as well as other PLs, can acquire novel biological 
activities, which are distinct from the non-oxidized PLs. These can include the 
participation in several important biological processes such as the immune response, 
inflammation, apoptosis and age-related diseases [114]. Still little is known about the 
relationship between specific oxidation products and distinct biological effects, because 
most of them are formed in low abundance and, in consequence, difficult to isolate and 
identify. Nevertheless, recently, new approaches to this problem using mass spectrometry 
(MS) allowed to obtain new knowledge on the oxidation of PLs, mainly in the oxidation of 
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PC, PE and cardiolipins [115,116,117]. MS has been also used to identify oxPS both in 
vitro and in vivo [118] .  
PS is an amino PL and the presence of a free amino group in PS polar head allows this 
PL of being a target of modifications such as glycation and to form adducts with small 
aldehydes (e.g. hexanoylation). The possible mechanism of modifications that can occur in 
PS structure will be addressed bellow. 
1.5.1 PS oxidation: chemistry and biological effects 
PS is enriched in unsaturated fatty acids, particularly in in brain where the major 
abundant PS molecular species have polyunsaturated fatty acids FA 20:4 and FA 22.6. 
This make PS very prone to be modified under oxidative conditions. There are several 
published works that have studied the PS oxidation and identified new molecular species 
formed during PS oxidation. In these studies, different oxidation processes have been used 
to induce the oxidative stress both in vivo and in vitro, such as 2,2-azobis(2-
amidinopropane) dihydrochloride (AAPH) an azo-initiator [96,119], ɣ-irradiation 
[120,121,122,123] or myeloperoxidase [104]. Depending of the oxidative conditions, 
different types of modifications may occur, so it is important clarify the influence of 
oxidant systems in the PS oxidation process. Oxidation of PLs and also of PS is usually 
mediated by ROS. These species are highly potent oxidants and can cause several 
oxidation reactions associated with disruptions in normal cellular signaling, genetic 
degradation and physiological dysfunction, which can lead to cell death and progressive 
aging in the organism [124]. In biological systems, these disruptions may occur through 
radical reactions involving non-enzymatic (HOO•, HO•, Fe2+, Cu+, radiation) or enzymatic 
systems such as lipoxygenases and myeloperoxidase. 
The hydroxyl radical (HO•) is the most reactive oxygen species generated in living 
systems, being responsible for the oxidation of the generality of biomolecules, including 
PLs. Hydroxyl radicals may be formed by the reaction of hydrogen peroxide and ferrous 
ion (Fe2+) (Fenton reaction) or by other metal catalyzed reactions, from peroxynitrite [125], 
or by high energy irradiation [126]. 
The lipid oxidation induced by the hydroxyl radical is initiated by the abstraction of 
one hydrogen atom from a reactive methyl group (C-H), producing alkyl radicals (R). This 
alteration will promote the reorganization of the adjacent double bonds producing other 
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alkyl radicals. In the presence of oxygen, the alkyl radicals will react to form peroxyl 
radicals (ROO) that in turn, by acquiring one hydrogen atom, will produce a lipid 
hydroperoxide (ROOH). The resulting lipid hydroperoxide may decompose in the presence 
of metal ions, yielding alcoxil (RO) or epoxyperoxyl (OROO) radicals. These species can 
abstract hydrogen atoms from lipids, with formation of hydroxyl and hudroxyperoxyl 
derivatives and the propagation of the lipid peroxidation reaction. This oxidation products 
have higher molecular weight than the non-modified lipid are named long-chain oxidation 
products. But the alkoxyl radicals formed during the oxidative reaction may undergo beta 
cleavage of the fatty acyl chain with formation of oxidation products with shortened fatty 
acyl chain, and with aldehydic or carboxylic terminal function. These products have lower 
molecular weight and are called short-chain PL products (Scheme 1) or truncated species. 
Polyunsaturated fatty acids have bis-allylic hydrogens, which is very reactive in oxidative 
conditions [20,127,128]. 
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Scheme 1: Generation of the oxidation products from 1-palmitoyl-2-linoleoyl-phosphatidylserine 
by radical oxidation. Formation of long chain products (hydroperoxides) and short chain products 
(aldehyde terminal function) 
OxPS molecular species, with oxidative modification in the unsaturated fatty acyl 
chains and with modified polar head were observed in model systems both in vitro and in 
vivo [118,129]. PS hydroperoxy and hydroxy are the most abundant species formed during 
oxidation process, and they have also been detected in several pathological conditions. 
Monitoring by electrospray (ESI)-MS the oxidation of PS induced by AAPH allowed the 
identification of the presence of mono and di-hydroperoxide derivatives of PS in liposomes 
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[96,119]. Richard A. Maki et al. [130] observed through fluorescence high-performance 
liquid chromatography (HPLC) and ESI-MS that phosphatidylserine hydroperoxides (PS-
OOH) were elevated in human Alzheimer disease (AD) brains as compared with non-
demented controls. The PS hydroperoxide and hydroxide have also been identified by MS 
in others pathological conditions, such as in intestinal and lung injury induced by γ-
irradiation [120,121,122,123], in traumatic brain injury after controlled cortical impact 
[131], during apoptosis induced by staurosporine [132] and in cells and tissues after pro-
apoptotic and pro-inflammatory stimuli [133]. The Kagan’s group showed that the pattern 
of PL oxidation during apoptosis is non-random and that PS is one of the preferred 
peroxidation substrates [96]. Greenberg et al. [104], when studying the role of oxPS in 
macrophages, have performed an extensive characterization of PS derived oxidation 
products from synthetic precursor and from apoptotic cell membranes. These studies were 
performed using multiple mass spectrometric approaches and resulted in the identification 
of oxidation products with truncated fatty acyl chain containing carboxylic or aldehyde 
function.  
Several works addressed also the oxidative modification of PS mediated by 
myeloperoxidase (MPO). The MPO is a heme protein secreted by activated phagocytes, 
such as neutrophils, and is the most abundant protein in polymorphonuclear leukocytes. 
MPO reacts with hydrogen peroxide in the presence of chloride and bromide to give 
hypochlorous acid (HOCl) and hypobromous acid (HOBr), which are strong oxidants and 
can oxidize biological molecules by free radical and non-radical pathways [134,135,136]. 
The hypochlorite and hypobromide acids promote the formation of oxidized lipids with 
unique structures, namely as chlorohydrines and bromohydrines, respectively, which can 
decompose to epoxides. Hypochlorite can react with hydrogen peroxide leading to the 
formation of singlet oxygen, which can react with lipids with formation of lipid 
hydroperoxides [137]. MPO mediated oxidation reaction contributes to inactivation and 
elimination of foreign microorganisms as well as to regulation of inflammatory processes 
[138,139]. It is known that MPO can bind to the surface of apoptotic cells on PS containing 
epitopes [140]. Other studies of PS oxidation in the presence of myeloperoxidase (MPO, 
hydrogen peroxide and chloride (MPO-H2O2-Cl
- system), showed the formation of 
phosphatidylglycoaldehyde and phosphatidylglyconitrile derivatives (Figure 6) 
[141,142,143]. HOCl converts α-amino acids via chlorinated amine derivatives to aldehyde 
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and nitrile species. These studies evidenced that in PS not only the fatty acyl chains are 
able to be modified during oxidation but also the polar head group can undergo structural 
modifications. 
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Figure 6: HOCl-induced alterations in PS polar head leading to the formation of aldehyde and 
nitrile species [142]. 
 
1.5.2 Modifications on PS amine group 
The presence of an amine group in PS, as in PE, polar head make this PL reactive 
towards lipid peroxidation products such as small molecules bearing carbonyl groups. 
Recent studies showed that amino groups in the aminophospholipids PE and PS could be 
modified by linoleic and arachidonic hydroperoxides, accompanied by the formation of 
hexanoyl moiety at ε-amino group via amide bond [144]. Shinsuke Hisaka and co-workers 
investigated the N-hexanoyl-PS and N-hexanoyl-PE formation and found that they can be 
detected in vivo. Figure 7 shows the N-hexanoyl-PS structure [145,146].  
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Figure 7: Chemical structure of N-(hexanoyl)phosphatidylserine. 
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Bucala et al. [147] hypothesized that the free amino groups of aminophospholipids are 
also targets for glycation, which expanded the concept of the Maillard reaction into 
biological systems. Glucose can react with the amino group of phosphatidylserine to form 
an unstable Schiff base, which undergoes an Amadori rearrangement to yield the stable 
deoxy-D-fructosyl PS, namely Amadori-PS (Scheme 2).  
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Scheme 2: Scheme for the glycation of phosphatidylserine (PS). Glucose reacts with amino group 
of PS to form a Schiff base, which undergoes an Amadori rearrangement. 
Ravandi et al. also studied the glycation of aminophospholipids, but this in this study 
only glycated PE, but not glycated PS, was detect in human plasma and red blood cell 
membranes [27]. Glycated PE was also detected in LDL (low-density lipoproteins) and 
atheroma [28], and in the human plasma and erythrocytes in diabetic patients 
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[24,25,26,29]. Glycated PS, in contrast, has not been detected in biological samples, but 
was produced in vitro by direct reaction of PS and glucose [148]. 
Glycation is associated with oxidative stress, mainly due to the formation of oxidation 
intermediaries like advanced glycated end products (AGEs) [27,149]. Some studies 
provide evidence that glycated PE promote lipid peroxidation, partly through the 
generation of ROS, which can be related to inflammation and other diabetes complications 
[150,151]. Glycated PEs are more prone to undergo oxidation than non-glycated PE. In 
fact, a recent study from our lab showed that, besides the oxidation of the fatty acyl chain, 
glycated PE also undertake oxidative modification in the glucose moiety, which makes 
glycated PE more prone to oxidation [152]. However, no studies on the glycation and 
glycoxidation of PS and their biological roles have been published. 
Although the effort that has been made, and the analytical advances that MS provided 
in the analysis of oxidized PS, there is still insufficient knowledge on the mechanisms of 
oxidation, on the nature of the oxidized species formed and in the biological roles of each 
specific oxidation products, and clearly, further studies are need in this field. 
 
1.6 Aim of this work  
As mentioned, the oxidation of PS may generate numerous oxidation products and the 
nature of these species may depend of the local and degree of unsaturation, so it is 
important to define exactly which oxidative species are being created, since different 
oxidation products may potentially exert distinct biologic effects. Despite the importance 
of oxidized PS has been recognized, only the primary oxidation products have been 
identified. In addition, no research has been found that surveyed the glycation and 
glycoxidation of PS, and their biological roles. This is still an unexplored field.  
This work will focus on the identification oxidized and glycoxidized PS, contributing 
for the understanding of the biological role of oxidation products of PS as well as of 
glycated PS, in immune and inflammatory responses. To fulfill our goals, the work 
developed in this PhD thesis embraced three main objectives:  
- Characterization of the oxidation products of PS and glycated PS formed under oxidative 
stress by LC-MS and LC-MS/MS.  
- Detection of oxidation products of PS in complex biological environments.  
- Evaluation of the biological effects of oxidized PS on the immune response. 
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The global strategy used in this work for the structural characterization of oxidation 
products of PS (oxPS) and glycated PS (oxgluPS), and to detected these species in cell 
extracts was based on the application of mass spectrometric approaches that were either 
available or were developed in the course of this thesis.  
The oxidation products were analyzed directly by electrospray mass spectrometry 
(ESI-MS) or/and by high performance liquid chromatography (HPLC) coupled on line to 
MS (LC-MS) or by off line thin layer chromatography- MS (TLC-MS). TLC and HPLC 
are key techniques used for the separation of different types of oxidation products within 
one PL class, allowing also the separation of PLs classes in extracts obtained from 
biological samples. The developed methodologies allowed the identification of the 
structural features of oxPS and oxgluPS, to identify specific fragmentation pathways of 
each product and to propose targeted lipidomic approaches to detect these products in 
biological environments. The evaluation of anti/pro-inflammatory activities of PS and 
oxidized PS also was also performed through the analysis of NO production by 
macrophages and macrophages stimulated by lipopolysaccharide (LPS). 
The global strategy used in this work for the structural characterization of oxidation 
products of PS and glycated PS, comprised an initial step of glycation of PS, followed by 
the in vitro oxidation of the PSs and the identification of the oxidation products and 
determination of their activity is illustrated in Scheme 3. The developed methodologies 
allowed the detection of oxPS in cell extracts.  
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Scheme 3: The flowchart representing analytical approach of this work. The PS standard used in 
this work were: 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-L-serine (POPS), 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine 
(DPPS) and 1-palmitoyl-2-arachidonoyl-sn-glycero-3phospho-L-serine (PAPS). 
2.1. Synthesis of glycated phosphatidylserine 
As referred previously, at the present there are no reports on the glycation of PS in 
vivo, although its formation is hypothesized [147]. In the present study, different solutions 
were tested in order to obtained high yield of glycated PS. Best results were obtained when 
PS was solubilized in methanol, and in the absence of water. The glucose and PLs were 
dissolved in absolute methanol in a proportion of 4:1 (glucose (20mM): phospholipid 
(5mM)) [25,148]. The final solution was left to react in boiling water during 15 min. 
In this conditions, glucose reacts with the amino group of phosphatidylserine to form 
an unstable Schiff base, which undergoes an Amadori rearrangement to yield the stable 
deoxy-D-fructosyl PS, namely Amadori-PS as was showed in Scheme 3 (section 1.6.2). 
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2.2. Oxidation of PS and glycated PS 
Oxidation of PS and glycated PS can be induced by different oxidant systems, either 
enzymatic or non-enzymatic. The study of the fragmentation pattern of non-glycated PS 
and glycated PS oxidation products is most useful for the identification of mass 
spectrometry characteristic fragmentation pathways that can be used targeted identification 
of PS glycoxidation products in complex samples. 
One the most important in vivo oxidant agent is the hydroxyl radical, usually generated 
by the Fenton reaction, where iron ions (Fe2+) react with hydrogen peroxide (H2O2) [153] 
(Scheme 4).  
In this study, oxidation of different species of PS and glycated PS was performed 
using the hydroxyl radical generated by the Fenton reaction, by incubating PS and gluPS at 
37 ºC with H2O2 (10 mM) and FeCl2 (40 μM). 
 
Fe2+ + H2O2 → Fe3+ +·OH + OH- 
Scheme 4: Formation of hydroxyl radical by Fenton reaction. 
AAPH is a water-soluble azo-initiator which generates peroxyl radicals (Scheme 5) at 
a constant rate and at a given temperature by thermal decomposition [154] which is 
independent of the cellular metabolism. The AAPH peroxyl radical intermediate is the 
reactive oxygen species responsible for the oxidation of biomolecules such as lipids, 
peptides and proteins. Azo compounds have been used successfully as radical initiators and 
it is suitable for studying oxidation in aqueous solutions [155]. Thus, AAPH is a water-
soluble azo-initiator is frequently used for oxidation studies in in vitro model systems 
[156].  
In this work this oxidative system was used to induce oxidation in POPS standard and 
in the immortal human keratinocyte line HaCaT. Two different concentration of AAPH 
were used (30 mM and 50 mM).  
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Scheme 5: Decomposition of AAPH produces molecular nitrogen and two carbon centered 
radicals. The carbon radicals may react with molecular oxygen to give peroxyl radicals. 
UVA radiation (320-400 nm) is the most prominent component of terrestrial UV 
radiation-contributing in 90-95%. The exposure to UVA radiation causes toxic effects in 
cells, DNA lesions, mutagenesis and carcinogenesis, representing a known factor for the 
development of malignant melanoma and leading to aging of the skin [157,158]. The 
exposure to UVA can also lead to the formation of reactive radical oxygen species that 
further can trigger damage to biomolecules including lipids [159]. Among the ROS, UVA 
preferentially yield singlet oxygen (1O2), that is well-known as a strong oxidant, highly 
reactive towards electron-rich organic molecules, such as PUFA. UVA can also trigger the 
formation of hydroxyl radical, already reported as an oxidant agent, able to modify lipids. 
Overall, UVA may induce photooxidation of molecules via two distinct reactions: type I 
reactions, which involve the formation of free radicals, and type II reactions, which involve 
energy transfer and singlet oxygen generation (Scheme 6).  
The UVA exposure biological effects and impact on photo-carcinogenesis and tumor 
progression has been receiving increasing attention [160,161,162]. In this work the PL 
response was evaluate in UVA-irradiated SK-MEL-28 cells (malignant melanoma cell 
line). The PLs and fatty acids were analyzed immediately after irradiation (total light dose 
60 J/cm2) and after 2 h and 24 h of irradiation (the cells after irradiation were re-incubated 
at 37 ºC during 2 h and 24 h). 
 
 
Scheme 6: Mechanisms of UVA-induced photooxidation. Photochemical reactions begin with 
photosensitizer (1S) and its activation to a singlet excited state (1S*) rapidly converted to excited 
triplet state (3S*), which can follow two distinct pathways: type I – Charge transfer to oxygen (3O2) 
produces superoxide radical anions (O2•-), which could produce hydrogen peroxide (H2O2) through 
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dismutation and, finally, hydroxyl radicals (HO•). Type II – A photosensitizer in an excited triplet 
state could suffer energy transfer to oxygen, producing singlet oxygen (1O2) [163]. 
 
2.3 Analytical approaches used in this work 
PS and oxPS are biomolecules of huge interest due to its role in the regulation of 
macrophage-dependent clearance of apoptotic cells. In particular, the recent findings that 
oxidized PS is key player in these processes, revealed that it is needed a more deep 
understanding of the chemistry of oxPS and also to develop sensitive methods that allows 
the identification and quantification of oxPS in biological samples.  
MS is the method usually used in the analysis of lipids in biological sample, due to its 
high sensitivity and is also becoming increasingly important in PL oxidation research 
[118]. MS has been used with success for the identification of oxidation products of PC 
[20,127,164,165], and in small extent to PE [152,166], PS [132,133,142] and CL 
[115,116,132,133,167]. Previous works in our laboratory showed that tandem mass 
spectrometry (MS/MS) alone or coupled with liquid chromatography (LC-MS/MS) allows 
the identification of huge number of oxidation products of PC, PE, glycated PE and CL. 
This research is the basis for their sensitive identification in biological samples using a 
lipidomic approach [20,115,152,164,166,168]. Accordingly, MS was the main method 
used for the analysis and monitoring of the PS oxidation although, so far, the published 
work regarding this issue is limited. 
The lipidomic approach for the study of lipids from biological samples, usually 
involve several steps, beginning with the extraction of lipids from biofluids, tissues or 
cells, additional analyses of the lipid profile through MS with or without chromatographic 
separation (Figure 8). This methodology is also applied in the analysis of lipid oxidation 
products that are generated in in vivo conditions. 
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Figure 8: The lipidomic approach comprise a few experimental steps: first lipids are extract from 
tissues or cells and then are analyzed through MS with or without previous separation. 
2.3.1 Lipid extraction 
The general procedures for lipid extraction either from liposomes or cells, tissues or 
biofluids used organic solvents, and the most used methods differ on the type of organic 
solvents, the number and proportion of the different organic solvents used. Traditionally 
chloroform – methanol – water mixture is the most common used approach. There are two 
main extraction protocols using this solvent mixture: one described by Folch et al in 1957 
[169] and other described by Blight and Dyer in 1959 [170]. The difference between these 
two methods is the proportion between chloroform and methanol: the Folch method uses 
CHCl3/CH3OH (2:1) while Blight and Dyer method use CHCl3/CH3OH (1:2). The basic 
principle of these two methods is that initially a mixture of chloroform and methanol is 
added in the sample creating a mono-phase system that extracts the lipids from the sample 
matrix. Then an amount of water is added to produce a biphasic system: the chloroform 
layer that contains lipids and methanol –water layer with the non-lipid components. 
Chloroform dissolves fat, methanol allows to breaks down the lipid protein bonds and 
inactivates the lipases, while water washes the non-lipid compounds.  
After lipid extraction, two different approaches can be used: separation of lipid 
extracts in different classes by thin layer chromatography or high performed liquid 
chromatography before their analysis by MS; or direct analysis of the total lipid extract by 
MS through a direct infusion (shotgun lipidomics). 
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2.3.2 Lipid separation  
The separation of separation of lipid extracts using chromatographic techniques have 
been extensively used and provide huge advantages in the lipid analysis. The most 
commonly used in lipid analysis are the gas chromatographic (GC), TLC and LC. 
Nowadays, the GC is frequently used in fatty acid analysis. The TLC and LC techniques 
are commonly used to separate different lipid classes before their analysis. Some 
researchers combine both techniques when analyzing PL: first, TLC is used to separate the 
different PL classes; and then each class is analyzed by LC-MS. This method is often used 
to assess phospholipid hydroperoxides [121,133]. 
Gas chromatography  
GC has been used as a method for analyzing lipids and is usually coupled to MS (GC-
MS) or with flame-ionization detection (GC-FID). To analyze and quantify the fatty acids 
by GC they need to be modified in order to be volatile. Thus, chemical derivatization is 
required. Evaluation of the PLs fatty acyl profile is usually performed by  transmethylation 
in the presence of alkaline or acid catalyst, with further analysis of the fatty acids methyl 
esters (FAME) [171]. BF3, HCl and H2SO4 are the most common used  acid catalysts to 
perform acid-catalyzed transesterification, usually in methanol to generate FAME of FA 
esterified to triacylglycerol’s and PLs. The most common base used  as a catalyst is 
CH3NaO, but it does not  allow the esterification of free fatty acids [172]. 
Transmethylation of esterified fatty acids can be easily performed at room temperature 
using methanolic KOH 2M, and, due to its simplicity, is one of the most used methods for 
FAME analysis, and was used during our lipidomic studies [171,173,174]. In this work, 
GC-MS of FAME obtained from the lipid extracts of melanoma cell lines after UVA 
exposure. The FAMEs were separated based on their polarities and molecular weights. 
Thin layer chromatography 
TLC is the oldest technique used for lipid separation and fractionation and is still 
widely used nowadays [175]. The mainly advantages of the TLC are the ability to obtain a 
rapid screening of the samples and it does not required a sophisticate equipment to separate 
lipids with different polarities. The major disadvantages are the low resolution and 
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sensitivity of the technique [175,176]. Several research groups have used TLC (one and 
two-dimensional) and MS in lipidomics, as reviewed in [177]. This technique also has 
been applied in PS oxidation studies by Tyurin et al., who used two-dimensional TLC in 
the identification of PS hydroperoxy- and hydroxy- derivatives [121,122,123,132,133]. 
Lipids are usually separated by TLC using silica as the stationary phase (designed 
normal phase TLC). When using adequate mixture of solvents it is possible to separate and 
subsequently quantify the different lipid classes [175,176,177]. For example, it is possible 
to separate the nonpolar lipids (triglycerides, free fatty acids, cholesterol and 
diacylglycerols) from the more complex lipids, like PLs, with an elution system containing 
ethyl ether and hexane [176]. For the separation of PL classes it is necessary a different 
elution system, such as, for example, a mixture of chloroform, ethanol, water and 
triethylamine [176]. In this, case the separation of PL classes reflects the differences in 
polarity of the polar head of PLs.  
In this work, TLC was used to separate phospholipid classes from cell extracts and to 
fractionate the oxidation products of PS and glycated PS. Separation of oxPS can be 
achieved, particularly if oxidative modifications occur in serine polar head, changing 
substantially the polarity of molecule. For that, we used silica gel 60 plates from Merck, 
with a concentrating zone of 2.5×20 cm, as the stationary phase. The polar groups of PS 
and resulting from oxidation interact strongly with the surface of the gel particle. For silica 
gel chromatography, the mobile phase we used was a mixture of organic solvents: 
chloroform/ethanol/water/triethylamine (30:35:7:35, vol/vol/vol/vol). 
The visualization of PLs in a TLC plate requires the use of visualization reagents, 
such as primule, a non-destructive dye specific for lipid visualization. The analysis of PLs 
can be performed on the TLC plate by observation of the intensity of the spots after UV 
irradiation, and is based on the fluorescent properties of primuline. Other revelation 
methods can be used including iodine vapor, ninhydrin and water. Ninhydrin is normally 
used to detect ammonia or primary and secondary amines. After visualization of the spots, 
the identification is based on the comparison with migration of lipid standards applied to 
the same TLC plate, and /or by the identification using MS analysis of the lipids. The 
relative quantification of PL classes can be achieved by the quantification of phosphate 
present in each spot, by measuring the phosphorous amount in each spot. 
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High-performance liquid chromatography  
Several HPLC methods have been developed for the separation and quantitation of 
PLs. These methods have shown to be sensitive and to provide reliable measurements of 
tissue PLs [178,179]. HPLC analysis of PLs can be performed either using normal phase or 
reverse phase columns [180,181]. Normal phase chromatography effectively separates 
different PLs class [182,183], whereas reverse phase effectively separates PL on the basis 
of fatty acid residues [184]. Oxidized PL species can be separated from the non-oxidized 
congeners by reversed-phase chromatography, due to the distinct polarity caused by the 
position and number of oxygen atoms in the molecule of PL oxidation products 
[165,166,185]. Hydrophilic Interaction Chromatography (HILIC) is also used to separate 
PL classes. The HILIC chromatography uses hydrophilic stationary phases with reverse-
phase eluents. This is an advantage comparing with normal phase, since it is possible 
separate PL classes very well similar normal phase chromatography, but using more 
appropriate solvents for MS analysis [186], such as methanol and acetonitrile. The HILIC 
methods also demonstrated excellent reproducibility [186]. Nowadays, HPLC is usually 
coupled with MS (HPLC-MS) as detection and identification method. This instrumental 
combination opened up completely new analytical perspectives in lipid research by 
combining the separation power of HPLC with selectivity and sensitivity of MS.  
In this work, we have used reversed-phase HPLC, coupled to the MS, for the 
identification and characterization of the oxidation products from PAPS, glycated PAPS, 
POPS, glycated POPS and PLPS. Different elution systems were used: one to separate and 
identify oxidation products from PAPS and glycated PAPS (more details chapter IV.I) and 
another to separate and identify oxidation products from POPS and glycated POPS (more 
details chapter IV.II). HILIC-MS and MS/MS were the methods used to analyze the 
variation of phospholipid profile from melanoma cell lines when exposed to UVA (more 
details chapter VI). 
2.3.3 Mass spectrometry 
MS is the method usually used for the analysis of the lipid profile in biological sample 
and in the study of PL oxidation research, due to its high sensitivity and capability of 
identifying compounds [118]. MS-based methods measure the mass of electrically charged 
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molecules. In the analysis of the PLs and PL oxidation products, ESI is the most 
commonly used ionization source [118]. Phospholipids can form positive and/or negatively 
charged molecular ions depending on the structure of the polar head group. Usually PC, 
SM, PE and PS ionize by the uptake of a proton, and thus being identified as [M+H]+ ions, 
while PE, PS, PI, PG and CL ionize preferentially with formation of negative ions [M-H]-. 
Although PS can be protonated, it is usually analyzed in the negative ion mode, by the 
identification of deprotonated ion [M-H]- [187]. To obtain more information about the 
molecular structure it is necessary to proceed to the study of fragmentation of selected 
molecular ions, in a methodology called tandem mass spectrometry (MS/MS). Information 
gathered from MS/MS data and the identified typical fragmentation pathways allows to 
draw several conclusions about the structure of the analyzed phospholipids, including the 
identification of the polar head group, the identification of the fatty acyl chains and their 
location at sn-1 versus sn-2 positions [7]. 
Product ion scanning tandem mass spectrometry is one of the MS/MS approach’s and 
is based in the isolation of a specific ion with a selected m/z value, which is induced to 
dissociate, usually by collision with an inert gas, to produce products ions with lower mass. 
Typically MS/MS involves multisteps, initiated with the isolation of the selected ion, 
performed by a first analyzer, followed by fragmentation in the collision cell and then the 
fragmented ions, called product ions, are separated based on their m/z value by the last 
analyzer (Figure 9). However some instruments (e.g. linear ion trap) with just one analyzer 
are able to perform multiple stage tandem mass spectrometry (MSn). A multi analyzer mass 
spectrometer, such as a triple quadrupole (QqQ) and a Qtrap can also perform other 
MS/MS scanning modes, such as precursor ion scanning (PIS) and neutral loss scanning 
(NLS). The tandem mass spectrometry has been widely used in the structural 
characterization of molecules, including PLs and also of oxidation products of PLs 
[7,10,188,189,190,191,192]. In the present work, several mass spectrometers coupled to 
electrospray ionization sources were used, namely an electrospray Q-TOF, a linear ion trap 
and a Q-trap. 
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Figure 9: Scheme of tandem mass spectrometry (MS/MS). The sample injected into the mass 
spectrometer is ionized by electrospray (ESI) or matrix assisted laser desorption ionization 
(MALDI) and analyzed (MS), then a selected ion is fragmented by collision induced dissociation 
(CID) and analyzed in a second analyzer (MS/MS) the fragment ions are collected in a detector and 
the result is a spectrum of the fragment ions. 
The presence of specific fragmentation patterns characteristic of each PL class, has 
turned PIS and NLS on powerful techniques for the identification and quantification of PL. 
The PIS and NLS modes allow targeted detection of PL polar head groups and the 
identification of PLs containing hydroperoxides in complex mixtures, as well as the 
detection of some individual oxidation products by their specific fragmentation patterns 
[193]. The analysis by PIS is based on a specific fragment ion exclusive to a particular 
class of PL. For example, PIS for ions at m/z 184 specifically detects PC, LysoPC and SM, 
while PIS for ions at m/z 241 allows detecting PI and LysoPI [193]. The NLS is based on 
identification of a neutral loss which is exclusive to a particular class of PL. For example 
the analysis of PS in negative ion mode can be screened by NLS of the specific neutral loss 
of 87 Da (loss of aziridine-2-carboxylic acid) [192,193,194].  PIS and NLS can be 
performed by direct infusion of the sample in the ESI source without prior separation or 
coupled with HPLC. The advantage of the former approach, usually called shotgun 
lipidomics, is the rapid processing of the samples with reproducibility and accuracy. 
However, this approach has the disadvantage of occurring ion suppression, a process that 
can be avoid using LC-MS [175]. Multiple reaction monitoring (MRM) approach, usually 
performed in triple quadruple spectrometers, is a target MS analysis that screen a specific 
parent ion/fragment ion pairs. This MS/MS mode is commonly used to quantify 
compounds, usually using the addition of an internal standard per PL class. 
Tandem mass spectrometry has been widely used in the structural characterization of 
molecules including PLs and also of oxidation products of PLs 
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[7,10,188,189,190,191,192]. In the present work, several mass spectrometers coupled to 
electrospray ionization sources were used, namely an electrospray Q-TOF, a linear ion trap 
and a Q-trap. The linear ion trap coupled to HPLC, was widely used throughout this work, 
to monitor PS oxidation, and to identify specific fragmentation pathways of each oxidation 
and glycation products. The Q-TOF spectrometer and matrix-assisted laser desorption 
ionization (MALDI)-TOF-TOF were used to perform exact mass measurements of the new 
products identified. Targeted lipidomics was performed in this work using a QTrap 
spectrometer. NLS (of 58 Da) and PIS (for ions at m/z 137) specific of fragmentation 
patterns of newly identified PS oxidation products allowed to detect these type oxidation 
products in total lipid extracts from keratinocytes treated with AAPH to induce oxidative 
stress. 
2.4. Evaluation of the anti/pro-inflammatory activity of PS and oxPS 
Few published works reported the evaluation of the anti-inflammatory activity of PS 
and the information regarding oxPS is scarce, despite the increasing reports about oxPS 
exposure on surface of apoptotic cells and their possible role in the resolution of 
inflammation. Thus it is important to determine whether the exposure on the surface of 
apoptotic cells of oxidized PS and/or non-oxidized PS differentially modulates the 
functional responses in macrophages and if these events have anti or pro inflammatory 
effects. So, in an attempted to discover if PS and oxPS differently modulate a response in 
macrophages, we have evaluated the effect of these species in macrophage and LPS-
induced macrophage activation response and the possible activation of intracellular 
signaling pathways. The pro inflammatory activity of PS and oxPS was evaluated by 
measuring the nitric oxide (NO) production by raw 264.7 macrophages incubated with 
PLPS and oxPLPS. To evaluate the anti-inflammatory properties of oxPS and PS, the 
macrophages were activated by LPS and co incubated with PS and oxPS. iNOS expression 
was also evaluated in the same conditions, as well as IL-1β by Real-time reverse 
transcription polymerase chain reaction (RT-PCR) analysis. In an attempt to elucidate the 
mechanism of the inhibition, MAPKs and NF-kB activation/inhibition were studied using 
Western blot analysis (Scheme 7). 
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Scheme 7: Experimental design used to evaluate the pro- and anti- inflammatory properties of 
PLPS and oxPLPS through NO production. The pro-inflammatory properties were evaluated in 
non-activated macrophages and the anti-inflammatory in activated macrophages by LPS 
The production of NO was measured by the accumulation of nitrite in the culture 
supernatants, using colorimetric reaction with Griess reagent [195] in macrophages and in 
lipopolysaccharide (LPS)-stimulated macrophages cell lines. LPS is in this context an 
endotoxin, which stimulates the production of pro-inflammatory mediators such as NO that 
is associated with the expression iNOS expression. A reduction in NO production indicate 
the potential of the PLPS and oxPLPS to attenuate an inflammatory response (the 
experimental details will be described in Chapter VIII) 
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Structural characterization of oxidized glycerophosphatidylserine: evidence of 
polar head oxidation 
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3.1 Abstract 
Non-oxidized phosphatidylserine (PS) is known to play a key role in apoptosis but 
there is considerable research evidence suggesting that oxidized PS also plays a role in this 
event leading to the increasing interest in studying PS oxidative modifications. In this 
work, different PS (1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS), and 1,2-dipalmitoyl-sn-
glycero-3-phospho-L-serine (DPPS) were oxidized in vitro by hydroxyl radical, generated 
under Fenton reaction conditions, and the reactions were monitored by ESI-MS in negative 
mode. Oxidation products were then fractionated by thin layer chromatography (TLC) and 
characterized by tandem mass spectrometry (MS/MS). This approach allowed the 
identification of hydroxyl, peroxy, and keto derivatives due to oxidation of unsaturated 
fatty acyl chains. Oxidation products due to oxidation of serine polar head were also 
identified. These products, with lower molecular weight than the non-modified PS, were 
identified as [M-29-H]– (terminal acetic acid), [M-30-H]– (terminal acetamide), [M -13-H]– 
(terminal hydroperoxyacetaldehyde), and [M-13-H]– (terminal hydroxyacetaldehyde plus 
hydroxy fatty acyl chain). Phosphatidic acid was also formed in these conditions. These 
findings confirm the oxidation of the serine polar head induced by the hydroxyl radical. 
The identification of these modifications may be a valuable tool to evaluate 
phosphatidylserine alteration under physiopathologic conditions and also to help 
understand the biological role of phosphatidylserine oxidation in the apoptotic process and 
other biological functions. 
 
Keywords: Phosphatidylserine, Oxidation, Hydroxyl radical, Electrospray, Mass 
spectrometry 
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3.2. Introduction 
Phospholipids are prone to oxidative modifications, generating a variety of oxidized 
products, mainly due to the modification of unsaturated fatty acyl chains [196]. Depending 
on the predominating oxidative process, different PLs oxidation products can be observed 
[197]. It is thought that oxidized PLs may have new biological properties, participating in 
various biological processes such as the immune response, inflammation, apoptosis, and 
age-related diseases [197]. However, little is known about the relationship between 
specific oxidation products and their biological effects. 
Hydroxy and hydroperoxy phospholipid species were identified in several 
pathological conditions [121,131,132,133,198]. Kagan and co-workers showed that the 
pattern of phospholipid oxidation during apoptosis is non-random and that PS is one of the 
preferred peroxidation substrates [96]. The mass spectrometry has been used in the 
identification these PS oxidation products [118,192,194,199,200]. 
Although several studied the role of PS oxidation products in inflammation and 
apoptosis, there is still insufficient data on the mechanisms of oxidation and on the nature 
of the oxidized species formed. The objective of this research is to evaluate the molecular 
changes induced in phosphatidylserines due to oxidation induced by hydroxyl radical, 
focusing on the oxidation products resulting from oxidation of the polar head. The serine 
head group of this phospholipid resembles in its structure an α-amino acid, that are known 
to be prone to oxidation. Studies with myeloperoxidase (MPO), that produce hypoclorous 
acid (HOCl) in the presence of hydrogen peroxide and chloride, shows the formation of 
phosphatidylglycoaldehyde as product of reaction of the MPO-H2O2-Cl
- system with PS 
[141,142,143] and phosphatidylglyconitrile [141,142]. HOCl converts α-amino acids via 
chlorinated amine derivatives to aldehyde and nitrile species.  
In order to know if oxidative modification can occur in the serine polar head, different 
PS species were subjected to oxidation induced by the hydroxyl radical generated under 
Fenton reaction (H2O2/Fe
2+) conditions and the oxidation products were subsequently 
separated by thin layer chromatography (TLC) and analyzed by electrospray (ESI), mass 
spectrometry (MS), and tandem mass spectrometry (MS/MS). 
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3.3. Experimental 
 
Materials 
1-Palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-L-serine (POPS), 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine 
(DPPS), and phosphatidic acid were obtained from Avanti Polar Lipids, Inc. (Alabaster, 
AI, USA) and used without further purification. FeCl2, EDTA and H2O2 (30%, w/w) were 
acquired fromMerck (Darmstadt, Germany). Triethylamine (Acros Organics, Geel, 
Belgium), chloroform (HPLC grade), methanol (HPLC grade) and ethanol absolute 
(Panreac) were used without further purification. TLC silica gel 60 plates with 
concentrating zone (2.5×20 cm) were purchased from Merck. 
 
Oxidation of Phosphatidylserine by Fenton Reaction  
Ammonium hydrogen carbonate buffer (5 mM, pH 7.4) was added to 1 mg of 
phospholipid  was vortex-mixed and sonicated for the formation of vesicles. Oxidative 
treatments using Fe (II) and H2O2 were carried out by adding 40 μM FeCl2/EDTA (1:1) 
and 10 mM of H2O2 to total a volume of 500 μL of solution. The mixture was left to react 
at 37 °C in the dark for several days with agitation. Controls were performed by replacing 
H2O2 with water and without H2O2 and Fe
2+. 
 
ESI-MS Conditions (Linear Ion Trap) 
The extent of oxidation was monitored by electrospray mass spectrometry in a linear 
ion trap mass spectrometer LXQ (ThermoFinnigan, San Jose, CA, USA). The LXQ linear 
ion trap mass spectrometer was operated in negative mode. ESI conditions were as follows: 
electrospray voltage was 4.7 kV; capillary temperature was 275 °C, and the sheath gas 
flow was 25 U. An isolation width of 0.5 Da was used with a 30 ms activation time for 
MS/MS experiments. Full scan MS spectra and MS/MS spectra were acquired with a 50 
ms and 200 ms maximum ionization time, respectively. For MS/MS experiments, 
normalized collision energy (CE) was applied in the range of 17 to 20 (arbitrary units) for 
MS/MS. Data acquisition was carried out on an Xcalibur data system (ver. 2.0). 
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Exact Mass Measurement and Elemental Composition 
Identification of the oxidation product ions corresponding to the oxidation in the polar 
head group was confirmed by exact mass measurement and elemental composition 
determination in a MALDI-TOF/TOF mass spectrometer. Elemental composition of the 
ion at m/z 721.5 (observed for DPPS) was confirmed by exact mass measurement and 
elemental composition determination using a ESI-Q-TOF2 mass spectrometer due to the 
presence of a contaminate with the same m/z value in the MALDI-MS spectrum. 
 
MALDI-MS Conditions 
MALDI mass spectra were acquired using a MALDI-TOF/TOF Applied Biosystems 
4800 Proteomics Analyzer (Applied Biosystems, Framingham, MA, USA) instrument 
equipped with a nitrogen laser emitting at 337 nm and operating in a reflectron mode. Full 
scan mass spectra ranging from m/z 650 to 4000 were acquired in the negative mode. All 
spectra were acquired with 2,5-dihydroxybenzoic acid (DHB) matrix. The matrix solution 
was prepared by dissolving 10 mg of DHB in a 1 mL mixture of methanol: aqueous (1:1, 
vol/vol). For the accurate mass measurements, the lock mass in each mass spectrum was 
the calculated monoisotopic mass/charge of the non-modified phosphatidylserine and 1-
palmitoyl-2-oleoyl-phosphatidylethanolamine as internal standard. 
 
ESI-MS Conditions (ESI-Q-TOF2) 
For the analysis in the ESI-QTOF2 instrument (Micromass, Manchester, UK), the 
flow rate was 10 μL min–1, the needle voltage was set at 3 kV, the cone voltage at 30 V, 
the ion source set at 80 °C, and the desolvation temperature at 150 °C. Mass spectra were 
averaged for 1 min. For the accurate mass measurements, the lock mass in each mass 
spectrum was the calculated monoisotopic mass/charge of the native phospholipid (non-
modified phospholipid). 
 
Separation of Oxidation Products of PS by Thin Layer Chromatography 
The oxidation products were separated by thin layer chromatography (TLC) using 
silica gel 60 plates with concentrating zone 2.5×20 cm (Merck KGaA). Prior to separation, 
plates were treated with boric acid 2.3% in ethanol. The plates were developed with 
solvent mixture chloroform/ethanol/water/triethylamine (30:35:7:35, vol/vol/ vol/vol). 
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Lipid spots on TLC plates were observed by exposure to primuline. The TLC spots 
identified as oxidized PS were scraped from the plates and extracted using 
chloroform/methanol (2:1, vol/vol). The oxidation products separated by thin layer 
chromatography (TLC) were analyzed by electrospray (ESI), mass spectrometry (MS), and 
tandem mass spectrometry (MS/MS). 
 
3.4. Results and Discussion 
This work focuses on the ESI-MS analysis of PS that was submitted to oxidation 
induced by the hydroxyl radical generated under Fenton reaction (H2O2/Fe
2+). Selected PS 
were dipalmitoyl-phosphatidylserine (DPPS; C16:0/C16:0; m/z [M–H]–=734), 1-palmitoyl-
2-oleoyl-phosphatidylserine (POPS; C16:0/C18:1; m/z [M–H]– =758), and the 1- 
palmitoyl-2-linoleoyl phosphatidylserine (PLPS; C16:0/ C18:2; m/z [M–H]– =756) (Figure 
10). Since DPPS contains saturated acyl chains, it is considered as a model for studying 
oxidation of the phospholipid polar head [196]. 
 
Figure 10: Molecular structures of PLPS, POPS and DPPS 
Comparing the ESI-MS spectra of the three PS obtained before and after oxidation 
(Figure 11), new ions can be observed. These ions correspond to the [M–H]– molecular 
ions of oxidation products. The ESI-MS spectra of PLPS (Figure 11a), acquired after 
exposure to oxidative conditions, show a larger number of new molecular ions. This is due 
to the presence in this molecule of two double bonds in the sn-2 fatty acyl chain, increasing 
the number of possible oxidation sites. Lower number of ions were observed for POPS 
(Figure 11c) and even lower for DPPS (Figure 11e). In the spectra of oxPLPS and 
oxPOPS, some oxidation products can be observed at higher m/z values than the non-
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modified PS, corresponding to the oxidation products with insertion of oxygen atoms as 
hydroperoxides ([M–H+2O]–), hydroxide ([M–H+O]–), and keto ([M–H+O–2 Da]–) 
derivatives. These oxidation products will be briefly discussed in this work since they have 
already been described and fully characterized [87,132,201]. 
 
Figure 11: ESI-MS spectra of PLPS (a), (b), POPS (c), (d) and DPPS (e), (f). Spectra a, c, and e 
were acquired after exposing samples to oxidative stress. Spectra b, d, and f were acquired from 
control samples 
In the spectrum obtained after oxidation of the PLPS (Figure 11a) we can observe new 
ions at m/z 666 and 682 (666 Da+16 Da), with lower m/z than the non-modified PLPS. 
These ions correspond to oxidation products with shortened acyl chain at C9 and a 
carboxylic acid terminal. Short chain oxidation products originated from cleavage of fatty 
acyl chains have been described for PS [201] and have been studied in 
phosphatidylcholine, phosphatidylserine, and cardiolipin phospholipids [116,127,166]. The 
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shortened oxidation products are generated after abstraction of the bis-allylic hydrogen 
atoms by the hydroxyl radical, which through a β- scission mechanism, break down to 
short-chain phospholipid products with terminal aldehydic or carboxylic acid functions. As 
reviewed elsewhere, these are well known products of lipid peroxidation [165,202]. No 
short chain oxidation products were formed during POPS oxidation, similar to previously 
observed POPC oxidation, using the same oxidative conditions [165].  
There are other ions observed at lower m/z than the non-modified PS in MS spectra of 
oxidized PLPS, POPS, and DPPS (Figure 11a, c, and e), which were not assigned as short 
chain compounds. These oxidation products, with less 29, 30, and 13 Da compared with 
the native PS, occur due to oxidative modification in PS polar head, as confirmed by 
separation using thin layer chromatography (TLC) (Figure 12), and analysis by tandem 
mass spectrometry will be described latter. Elemental composition determination for the 
ions with less 29 Da (for DPPS: C37H70O10P, error 18.7 ppm; for POPS C39H72O10P, error 
27.8 ppm, for PLPS C39H70O10P, error −15.4 ppm), with less 30 Da (for DPPS, 
C37H71NO9P error 10.3 ppm; for POPS C39H73NO9P, error −1.3 ppm; for PLPS 
C39H71NO9P error −32.1 ppm), and with less 13 Da (for DPPS C37H70O11P error −9.9 ppm; 
for POPS C39H72O11P error 20.9 ppm) confirmed the modification of serine polar head. 
Mass spectrometry analysis, in positive mode, of these oxidized PS, showed molecular 
ions that correspond to the same oxidation products, but observed as low abundant 
[M+H]+, [M+Na]+, and [M–H+2Na]+ ions (data not shown). However, the oxidation 
product resulting from loss of 29 Da was not observed. We propose that this oxidation 
product contains a carboxylic acid group polar head, as will be described latter, forming, 
preferentially, negative ions. To better characterize these new oxidation products, they 
were further analyzed by TLC, MS, and MS/MS in negative mode. 
Phosphatidylserine Oxidation in Fatty Acyl Chains – Analysis by ESI-MS/MS 
Hydroperoxide and hydroxide derivatives are primary oxidation products of lipids and 
phospholipids, and occur during PLPS and POPS oxidation. DPPS does not yield these 
oxidation products because it has two saturated fatty acyl chains that do not oxidize  [196]. 
ESI-MS/MS spectra of PLPS and POPS oxidation products show formation of hydroxy 
[M–H+O]–, keto [M–H+O–2 Da]–, peroxy [M–H+2O]–, and hydroxy peroxy [M–H+3O]– 
derivatives, as summarized in Table 1. In all these MS/MS spectra, we can observe a major 
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product ion formed by loss of 87 Da, due to loss of phospholipid polar head. This is an 
abundant loss, typical of PS [194]. MS/MS analysis (Table 1) shows that insertion of 
oxygen atoms occur in the linoleic (for PLPS) or oleic acids (for POPS), as confirmed by 
the observation of the carboxylate anions of modified fatty acyl chains R'COO–, in 
agreement with previous published work [115,116,133,165,166]. 
 
Table 1: Product Ions Observed in ESI-MS/MS Spectra of Oxidized PLPS and POPS, which were 
determined by Tandem Mass Spectrometry to Contain Modified Fatty Acyl Chains 
 
 
 
 
 
 
   
    *Short chain oxidation product in C9 with carboxylic acid terminal. 
 
Phosphatidylserine Oxidation with Modification of in Polar Head—Analysis by TLC 
and ESI-MS/MS 
Oxidative modifications in the PS polar head should change significantly the polarity 
of these species. Consequently, their separation may be possible through simple techniques 
such as TLC, which is widely used for separation of different classes of phospholipids. 
Thus, oxidative mixtures of the three PS under study were fractioned by TLC, as is 
illustrated in Figure 12. 
In the TLC of the oxidized PS, five new spots were resolved using the same conditions 
used to separate phospholipid classes, demonstrating that significant changes of polarity 
have occurred, presumably with formation of new compounds with different polar head 
structures. The new spots were scraped from the plate, the oxPL extracted, and further 
analyzed by ESI-MS and MS/MS. Table 2 summarizes are all molecular ions observed in 
MS spectra for each spot of TLC and the proposed structure. 
 Modifications  [M-H]- R2'COO- [M-R1COOH-87-H]- 
PLPS 
+1 O 
-OH 
-=O 
774 
772 
295 
293 
431 
429 
+2 O 790 311 447 
+3 O 806 327 463 
Short (C9)* 666 187 323 
Short (C9)+O 682 203 339 
POPS 
+1 O 
776 
774 
297 
295 
433 
431 
+2 O 792 313 449 
DPPS - - - - 
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Figure 12: TLC of oxidation products of phosphatidylserines with modifications in the polar head 
(oxPLPS (lines 1, 2, and 3), oxPOPS (lines 4, 5, and 6), and oxDPPS (lines 8, 9, and 10). PS and 
PA standards were applied in line 7 
Table 2: Molecular ions observed in the ESI-MS spectra from the different spots identified in the 
TLC plate for each PS. The Table shows the m/z value of the [M–H]– ions, their most probable 
identification, including the modified polar head group, and the typical neutral loss observed in the 
MS/MS spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spots 
# 
Modification 
 [M-H]- Polar 
Head 
Neutral 
Loss PLPS POPS DPPS 
1 
- 
+14 
+16 
+30 
+32 
+46 
+48 
758 
772 
774 
788 
790 
804 
806 
760 
774 
776 
790 
792 
- 
- 
734 
- 
- 
- 
- 
- 
- 
CO2
NH2
-H2C
 
87 
2 
-29 
-29+14 
-29+16 
-29+30 
-29+32 
729 
743 
745 
759 
761 
731 
745 
747 
761 
763 
705 
- 
- 
- 
- 
O
O
-
-H2C
 
58 
3 
-87 
-87+14 
-87+16 
-87+30 
-87+32 
671 
685 
687 
701 
703 
673 
687 
689 
703 
705 
647 
- 
- 
- 
- 
absent - 
4 
-30 
-30+14 
-30+16 
-30+30 
-30+32 
728 
742 
744 
758 
760 
730 
744 
746 
760 
762 
704 
- 
- 
- 
- 
O
NH2
-H2C
 
57 
5 
-13 
-13+16 
- 
- 
747 
763 
721 
- 
O
-HC
OOH
 
74 
5* -13 
 
747  O
OH
 
58 
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In spots #1 (Figure 12, Table 2) we have identified the non-modified PS together with 
the hydroperoxides, keto, and hydroxides oxidation products (Table 1), in agreement with 
previous results [133]. In the spots #2 (Figure 12, Table 2) we identified, for all PS, 
oxidation products with polar head modifications [M–H–29]–. Spots #3 (Figure 12, Table 
2) shows a Rf similar to the phosphatidic acid (PA) standard. The MS spectra acquired 
from samples of these spots show [M–H–87]– ions, thus indicating that PA is generated 
during PS oxidation, with complete loss of polar head. PA was also observed during 
cardiolipin oxidation by γ- irradiation [203,204]. The oxidation products from spots #4 
(Figure 12, Table 2) contained a head modification, with a mass difference of less 30 Da. It 
is also possible to observe spots #5 (Figure 12, Table 2) in the DPPS and POPS. Analysis 
of the MS spectrum of these samples shows the presence of ions at m/z 747 and 763 for 
POPS, and an ion at m/z 721 for DPPS. These ions have a difference of 13 Da compared 
with the non-modified PS. In the case of PLPS, these oxidation products were not 
observed, probably because they might decompose to fatty acyl short chain derivatives, 
which are not observed in TLC plate. The MS spectra of POPS samples from spots #5 
show ions at the same m/z of ions found in spots #2. These are necessarily different 
compounds, since they have different Rf. The nature of these ions was determined by 
MS/MS analysis and will be discussed in another section of this manuscript. In each spot 
of PLPS and POPS oxidized samples, additional ions with plus 14 Da (+O-2 Da), 16 Da 
(+O), 30 Da (+2O-2 Da), 32 Da (+2O) 46 Da (+3O-2 Da), and 48 Da (+3O) were 
observed. These ions resulted from additional oxidation in unsaturated fatty acyl chain, as 
is shown in Table 2. 
In order to confirm the structure of the oxidation products found in spots #2 to #5, 
MS/MS of all the identified molecular ions (Table 2) were obtained and analyzed. These 
spots corresponded to oxidation products resulting from modification of PS polar head. 
The oxidation products with less 29 Da than the non-oxidized PS, found in spots #2, 
show a neutral loss of 58 Da, instead of the typical 87 Da of PS (Figure 13). The MS/MS 
of these ions [M–H–29]– show the non-modified carboxylate anions RCOO–, thus 
confirming that the structural changes occurred at the polar head and not at the fatty acyl 
chains. This main fragmentation pathway (loss of 58 Da) is also observed for the oxidation 
products with additional oxidation (+nO) in the unsaturated fatty acyl chains observed for 
PLPS and POPS. Tandem mass spectra of these ions also showed the modified RCOO–. 
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Oxidation products with less 29 Da were observed during the oxidation of amino acids and 
were identified as the result of oxidative reactions that lead to loss of an amine group and 
CO2, with formation of a terminal carboxylic acid group [205]. We propose that oxidation 
products observed in spots #2 are glycerophosphoaceticacid derivatives (GPAA) (Scheme 
8). 
 
 
Figure 13: ESI-M/MS spectra of [M–H–29]– molecular ions that resulted from oxidation of PLPS 
(m/z 729 and 745), POPS (m/z 731 and 747), and DPPS (m/z 705), found in spots #2. The proposed 
structures of each molecular ion are also shown. The structures of the oxidation products PLPS–29 
Da+O and POPS –29 Da+O illustrate one possible location of the hydroxyl group in the 
unsaturated fatty acyl chains 
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Scheme 8: Oxidation products of PS formed by Fenton reaction with observed modifications on the 
polar head group: terminal hydroperoxyacetaldehyde (−13 Da), terminal acetic acid (−29 Da), and 
terminal acetamide (−30 Da) 
 
The new oxidation products identified in spots #3 are due to oxidation in polar head 
group of the PS. These oxidative modifications are not observable when a neutral loss scan 
of aziridine-2-carboxylic acid (neutral loss of 87 Da) is performed to detect oxidized PS 
from in vivo samples [201]. 
The MS/MS spectra of molecular ions [M–H–30]– found in spots #4 of the three PS 
show loss of the head group as loss of 57 Da, but typical loss of 87 Da is not observed. We 
propose that these oxidation products resulted from decarboxylation and generation of a 
keto moiety, as observed during amino acid and peptides oxidation (Scheme 8) [205]. In 
these species, loss of modified polar head group (−57 Da) is not the base peak of the 
spectra, in contrast with the typical behavior of PS and the other identified PS oxidation 
products. A minor loss of polar head group resembles the behavior observed in negative 
mode tandem mass spectra of PE. Also, as observed in PE tandem mass spectra, R1COO
– 
ions were found to be more abundant than R2COO
– ions. This is in contrast with the typical 
behavior of PS and other oxidation products with a terminal carboxylic acid function, 
which show in their MS/MS spectra that RA of R2COO
–>R1COO
– [7]. These findings also 
contributed to proposing the presence of a free amine moiety in these oxidation products 
(M-30 Da). We propose that oxidation products observed in spots #3 are 
glycerophosphoacetamide derivatives (Scheme 8) (Figure 14). 
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Figure 14: ESI–MS/MS spectra of [M–H–30]– ions that resulted from oxidation of PLPS, POPS 
and DPPS, found in spots #4. The proposed structures of each molecular ion are also shown 
 
The MS/MS spectra of [M–H–13 Da]– molecular ions that resulted from oxidation of 
DPPS and POPS (Figure 15) and were found in spots #5 (Table 2), are very similar. In 
these spectra, we observe a major fragment ion formed by loss of 32 Da (−O2), indicating 
the presence of a hydroperoxides [116,206]. Due to the fact that DPPS does not oxidize in 
the fatty acyl chain, the hydroperoxide moiety should be located in polar head group. We 
propose that these oxidation products resulted from oxidation in the polar head group, with 
formation of terminal hydroperoxydeacetaldehyde, as shown in Table 2. The presence of a 
modified polar head group is also evidenced by the presence of carboxylate anions of the 
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non-modified fatty acyl chains in the MS/MS spectra and the observation of a neutral loss 
of 74 Da (hydroperoxydeacetaldehyde). The MS/MS spectra of POPS (m/z 747) found in 
spots #5* also shows oleoyl carboxylate anion +16 Da (m/z 297) and loss of 58 Da 
(CH2(OH)HC=O). This suggests the presence of an isobar originated by oxidation of the 
polar head group, with formation of a species containing a terminal hydroxyacetaldehyde, 
and a hydroxylated acyl chain (Figure 15a). The ion at m/z 763, observed in POPS spots 
#5, corresponds to a species with a hydroperoxydeacetaldehyde polar and a hydroxylated 
acyl chain, as suggested by the fragment ion at m/z 297 [RCOO+O]– and a neutral loss 74 
Da (Figure 15 b). 
 
 
Figure 15: ESI-M/MS spectra of the [M – H – 13]– ions that resulted from oxidation of POPS (m/z 
747 and 763) and DPPS (m/z 721), found in spots #5. The proposed structures of each molecular 
ion are also shown 
 
Phosphatidylserine polar head group has a serine amino acid moiety linked to the 
phosphate group It is well known that amino acids are prone to oxidation, not only in the 
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side chains but also in the alpha carbon [205,207,208]. Oxidative modification of the PS 
polar head group has been reported to occur during oxidation induced by HClO and 
catalyzed by myeloperoxidase [141,142], confirming the reactivity of serine under 
oxidative conditions. The oxidation products reported to be formed in those conditions 
were not the same as the ones reported in this work. In those works, the authors reported 
the formation of 1,2-dipalmitoyl-sn-glycero-3-phosphoacetaldehyde and 1,2dipalmitoyl-
sn-glycerol-3-phosphonitrile derivatives. 
The changes of the serine polar head group induced by the hydroxyl radical resemble 
the oxidative modifications of the amino acid structure, such as the oxidative 
decarboxylation with formation of an additional keto group (oxidation products with −30 
Da). Decarboxylation of amino acids is a well-known reaction occurring during amino acid 
and peptide oxidation. Loss of CO2 from the C terminal is due to β-scission of an alkoxyl 
radical at the C terminal alpha carbon. This reaction is proposed to be initiated from the 
abstraction of hydrogen linked to an alpha carbon, generating a tertiary radical that is 
stabilized by the amine nitrogen and carbonyl group [207,209]. 
The modification in the PS polar head group leading to the formation of the oxidation 
products with less 29 Da should occur by decarboxylation plus deamination with formation 
of a terminal carboxylic acid moiety (oxidation products with −29 Da). Loss of amine and 
CO2 resembles typical modification already observed during amino acid oxidation, as 
reviewed elsewhere [205,208]. 
  
3.5. Conclusions 
Oxidative modifications induced to phosphatidylserine were identified and 
characterized by thin layer chromatography combined with tandem mass spectrometry. 
Oxidation products were fractionated by TLC and further characterized by MS/MS. This 
approach allowed the identification of hydroxyl, peroxy, and keto derivatives due to 
oxidation of unsaturated fatty acyl chains. Additionally, we have identified for the first 
time five families of oxidation products, with lower molecular weight than the non-
modified PS, which resulted from oxidative modifications on the serine polar head group. 
They were identified as [M–29–H]– (terminal acetic acid), [M–30–H]– (terminal 
acetamide), [M–13–H]– (terminal hydroperoxideacetaldehyde), and [M–29–H]– (terminal 
hydroxyacetaldehyde). Phosphatidic acid derivatives were also formed as result of PE 
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oxidation. Hydroxy, keto, peroxy, and short chain acyl derivatives of these new molecules 
were also identified for PS phospholipids with unsaturated fatty acyl chains. The results 
presented here allowed the identification, for the first time, of modification of PS polar 
head group induced by the hydroxyl radical mediated oxidation in vitro conditions. The 
identification of oxidation products of PS is far from being completely explored, although 
it is essential to understanding the relation between the PS oxidation products formed and 
the specific biological activity that they mediate. 
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4.1.1 Abstract  
Phosphatidylserine (PS) is an aminophospholipid found mainly in the plasma 
membranes of all mammalians cells, playing important roles in biological processes such 
as apoptosis and cell signaling. Due to the presence of a free amine group, under 
hyperglycemic conditions, PS can undergo glycation reaction, which may increase the 
susceptibility to oxidation. However, far too little attention has been paid to glycation and 
oxidation of PS. In this work we studied the oxidation, glycation and glyco-oxidation of 1-
palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-l-serine (PAPS). PAPS and glycated 
PAPS were oxidized through a Fenton reaction and the oxidation products were monitored 
by ESI-MS in negative mode. Also, we developed a new sensitive liquid chromatography 
method coupled with tandem mass spectrometry (LC–MS/MS) to provide a complete 
profile of oxidized and glyco-oxidized PS. We were able to separate and identify several 
oxidation products of PAPS and glycated PAPS with modifications in unsaturated fatty 
acyl chain as long chain oxidation product (hydroxy and mono to tetra-hydroperoxy 
derivatives), and short chain products with a shortened fatty acyl chain with C5 and C8 
length and aldehyde or carboxylic terminal. We have also observed oxidation products 
arising from structural changes in the serine polar head, which lead to oxidation products 
with an acetic acid terminal (glycerophosphoacetic acid derivatives) and lysoPS species. 
Oxidation of glycated PAPS gave rise to several products involving oxidative cleavages of 
the glucose moiety, mainly between C1 and C2 of the sugar unit. These oxidation products 
with different polar head groups have shown distinct neutral loss fragmentation patterns. 
Simultaneous oxidative modifications of the polar head and the fatty acyl chains were also 
observed. The findings from this study contribute to an ongoing effort to detect PS 
oxidation and glycoxidation products in biological systems. 
 
Keywords: Phosphatidylserine; Aminophospholipid; Oxidative stress; Glycation; Mass 
spectrometry 
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4.1.2 Introduction 
Phosphatidylserine (PS) is an acidic natural occurring phospholipid, found in the 
cellular membrane of a great variety of organisms [38,210]. PS is present in higher 
proportions in brain and the central nervous system, comprising about 15% of the total 
phospholipid pool [39]. Changes in PS composition have been correlated with brain 
diseases, such as depression and neurodegenerative diseases [211]. In fact, there is 
increasing evidence that neurodegenerative diseases are associated with oxidative stress 
[212] and lipid peroxidation [213]. Hydroxyl and hydroperoxy derivatives of oxidized PS, 
arising from oxidation in fatty acyl chains were detected in pro-inflammatory conditions by 
Kagan and co-workers [133]. Maki et al. [130] observed that peroxidation products of 
phosphatidylserine (PS-OOH) and phosphatidylinositol (PI-OOH) were elevated in human 
brains of patients with Alzheimer's disease (AD). Hyperglycemic conditions are usually 
associated with glycation of biomolecules, such as nucleotides, proteins and 
aminophospholipids. Consequences of glycation damage include increased oxidative 
stress, DNA mutations and compromised lipid membrane integrity [214]. Recently, it has 
been recognized that hyperglycemia due to Type 2 diabetes mellitus (T2DM) is a risk 
factor for cognitive dysfunction or dementia, especially related to Alzheimer's disease 
(AD) [215]. However, the research to date has tended to focus on protein glycation rather 
than phospholipid glycation. Nevertheless, glycated phosphatidylethanolamine (PE) has 
been implicated in the in vivo rise of ROS production [24,25,26,27,28,29]. Also, early 
evidence suggested that glycated PE promote lipid peroxidation, partly through the 
generation of ROS [28,216]. Glycation is associated with oxidative stress, mainly due to 
the formation of oxidation intermediaries like Schiff bases, Amadori rearrangement 
products, and advanced glycation end products (AGEs) [27,149]. This dual relation 
between glycation and oxidation may play a key role in inflammation and other diabetes 
complications [150,151]. 
A detection method for analyzing oxidized phospholipids in biological systems should 
be able to detect modified phospholipids, including the modified polar head groups. In fact, 
modified serine head groups, arising from PS oxidation, have been identified in 
mitochondria of brain of rats subjected to oxidize stress induced by tacrine [217]. It has 
been described that the brain is more vulnerable to oxidative stress oxidative stress than 
other organs, due to the high content in polyunsaturated fatty acyl chains, including 
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arachidonic acid [218,219]. In this work we developed a new sensitive liquid 
chromatography method coupled with tandem mass spectrometry to provide a complete 
profile of oxidized and glycoxidized PS. We have tested this method studying oxidative 
modifications induced by the hydroxyl radical in 1-palmitoyl-2 arachidonoyl-PS (PAPS) 
and glycated PAPS (gluPAPS). 
The generation of phospholipid oxidation products in model systems using pure 
phospholipids and glycated phospholipids standards allows the mass spectrometric 
characterization of these products. This knowledge is essential to design diagnostic assays, 
which can be used as methodology in analyzing complex biological matrices. However, 
since PSs are minor phospholipids (~10% of the total PL content), it is expected that such 
methodologies should require targeted analysis using multiple resonance monitoring 
(MRM) [220,221]. This work provides information of fragmentation pattern of the 
different oxidation products, providing information needed for targeted analysis. 
 
4.1.3 Material and methods 
Materials 
1-Palmitoyl-2-arachidonoyl-phosphatidylserine was purchased from Avanti and was 
used without further purification. Ferrous chloride and hydrogen peroxide (30%, w/v) 
(Merck, Darmstadt, Germany) were used for oxidation reactions. Triethylamine (Acros 
organics), chloroform (Analytical reagent grade), methanol (HPLC grade, Fisher 
Chemical), ethanol absolute (Panreac) and TLC silica gel 60 with concentrating zone (2.5 
cm × 20 cm) (Merck Darmstad, Germany) were used for the separation of oxidized and 
glyco-oxidized samples. 
 
Phosphatidylserine glycation 
Glycated PS samples were synthetized by adding 1 mg of phospholipid to 1,2 mg of 
glucose, dissolved in 300 μL of methanol. The solution was mixed and the reaction tube 
was immersed in the boiling water during 15 min, as previously described for the glycation 
of aminophospholipids [24,25]. The glycation reaction was monitored by electrospray 
mass spectrometry (ESI-MS). 
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Oxidation of phosphatidylserine and glycated phosphatidylserine by Fenton reaction 
Vesicles of phospholipids and glycated phospholipids were prepared in ammonium 
bicarbonate buffer 5 mM (pH 7.4). In a typical experiment, 1 mg of phospholipid in 
chloroform was evaporated to dryness, 446 μL of buffer was added, and the mixture was 
shaken mechanically on a vortex mixer for 10 min and then sonicated for 1 min. The 
sample was kept under nitrogen atmosphere at all times [222]. The oxidation was induced 
by hydroxyl radical generated under Fenton reaction conditions (Fe2+/H2O2). Hydroxyl 
radical is highly reactive oxygen species, involved in lipid peroxidation in vivo [223]. The 
oxidation was performed by adding to the solution 4 μL of FeCl2 (5 mM stock solution) 
and 50 μL of H2O2 (500 mM stock solution) in order to obtain a final concentration of 40 
μM of FeCl2 and 50 mM of H2O2 in a total volume of 500 μL. The mixture was incubated 
at 37 °C in the dark for 2 days. Controls were performed by replacing hydrogen peroxide 
with water. The oxidation was monitored by ESI-MS. 
 
LC–ESI-MS conditions 
HPLC–MS and HPLC–MSn experiments were performed on a Waters Alliance 
(Milford, USA) Model 2690 chromatographic system equipped with a pre-column split 
(Accurate, LC Packings, USA) and a Supelco Bio Wide Pore C5 column (15 cm × 0.5 mm, 
5 μm) kept at room temperature (22 °C). The reaction mixture was diluted 50 fold before 
injection and a volume of 10 μL was introduced into the column, using a flow rate of 20 
μL min−1. The phospholipid oxidation products were separated using water–methanol 
(90:10, v/v, eluent A) and methanol (100%, eluent B) programmed as follows: isocratic 
mode for 5 min with 20% B and a linear increase from 20% B to 80% B in 35 min and a 
further increase to 100% B in 5 min. The mobile phase was brought back to the initial 
conditions in 10 min and allowed to equilibrate for 15 min until the next injection. 
The LXQ linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) was 
operated in negative mode. ESI conditions were as follows: electrospray voltage was 4.7 
kV; capillary temperature was 275 °C and the sheath gas flow was 25 units. An isolation 
width of 0.5 Da was used with a 30 ms activation time for MS/MS experiments. Full scan 
MS spectra and MS/MS spectra were acquired with a 50 ms and 200 ms maximum ion 
injection time, respectively. Normalized collision energy™ (CE) was varied between 15 
and 20 (arbitrary units) for MS/MS. To obtain the product-ion spectra of the major 
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components during LC experiments, cycles consisting of one full scan mass spectrum and 
four data-dependent MS/MS scans were repeated continuously throughout the experiments 
with the following dynamic exclusion settings: repeat count, 3; repeat duration, 15 s; and 
exclusion duration, 45 s. Data acquisition was carried out on an Xcalibur data system 
(V2.0). 
 
Thin layer chromatography 
The oxidation products were separated by thin layer chromatography (TLC) using 
silica gel 60 plates with concentrating zone 2.5 cm × 20 cm (Merck KGaA). Prior to 
separation, plates were treated with 2.3% boric acid in ethanol. The mobile phase was 
chloroform/ethanol/water/triethylamine (30:35:7:35, vol/vol/vol/vol) [224]. The lipid spots 
on TLC plates were observed by exposure to primuline. The TLC spots identified as 
oxidized PS were scraped from the plates and extracted using chloroform/methanol (2:1, 
vol/vol). The oxidation products separated by thin layer chromatography (TLC) were 
further analyzed by ESI-MS. 
 
4.1.4 Results 
PAPS and gluPAPS were oxidized under Fenton reaction conditions (H2O2/Fe
2+). 
Oxidative reactions were monitored by ESI-MS in the negative mode (Figure 16). The 
oxidation products of PAPS (oxPAPS) and of gluPAPS (oxgluPAPS) were identified and 
structurally characterized by LC–MS and MS/MS as resumed in Table 3 and Table 4. The 
ions identified as oxidation products of PAPS and gluPAPS were detected both at higher 
m/z values and at lower m/z values when compared with the non-oxidized PL species 
(PAPS and gluPAPS). The oxidation products with higher molecular weight were assigned 
as hydroxy and hydroperoxy derivatives. These typical oxidative modifications occur 
mainly in fatty acyl chains (PL+nO) and are named long chain oxidation products 
[20,118,133]. Scheme 9 shows the proposed structure of the observed oxidation products 
resulting from oxidation of PAPS and gluPAPS. 
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Figure 16: ESI-MS spectra, acquired in the negative mode of: (A) PAPS, (B) glycated PAPS, (C) 
oxidized PAPS, and (D) oxidized glycated PAPS. 
Oxidative cleavages involving the fatty acyl chains gave rise to oxidation products 
with lower m/z values, named short chain oxidation products. These short chain oxidation 
products are oxidation products with shorter fatty acyl chain (C5 or C8) and carboxylic or 
aldehyde terminals. LysoPS were also observed, arising from oxidative elimination of one 
fatty acyl chain (loss of R2C=O). These modifications have also been observed in the 
oxidation induced by the hydroxyl radical in phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) [20,118,127,165,166]. 
Glycerophosphoacetic acid derivatives (GPAA) were also observed. These lower 
molecular weight PS oxidation products arise from polar head oxidation and cleavage of 
the serine group, originating oxidation products with a mass shift of −29 Da (Scheme 9). 
Combined cleavage of polar head group and fatty acyl chain (short chain products) was 
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also observed as result of PAPS oxidation. The cleavage in the serine moiety has been 
described in when studying the oxidation of serine amino acid but also in peptides 
[205,225]. This cleavage involves the loss of the amine group and CO2, with formation of 
terminal carboxylic acid group. However, oxidative modification of phospholipids polar 
head groups is not commonly observed. These polar head modifications have been 
identified in the oxidation glycated PE but not in non-glycated PE [152]. In Figure 16 we 
can see that the ions corresponding to the GPAA have a higher relative abundance in the 
gluPAPS spectrum. These GPAA derivatives can be separated by thin layer 
chromatography (TLC) (Figure 17), as reported in a previous work [168]. 
 
Figure 17: Mobility rate along a TLC plate of phosphatidylserine, oxidized phosphatidylserine, 
oxidized glycated phosphatidylserine and glycated with other phospholipid classes 
(phosphatidylcholine (PC), lysophosphatidic acid (LPA), phosphatidylinositol (PI), phosphatidic 
acid (PA), phosphatidylethanolamine (PE) and cardiolipin (CL)) 
In gluPAPS, we have also detected oxidation products arising from oxidative 
modifications in the glucose moiety. During oxidation of gluPAPS, cleavages in the C1 
single bond C2 bonds of glucose moiety can occur, leading to the formation of new 
oxidation products. In this study we identified oxidation products with formamide terminal 
in polar head group, arising from cleavage of C1 in the glucose moiety. 
 
4.1.4.1 Analysis of oxidation products of PAPS by LC–MS and LC–MS/MS 
After using MS for an initial characterization of the oxPAPS and oxgluPAPS samples, 
we further characterized the oxidation products of PAPS using LC–MSn. Table 3 shows 
the main oxidation products that were identified in the LC–MS spectra of oxPAPS, along 
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with the corresponding retention times (RT). In this table, the observed oxidation products 
were grouped accordingly to the location and nature of the modifications. GPAA oxidation 
products were found to have a lower retention time than the non-modified PAPS (Figure 
18) and the corresponding oxidation products with the serine polar head. The short chain 
products, as expected, had the shorter RT. 
Table 3: Identification of the main oxidation products observed in the LC-MS spectrum of 
oxPAPS, grouped accordingly to the location and nature of the modifications. The table also shows 
the m/z values of the [M-H]- ions and the retention time (RT). 
 
NL – neutral loss. 
The long chain oxidation products (hydroperoxy and hydroxy derivatives) eluted 
between 35 and 37 min (Figure 18). These products were observed at m/z 798.4 (782 + 16 
Da), 814.4 (782 + 32 Da), 830.4 (782 + 48 Da), 846.4 (782 + 64 Da), 862.4 (782 + 80 Da), 
878.4 (782 + 96 Da), 894.4 (782 + 112 Da) and 910.4 (782 + 128 Da) ( Table 3). The long 
chain oxidation products of the GPAA derivatives, arising from the addition of 1–8 oxygen 
atoms to the arachidonoyl chain, eluted between 31 and 35 min. These species were 
observed as deprotonated molecular ions at m/z 769.4, 785.4, 8014, 817.4, 833.4, 849.4, 
865.4 and 881.4 (Table 3). Tandem mass spectra, obtained using data dependent 
acquisition, were used to identify the structures of these oxidation products. The LC–
MS/MS spectra of these ions showed the neutral loss of 58 Da, instead of the characteristic 
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loss observed in the spectra of PS molecular ions (−87 Da) [189]. As an example, we show 
in Figure 19 the LC–MS/MS spectra of the molecular ions at m/z 846 (PS-
(C16:0)(C20:4+4O)) and 769 (GPAA-(C16:0)(C20:4+O)).  
 
Figure 18: LC–MS recorded ion chromatogram (RIC) of the deprotonated molecular ions [M-H]− 
of the oxidation products of PAPS (NL = absolute intensity). 
The short chain oxidation products, arising from cleavage of unsaturated sn-2 acyl 
chain, eluted between 12.5 and 13.9 min when a carboxyl group was present and between 
29.0 and 29.9 min when an aldehyde group was present (Table 3). The most abundant short 
chain oxidation product was observed at m/z 610, corresponding to the oxidation product 
with a carboxyl group at C-5 (R′2C4COOH, RT=13.9   min). The deprotonated molecular 
ion at m/z 594.4, eluting at RT 29.9 min, corresponds to the short chain oxidation product 
with a C5 aldehyde group (R′2C4CHO). 
The GPAA with fatty acyl chain shortened at C5 and C8 eluted between 10 and 11 
min (carboxyl group) and between 16 and 17 min (aldehyde group) (Table 3). In Figure. 
19C we can see the LC–MS/MS spectra and the proposed structures of the deprotonated 
molecular ion [M-H]− at m/z 610, identified as oxPS with a short fatty acyl chain and a C5 
terminal carboxylic acid. The LC–MS/MS spectra of the product ion at m/z 581, identified 
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as a GPAA oxidation product with a short fatty acyl chain with C5 carboxyl group are 
shown in Figure 19D. In both spectra we can see the fragment ion at m/z 523, arising from 
the neutral loss of polar head (87 Da for the ion at m/z 610 and 58 Da for the ion at m/z 
581). The fragment ions at m/z 496 ( Figure 19C) and 467 ( Figure 19D) arise from the 
neutral loss of the C5 fatty acyl chain with a carboxylic acid group (R′2COOH), while the 
fragment ion at m/z 267 arises from the neutral loss of palmitoyl (R1COOH) from the ion at 
m/z 523 ([PA′-H]−). 
 
Figure 19: LC–MS/MS spectrum of the ion at m/z 798, identified as PS-(OH) (A). LC–MS/MS 
spectrum of the ion at m/z 769 identified as GPAA-OH (B). LC–MS/MS spectrum of the molecular 
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ion at m/z 610, identified as PS-(C4CHO) (C). LC–MS/MS spectrum of the ion at m/z 581 
identified as PS-(C4CHO) (D). All spectra were recorded in the negative mode. 
In this work, we have also observed the formation of lysoPAPS ([PAPS-R2C=O]−) as 
PS and gluPS oxidation products. The lysoPAPS with no modification in the polar head 
group was observed in the LC–MS spectrum at m/z 496 (RT 26.1 min) and the lyso 
oxidation product with a glycerophosphoacetic acid polar head group was observed at m/z 
467 (RT 13.2 min) (Figure 20). These lysoPS with modifications in polar head group were 
observed for the first time in this work. 
 
Figure 20: LC–MS recorded ion chromatogram (RIC) of the ions: at m/z 496 (RT 26.6 min) 
identified as lysoPS without modifications in polar head group (A) and at m/z 467 (RT 13.5 min) 
identified as lysoPS with modification in polar head group (acetic acid as polar head group) (B) 
(NL = absolute intensity). 
Isobaric compounds were also separated and further identified by LC–MS/MS. As it is 
shown in Figure 21, the isobaric ions observed at m/z 666.3 (RT 12.5 and 29 min) were 
identified as the oxidation product with a hydroxylated C8 carboxylic group chain 
(R′2C5(O)C7COOH) and the oxidation product with an hydroperoxylated C8 aldehyde 
group (R′2C5(OO)C7C=O), respectively. The characterization of these structures was only 
possible due to their different retention times: In the LC–MS/MS spectrum acquired at 12.5 
min, we can observe de neutral the loss of 44 Da due to the loss of CO2 from the 
carboxylic acid group, indicating that this was an oxidation product with a carboxylic 
group in the fatty acyl chain (Figure 21). The neutral loss of 44 Da was not observed in the 
LC–MS/MS spectrum acquired at 29 min. 
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Figure 21: LC–MS recorded ion chromatogram (RIC) (A) and LC–MS/MS spectra of isobaric 
compounds observed at m/z 666.3, observed at a retention time of 12.5 min (B) and29 min (C) and 
proposed structures. 
4.1.4.2 Analysis of oxidation products of gluPAPS by LC–MS and LC–MS/MS 
The free amino groups of aminophospholipids (PE and PS) are targets for glycation. 
This corresponds, as described for peptides and proteins, to an extension of the concept of 
the Maillard reaction into biological systems [147]. Glycated phosphatidylethanolamines 
(gluPE) were characterized by tandem mass spectrometry, showing a predominant neutral 
loss of the glucose moiety (−162 Da) [152]. However, the fragmentation pattern of 
glycated PS has not been described before. In this work, we have studied the fragmentation 
pattern of gluPAPS in the negative ion mode. The MS/MS spectrum of the deprotonated 
molecular ions [M-H]− of gluPAPS is shown in Figure 22. The most abundant product ions 
were observed at m/z 782.3 and 695.3, arising respectively from the loss of the glucose 
moiety (−162 Da) and from the combined loss of aziridine-2-carboxylic acid and the 
glucose moiety (87 Da+ 162 Da) (Figure 22). Other minor fragment ions were also 
observed in the MS/MS spectra: product ions arising from glucose fragmentation with the 
loss of 90 Da (-C3H6O3); product ions arising from loss of the fatty acyl chain; and the 
product ion at m/z 303.1, identified as the fatty acid anion (R2COO
−). 
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Figure 22: LC–MS/MS spectrum, recorded in the negative mode, of the deprotonated molecular ion 
of glycated PAPS observed at m/z 944. 
Subsequently, the glycated PAPS was oxidized by Fenton reaction and analyzed by 
LC–MS and LC–MS/MS, as described in Section 4.1.3. The oxidation of gluPAPS leaded 
to modifications in unsaturated fatty acyl chain and formation of glycerophosphoacetic 
acid derivatives (Scheme 9) and lysoPS. Table 4 shows the main oxidation products that 
were identified in the LC–MS spectra of oxgluPAPS. Oxidation products identified as 
formamide (R-NHCHO) derivatives arising from oxidative cleavage of glucose were also 
identified in oxgluPAPS, but not in oxPAPS. 
Table 4: Identification of the main oxidation products observed in the LC–MS spectrum of 
oxgluPAPS, grouped accordingly to the location and nature of the modifications. The table also 
shows the m/z values of the [M-H]− ions and the retention time (RT). 
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The oxidation products of glycated PS with additional 2–6 oxygen atoms in the 
unsaturated fatty acyl chain (m/z 976, 992, 1008, 1024 and 1040) eluted between 30 and 33 
min, while the hydroxyl derivative (gluPAPS + O), observed at m/z 960.4, eluted at 39.6 
min (Figure 23). The oxidation products with additional oxygen atoms are more polar 
compounds, eluting with a shorter retention time when compared to gluPAPS (RT = 42 
min). 
 
 
Oxidation products of gluPS, with shortened fatty acyl chains and carboxylic or 
aldehyde groups were also observed. The oxidation products with carboxylic groups, 
identified at m/z 772 (R′2C5OOH) and m/z 828 (R′2C5(O)C7COOH), eluted between 11.8 
and 10.8 min, respectively. Short chain oxidation products with an aldehyde group, 
identified at m/z 756 (R′2C5=O) and 828 (R′2C5(OO)C7C=O), eluted at 27.9 and 27.5 min, 
respectively. The lysogluPAPS oxidation product ([gluPAPS-R2=C=O]
−) was detected at 
m/z 658 (RT 25.6 min) ( Table 4). 
Other oxidation products, arising from oxidative cleavages in glucose moiety, were 
observed in the LC–MS spectrum of oxgluPAPS (Scheme 9). These oxidation products 
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Figure 23: LC–MS recorded ion chromatogram (RIC) of the deprotonated molecular ion [M-
H]− of the oxidation products of glycated PAPS. (NL = absolute intensity). 
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arise from cleavage of the C1-C2 bond of the glucose moiety, leading to the formation of 
an aldehyde group (-NHCHO derivative) and were identified at m/z 810.3 (with 
unmodified fatty acyl chain, RT = 31.6 min) and 638.3 (with carboxylic C5 acyl group, RT 
= 9.1 min). Figure 24 shows the LC–MS/MS spectrum and the proposed structure for the 
ion at m/z 638. In this spectrum we can see the fragment ion at m/z 594, arising from loss 
of CO2, and the fragment ion at m/z 523, arising from neutral loss of 115 Da 
(CH2CH(COOH)NHCHO). These type of oxidative cleavages in glycated species were 
also observed in the oxidation of glycated PE [152]. 
 
 
 
Scheme 9: Proposed structures for the main oxidation products of PAPS and gluPAPS observed in 
this work 
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Figure 24: LC–MS/MS spectrum, recorded in the negative mode, of the ion at m/z 638.5. The 
proposed structure is also shown. 
 
4.1.5 Conclusion 
In this work, we have characterized by negative mode LC–MS and –MS/MS the 
oxidation products resulting of oxidation of PAPS and glycated PAPS using Fenton 
reaction. Therefore, we developed a new sensitive liquid chromatography method coupled 
with tandem mass spectrometry to provide a complete profile of oxidized and glyco-
oxidized PS. This LC–MS/MS study of oxidation of PAPS and gluPAPS has identified 
new oxidation products. In oxPAPS samples, we identified long chain oxidation products 
as hydroxy and peroxy derivatives, short chain products with aldehyde and carboxyl 
moieties at C5 and C8, lysoPS and glycerophosphoacetic acid derivatives. In oxgluPAPS 
samples, we identified long chain oxidation products, short chain oxidation products and 
lyso products of gluPAPS and GPAA derivatives, long chain oxidation products and short 
chain oxidation products of PAPS. Some oxidation products were only observed as 
oxidation products of gluPAPS: phosphatidic acid derivatives (PA), lysophospahtidic acid 
(lysoPA) and formamide derivatives. With the exception of short-chain oxidation products, 
the main oxidation products that were observed were lysoPAPS at m/z 496 ([PAPS-
R2=C=O]
−), lyso gluPAPS at m/z 658 ([gluPAPS- R2=C=O]
− and lysoPAPS with modified 
polar head (at m/z 467). It is worth noting that lysoPS phospholipids have been detected in 
many biological fluids, and are known as signaling phospholipids in mast cells, enhancing 
histamine release and eicosanoid production [226,227,228]. Also, it has been suggested 
that in skeletal muscle and adipose tissue, lysoPS species are involved in the regulation of 
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glucose homeostasis [229]. When assessing the influence of glycation on PS oxidation we 
can conclude that glycated PS species are more susceptible to the formation of oxidation 
products with modified polar head (acetic acid terminal) than the non glycated PS. They 
are also more susceptible of forming phosphatidic acid derivatives. Both modifications 
were observed to occur simultaneously with the oxidation in polyunsaturated fatty acyl 
chain. The glycerophosphoacetic acid derivatives were previously observed in oxidized 
glycated phosphatidylethanolamines. This oxidation product was detected in vivo although 
its biological significance is not known. The differences in the oxidative modifications 
observed between glycated and non glycated PS can be important, as it appears that 
glycation enhances the oxidative damage in PS. 
 
This work has performed a detailed molecular characterization of different oxidation 
products of phosphatidylserine and glycated phosphatidylserine. We have determined the 
fragmentation pattern of the different oxidation products, providing information about the 
characteristic neutral loss accordingly with the nature of the oxidative modification. This 
information is essential for targeted analysis methods to be developed, as for example the 
use of multiple reaction monitoring (MRM) mass spectrometry. Also, we have developed a 
chromatographic method that allows the separation of these oxidation products. The results 
of this study can be an important contribution for the identification of oxidative and 
glycated modifications of phosphatidylserines in biological systems. 
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4.2.1 Abstract 
Phosphatidylserine (PS) is an aminophospholipid that is prone to glycation. In 
oxidative conditions, glycated PS may lead to the formation of Amadori compounds and 
advanced glycated end products (AGEs), which are known to accumulate in diabetic 
patients. Nevertheless, there have been no studies that identified products from the 
oxidative reaction of glycated PS. In this study, glycated 1-palmitoyl-2-oleoyl-PS was 
synthesized and further oxidized by Fenton reagent. The AGES formed were structurally 
characterized by liquid chromatography coupled to tandem mass spectrometry (LC–
MS/MS) in negative mode. The oxidation products from glycated PS that we have found 
include products arising from the oxidation of the fatty acyl chains (hydroperoxides, 
hydroxides and keto derivatives), and arising from oxidative cleavage of serine polar head 
and lyso-glycated PS. Oxidation in C6 of glucose lead to the formation of glucuronyl-PS. 
In addition, new products arising from oxidative cleavage of glucose moiety (between 
C1single bond C2, C2single bondC3 and C3single bondC4 bonds) were identified as PS-
AGES. The current findings add substantially to the best of our knowledge of PS 
glycoxidation products, opening new perspectives for the detection of these products in 
complex biological matrices. 
 
Keywords 
Phospholipid; Glycation; Oxidation; Hydroxyl radical; HPLC–MS/MS; AGES
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4.2.2 Introduction 
Protein glycation has recently attracted increased attention in proteomics research 
because of its association with oxidation and oxidative stress pathologies. In fact, 
considering the negative impact in cell homeostasis of non-enzymatic glycation, this 
reaction has been thoroughly investigated (reviewed in [230]). The aminophospholipids 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) also have a free amino group 
that is prone to non-enzymatic glycation. Although not well studied, in vivo lipid glycation 
has also been described to occur, for example in blood plasma and red blood cells 
[25,27,147,231]. This reaction is more likely to occur among persons with diabetes 
mellitus, as a consequence of the increased levels of glucose and other saccharides 
derivatives in the plasma. Also, lipid glycation can be involved in the pathogenesis of 
several diseases, including atherosclerosis, retinopathy and nephropathy, and its 
complications. The mechanisms underlying these complications are not completely 
understood, but are related to increased oxidative stress, DNA damage and compromised 
lipid membrane integrity. These processes can be promoted by glycation products [214] 
such as Schiff bases, Amadori rearrangement products, and advanced glycation end 
products (AGEs) [27,149]. 
As referred previously, so far, there has been little discussion about glycation of 
aminophospholipids. Nevertheless, Ravandi et al. [27] identified glycated PE in in vitro 
systems and also in human plasma and red blood cell membranes. In this study, in vitro 
glycated PS were also studied, but these species were not detected in vivo. In other studies, 
glycated PE was also detected in isolated LDL (low-density lipoproteins), in atheroma 
[28], and in the human plasma and erythrocytes of diabetic patients [24,25,26,29]. 
However, until now glycated PS (gluPS) was only characterized in in vitro systems with 
phospholipid standards [148]. Nevertheless, it seems reasonable to suppose that glycated 
PS can as well be formed in vivo. 
A recent study from our group showed that, besides the oxidation in the fatty acyl 
chain, gluPE also oxidizes in the glucose moiety. In fact, gluPE species were found to be 
more prone to oxidation and consequently to degradation [152], which may difficult the 
detection of these species. In addition, oxidation of glycated aminophospholipids and 
particularly glycated PS may generate AGEs, as observed in protein glycoxidation 
[232,233]. However, these oxidation products have not been detected in the oxidation of 
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gluPS. To overcome the difficulties of detecting PS glycation products in complex 
biological matrices, it is necessary to previously characterize these phospholipid oxidation 
products in model systems. It is expected that this approach allows detecting and 
quantifying PS-AGEs under oxidation and glycoxidation conditions. 
In this work, we have characterized the oxidation products of glycated 1-palmitoyl-2-
oleoyl-phosphatidylserine (POPS) by electrospray tandem mass spectrometry. POPS was 
selected because it has been previously detected in many cells and tissue, such as 
keratinocytes [234], intestinal [121] and lung tissues [122]. For this purpose, glycated 
POPS (gluPOPS) was synthesized and MS/MS fragmentation patterns were studied in the 
negative mode. In this study, we have identified, using HPLC–MS/MS, glycoxidized 
POPS (oxgluPOPS) products formed under the Fenton. 
 
4.2.3 Experimental 
Materials 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS) was purchased to Avanti 
polar lipids, Inc. and used without further purification. d-glucose was purchased from 
Merck (Darmstadt, Germany). FeCl2, EDTA and H2O2 (30%, w/w), used for the oxidation 
reaction, were acquired from Merck (Darmstadt, Germany). Chloroform, methanol and 
acetonitrile HPLC grade were acquired from Fisher Scientific. 
 
Phosphatidylserine glycation 
Glycated POPS was synthetized in methanol, as previously proposed for the glycation 
of aminophospholipids [25,235]. Briefly, 1.2 mg of glucose dissolved in methanol (300 
μL) and 1 mg of phospholipid were mixed and the reaction tube was immersed in boiling 
water during 15 min. Phospholipids were extracted from the reaction mixture following the 
modified Folch method [169]. The glycation reaction was monitored by electrospray mass 
spectrometry (ESI-MS). 
 
Oxidation of glycated phosphatidylserine by Fenton reaction 
Vesicles of glycated phospholipid were prepared in ammonium bicarbonate buffer 5 
mM (pH 7.4). In a typical experiment, 1 mg of glycated phospholipid in methanol was 
evaporated to dryness, 446 μL of buffer was added, and the mixture was mechanically 
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stirred on a vortex for 2 min and then sonicated for 1 min. The sample was kept under 
nitrogen atmosphere at all times [222]. The oxidation was initiated with the Fenton oxidant 
(Fe2+/H2O2) by adding to the solution 4 μL of FeCl2 and 50 μL of H2O2 in order to obtain a 
final concentration of 40 μM of FeCl2 and 50 mM of H2O2 in a total volume of 500 μL. 
The mixture was incubated at 37 °C in the dark for two days. Controls were performed by 
replacing hydrogen peroxide with water. The oxidation was monitored by ESI-MS, after 
diluting the oxidative mixture in methanol (1:100, v/v). 
 
ESI-MS conditions (linear ion trap) 
The extent of glycation and oxidation reactions was monitored by electrospray mass 
spectrometry in a linear ion trap mass spectrometer LXQ (ThermoFinnigan, San Jose, CA, 
USA). The LXQ linear ion trap mass spectrometer was operated in negative mode. ESI 
conditions were as follows: electrospray voltage was 4.7 kV; capillary temperature was 
275 °C and the sheath gas flow was 25 U. An isolation width of 0.5 Da was used with a 30 
ms activation time for MS/MS experiments. Full scan MS spectra and MS/MS spectra 
were acquired with a 50 ms and 200 ms maximum ion injection time, respectively. For 
MS/MS experiments, normalized collision energy™ (CE) was applied in the range of 17–
20 (arbitrary units). Data acquisition was carried out on an Xcalibur data system (V2.0). 
 
HPLC–MS and HPLC–MS/MS conditions 
The glyco-oxidized mixture was separated by HPLC performed on a HPLC system 
(Waters Alliance 2690) coupled to a linear ion trap mass spectrometer LXQ 
(ThermoFinnigan, San Jose, CA, USA). 5 μL of glyco-oxidized mixture, diluted in water 
with 20% of methanol, were introduced into a Supelco Bio Wide Pore C5 column (15 cm × 
0.5 mm, 5 μm). The mobile phase A consisted of 95% water and 5% acetonitrile. The 
mobile phase B consisted of 100% of acetonitrile. The mobile phase gradient was 
programmed as follows: the initial conditions were 40% of B for 5 min; 5–30 min linear 
gradient to 60% of B; 30–65 min linear gradient to 80% of B. To obtain the product-ion 
spectra of the major components during LC experiments, cycles consisting of one full scan 
mass spectrum and four data-dependent MS/MS scans were repeated continuously 
throughout the experiments with the following dynamic exclusion settings: repeat count 3; 
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repeat duration 15 s; exclusion duration 45 s. Data acquisition was carried out on an 
Xcalibur data system (V2.0). 
 
4.2.4 Results and discussion 
In this work, glycated POPS (gluPOPS) was used as a model for evaluating the 
oxidative modification of glycated PS. POPS was chosen as model due to its prevalence in 
biological systems and the potential outcomes of its structural alterations. The fatty acid 
composition of POPS, i.e., saturated chain in the sn-1 position and mono-unsaturated chain 
in sn-2 position, makes it less susceptible to oxidation in comparison with polyunsaturated 
fatty acids (PUFA). This property facilitates the evaluation of the oxidative changes that 
can occur in glycated polar head group and the identification of potential advanced 
glycated end products. 
Glycation of POPS was monitored by electrospray tandem mass spectrometry (ESI-
MS/MS) in negative mode (Figure 25) and the representative fragmentation pathways were 
identified. In the ESI-MS/MS spectrum of the [M−H]− ion of gluPS the most abundant 
product ions were observed at m/z 760.3 and 673.3, arising respectively from the loss of 
the glucose moiety (−162 Da) and from the combined loss of aziridine-2-carboxylic acid 
plus glucose moiety (loss of 87 Da + 162 Da) ( Figure 25B). Neutral loss of 87 Da is a 
well-known PS fragmentation pathway, observed when performing ESI-MS/MS in 
negative mode. Other minor product ions were also observed, which can be attributed to 
glucose cleavages with loss of 90 Da (C3H6O3) (m/z 832.3), loss of the fatty acyl chains 
(m/z 391.2 and 417.2) and, the oleoyl carboxylate anion (R2COO−) (m/z 281.2). 
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Figure 25: Tandem Mass spectrometric analysis of glycated POPS in negative mode: ESI-MS/MS 
spectrum of the ions at m/z 992.4 ([M-H]-) correspondent to the glycated POPS 
Oxidation of glycated POPS was induced using Fenton oxidant (H2O2/Fe
2+), as 
described in the experimental section, and the formation of oxidation products were 
monitored by ESI-MS and LC-ESI-MS in negative mode. Analysis of the ESI-MS spectra 
of the solutions after (Figure 26B) and before the oxidative reaction (Figure 26A) revealed 
the presence of new [M−H]− ions, assigned as oxidation products. Also, in these spectra, 
we can observe the ions at m/z 760.3 correspondent to native POPS, and the ions at m/z 
922.4 correspond to gluPOPS. In Figure 26B we have assigned some of the ions that were 
attributed to the oxidation products of POPS (m/z 774.4, 776.4, 792.3) and gluPOPS (m/z 
936.3, 938.3, 954.3, 984.2), as keto (+14 Da), hydroxyl (+16 Da) and hydroperoxy (+32 
Da) derivatives. An oxidation product resultant from the oxidative cleavage of serine 
moiety in glycated polar head with lower molecular weight than POPS was also identified 
as [PS−29 Da−H]−. This oxidation product was assigned as [M−H]− ion at m/z 731.4 and 
presents a terminal acetic acid linked to the phosphate group, as shown in Scheme 10. A 
similar cleavage in the serine moiety was previously identified in PS oxidation, and 
presumably results from a radical attack to the alpha carbon of serine in polar head group 
[168]. In Figure 26B, other oxidation products can be observed in the mass range between 
m/z 760.5 (POPS) and 922.5 (gluPOPS). This suggests the presence of oxidative species 
resulting from the oxidative cleavage of the glycated moiety in gluPOPS (Scheme 10). In 
order to identify the gluPOPS oxidation species and to unveil possible isomeric structures, 
we have further analyzed the oxidative mixture using LC–MS and LC–MS/MS. 
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Figure 26: Mass spectrometric analysis of oxidized glycatedPOPS: ESI-MS spectra 
obtained in negative ion mode of the glycated POPS under non-oxidized (A) and oxidation 
(B) conditions. * Impurities of solvents. 
5.4.1 Oxidation products of glycated POPS analyzed by LC–MS and LC–MS/MS 
The oxidation products of glycated POPS observed at m/z 954.3 and 938.3 in MS 
spectra of the oxidative mixture ( Figure 26B) were identified as hydroperoxy (m/z 954.3) 
and hydroxy (m/z 938.3) derivatives of gluPOPS. In the LC–MS run, both these species 
eluted in one major peak at 18.9 min and 20.8 min, respectively ( Figure 27A), indicating 
the absence of isomeric species. The LC–MS/MS spectrum of the hydroxyl gluPOPS, 
[gluPS+16 Da−H]− at m/z 938.4 ( Figure 27A) showed the product ions arising from the 
loss of glucose (−162 Da) at m/z 776.4, loss of glycated polar head (−(162 Da + 87 Da)) at 
m/z 689.4 and the carboxylate anion of the hydroxyl-oleic acid at m/z 297.1 ([R2COO+16 
Da]−). Altogether, this data shows the presence of the hydroxyl group in the unsaturated 
fatty acyl chain. The LC–MS/MS spectrum of the hydroperoxy derivative ([gluPS+32 
Da−H]−) at m/z 954.4, showed the most abundant product ions arising from the loss of 
glucose at m/z 792.4.4, and loss of glycated polar head at m/z 705.4, also confirming the 
presence of hydroperoxyl group in the unsaturated fatty acyl chain ( Figure 27B). 
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Figure 27: LC-MS and MS/MS analysis of hydroxy and hydroperoxy derivatives of glycated 
POPS: Reconstructed ion chromatogram and the LC-MS/MS spectrum of the ions at m/z 938.4 
([M-H]-) correspondent to the hydroxide derivative of gluPOPS (gluPOPS+16 Da) (A). 
Reconstructed ion chromatogram and the LC-MS/MS spectrum of the ions at m/z 954.4 ([M-H]-) 
correspondent to the hydroperoxide derivative of gluPOPS (gluPOPS+32 Da) (B). 
Other oxidation products of glycated POPS like keto derivatives (m/z 936.4 (922.4 + 
14 Da)) eluted in two major peaks, one at 11.0 min and the other at 19.7 min (Figure 29A). 
This suggests the presence of two isomeric structures, confirmed by the LC–MS/MS 
spectra obtained in each retention time. The LC–MS/MS spectrum of the [M−H]− at m/z 
936.3 obtained at RT 11.0 (Figure 28B) showed product ions at m/z 760.4 identified as 
[POPS−H]−, arising from loss of a neutral with (162+14) Da, at m/z 673.3, arising from the 
neutral loss of (162+87+14) Da and the product ions at m/z 281.2, assigned as the non-
modified carboxylate anion (oleic acid anion). Altogether, these product ions indicate that 
the presence of the keto group in the glucose moiety of this oxidation product. The product 
ions at m/z 832.5 (Figure 28B) further suggests that the keto group is at C6 of the glucose 
residue, corresponding not to a keto derivative but to the formation of a glucuronic acid. 
The LC–MS/MS spectrum of the [M−H]− ion at m/z 936.3 obtained at RT 19.7 min ( 
Figure 29D), showed product ions at 774.3 (−162 Da, [PS+14 Da−H]−), m/z 687.4 (−162 
Da−87 Da, [PA+14 Da−H]−), and 295.1 ([R2COO+14 Da]−), confirming the presence of 
the keto group in the unsaturated fatty acyl chain (Figure 28E). 
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Figure 28: Differentiation of isomers of glycated POPS+O - 2Da by LC-MS and MS/MS analysis: 
Reconstructed ion chromatogram of the ions at m/z 936 ([M-H]-) correspondent to glu-PS +14 Da) 
(A). LC-MS/MS spectrum of the ions at m/z 936 ([M-H]-) , RT= 11.0 minutes (B) and the proposed 
structure (C). LC-MS/MS spectrum of the ions at m/z 936 ([M-H]-) RT= 19.7 minutes (D) and 
proposed structure (E). 
The glycated lysoPS (m/z 658.3) formed due to loss of the oleoyl fatty acyl chain was 
observed with a retention time of 7.2 min (Figure 29A). The LC–MS/MS spectrum shows 
a fragment ions arising from loss of 162 Da (m/z 496.1) loss of the glycated polar head 
(loss of 162 Da + 87 Da) (m/z 409.2). Also, we have observed the formation of a lyso the 
oxidation product at m/z 467.2 (RT 6.6 min, Figure 29B), arising from the modification of 
the polar head with the acetic terminal linked to the phosphate (lysoPS−29 Da). 
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Figure 29: LC-MS/MS analysis of lyso- derivatives formed during glycated POPS oxidation. 
Reconstructed ion chromatograms, LC-MS/MS spectra of the ions at m/z 658.3 ([M-H]-), and the 
proposed structure (A). Reconstructed ion chromatograms, LC-MS/MS spectra the ions at m/z 
467.2 ([M-H]-) and the proposed structure (B). 
Radical induced oxidation also observed in the glucose located at the glycated polar 
head. This oxidative pathway generated several products observed at lower m/z than the 
glu POPS. The occurrence of oxidative cleavage of the glucose moiety between C1-C2, 
C2-C3 and C3-C4 bonds was assigned after LC–MS/MS analysis and identification of 
typical neutral losses arising from the modified polar head, as represented in Scheme 10. 
These oxidation products were observed in the LC–MS chromatogram at m/z 788.4 
(gluPOPS−134 Da), m/z 818.4 (gluPOPS−104 Da) and m/z 832.4 (gluPOPS−90 Da). The 
retention times of these oxidation products were lower than the retention of non-modified 
gluPOPS (Figure 30).  
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Figure 30: LC-MS of POPS advanced glycated end products. Reconstructed Ion Chromatograms 
(RIC) of the ions m/z 922.5 ([M-H]-) [of glycated POPS (and of their oxidation products formed 
due to cleavages in the glucose moiety at m/z 788.2 (cleavage in C1-C2 bond), m/z 818.4 (cleavage 
in C2-C3 bond) and m/z 838.4 (cleavage in C2-C3 bond with oxidation in fatty acyl chain and 
cleavage in C3-C4 bond).  
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Scheme 10: POPS advanced glycated end products arising from hydroxyl radical oxidation. 
Oxidation in glycated serine polar head induced by the hydroxyl radical (Fenton reagent) generated 
different glycated end products due to cleavage in glucose moiety. 
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The oxidation product arising from cleavage of the glucose moiety between C1-C2 
bond (m/z 788.4) eluted in one peak at 12.0 min. The LC–MS/MS spectrum showed a 
fragment ion arising from loss of 115 Da, suggesting that the formation of formamide 
terminal (-CH2CH(COOH)NHCHO) had occurred (Figure 31A). The presence of product 
ions at m/z 673.3 ([PA−H]−), arising from the loss of the modified polar head, indicates 
that the oxidation in the fatty acyl chains has not occurred. The fragment ions observed in 
the MS/MS spectra of this oxidation product were similar to the fragment ions previously 
observed in the oxidation product of gluPAPS [236]. 
The oxidation product at m/z 818.4, arising from cleavage of the glucose moiety 
between C2-C3 bond, eluted at 11.9 min. In the LC–MS/MS spectrum (Figure 31B) we 
can see product ions at m/z 760.6, arising from the neutral loss of 58 Da. This suggests the 
presence of acetic acid attached to the amine group of phosphatidylserine (NHCH2COOH). 
The absence of evidences of oxidation in oleic acid was reinforced by the presence of the 
product ions at m/z 673.3 ([PA-H]−) and 281.1 (R2COO−) in the MS/MS spectrum. 
Glucose oxidative cleavages in C2-C3 and C1-C2 were previously identified during 
glycated PE oxidation induced by the hydroxyl radical and by photoxidation [152,235]. 
The oxidation product of gluPOPS observed at m/z 832.4 eluted at several different 
retention times, with two peaks at RT 8.6 min and 28.3 min (Figure 30). The LC–MS/MS 
spectrum obtained at 8.6 min (Figure 31C) showed the product ions at m/z 774.4 ([PS+14 
Da−H]−) arising from the loss of 58 Da. This data supports the presence of an oxidation 
product with a keto derivative in oleoyl fatty acyl chain, and a polar head with a terminal 
NHCH2COOH (formed by C2-C3 glucose cleavage). The location of the keto group in the 
oleoyl acid, was confirmed by the product ions at m/z 687.3 ([PA+14 Da−H]−), arising 
from the loss of the modified polar head group. The analysis the LC–MS/MS spectrum of 
the precursor ions at m/z 832.4 obtained at 28.3 min suggests the presence of an isomer. 
This spectra shows the product ions at m/z 760.4 ([PS−H]−), 673.3 ([PA−H]−) and 281.1 
(R2COO
−). The presence of these product ions confirmed both that the fatty acyl chains 
were not oxidized, and that the cleavage in the C3-C4 bond, with the formation of 
NHCHOHCH2CO (hydroxypropanone) terminal in the polar head, had occurred. Oxidation 
products resulting from the cleavage of the glucose moiety are well known in glycated 
peptides [237,238]. These products have been also described for glycated PE when subject 
to oxidation [152,235]. Nevertheless, there are few studies reporting the presence of 
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glycated PE oxidation products, usually called AGEs, in diabetic patients [239,240]. It is 
believed that AGE-PE accumulates more in diabetic patients with severe complications, as 
a consequence of the oxidative stress underlying hyperglycemic conditions [240]. Due to 
their similar nature, the same effect is expected to occur with PS and the search for in vivo 
oxidized glycated PS species that were identified in this study may help to define the 
molecular mechanisms underlying some pathogenic conditions. It is expectable that the 
structural alterations associated with glycation in PS, an important phospholipid in brain, 
and accumulation of PS-AGES can contribute to the increased risk of neurodegenerative 
diseases associated with diabetes. Moreover, considering the involvement of PS in cellular 
processes as apoptosis, the knowledge of PS structural alterations in response to oxidative 
stress and hyperglycemia might also help to understand the pathogenic pathways 
underlying some pathophysiological processes like diabetes mellitus and diabetic 
complications. 
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4.2.5 Conclusion 
In the present work, we have synthesized glycated PS and characterized this adduct by 
ESI-MS/MS. The glycated product was further oxidized using the Fenton reagent and the 
glyco-oxidation products were separated and analyzed by LC–MS and LC–MS/MS. We 
have found oxidation products arising both from oxidation of the fatty acyl chains and the 
glycated phospholipid head. The oxidation products, arising from the oxidation of the fatty 
acyl chains that we have found and characterized include hydroperoxides, hydroxides and 
keto derivatives. Also, we have found evidence for the presence of positional and 
functional isomers, both from the retention time and the MS/MS spectra. Oxidation 
products resulting from the cleavage of the glucose moiety were also found, including 
products arising from cleavage of the glucose moiety between C1-C2 bond with formation 
of formamide terminal; between the C2-C3 bond with acetic acid attached to amine group 
and between the C3-C4 bond with formation of hydroxypropanone terminal in polar head 
group. 
In overall, the in-depth structural characterization of glycated and glycoxidated PS 
shown in this study provides a basis for the future understanding of PS susceptibility to 
glycation and oxidation in vivo and its relevance in specific pathophysiological conditions.
Figure 31: Tandem mass spectrometry analysis of POPS advanced glycated end products: LC-
MS/MS spectra and proposed structures for the oxidations products that result from cleavages of 
carbon bonds in the glucose moiety. LC-MS/MS spectrum and structure of the ions at m/z 788.4 
([M-H]-) (cleavage in C1-C2 bond) (A). LC-MS/MS spectrum and structure of the ions at m/z 
818.4 ([M-H]-) (cleavage in C2-C3 bond) (B). LC-MS/MS spectrum and structure of the ions at 
m/z 832 ([M-H]-) (cleavage in C2-C3 bond and with keto/epoxy group in fatty acyl chain) (C). 
LC-MS/MS spectrum and structure of the ions at m/z 832.4 ([M-H]-) (cleavage in C3-C4 bond) 
(D). 
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5.1 Abstract 
Phosphatidylserine (PS) is preferentially located in the inner leaflet of the cell 
membrane, and translocation of PS oxidized in fatty acyl chains to the outside of 
membrane has been reported as signaling to macrophage receptors to clear apoptotic cells. 
It was recently shown that PS can be oxidized in serine moiety of polar head-group. In the 
present work, a targeted lipidomic approach was applied to detecting oxPS modified at the 
polar head-group in keratinocytes that were exposed to the radical generator AAPH. 
Glycerophosphoacetic acid derivatives (GPAA) were found to be the major oxidation 
products of oxPS modified at the polar head-group during oxidation induced by AAPH-
generated radicals, similarly to previous observations for the oxidation induced by 
OHradical dot radical. The neutral loss scan of 58 Da and a novel precursor ion scan of m/z 
137.1 (HOPO3CH2COOH) allowed the recognition of GPAA derivatives in the total lipid 
extracts obtained from HaCaT cells treated with AAPH. The positive identification of 
serine head group oxidation products in cells under controlled oxidative conditions opens 
new perspectives and justifies further studies in other cellular environments in order to 
understand fully the role of PS polar head-group oxidation in cell homeostasis and disease. 
 
Keywords: Phosphatidylserine; Keratinocytes; AAPH; Oxidative stress; Mass 
spectrometry; Shotgun lipidomic 
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5.2 Introduction 
Phosphatidylserine (PS) is a phospholipid that has been identified to be a preferential 
target of in vivo oxidation. PS is located preferentially in the inner leaflet of cell 
membranes, but PS oxidation products are translocated to the outside of membrane. These 
products are considered to be markers of the early stages of apoptosis. It is known that one 
of the first steps of cellular apoptosis involves PS oxidization in the fatty acyl chains that 
are recognized by macrophages receptors for the clearance of apoptotic cells [98,102,241]. 
Several studies showed that oxidized PS is preferentially recognized by macrophage 
scavenger receptors over non-oxidized PS [96,100,103,104]. The oxidation products of PS 
identified in vivo consisted of oxidative modifications in the fatty acyl chains, such as PS 
hydroxide and hydroperoxide derivatives and truncated sn-2 fatty acyl species 
[104,132,133]. These types of oxidation products retained an intact PS head-group and are 
usually identified by the typical fragmentation pathways under MS/MS conditions, which 
involved the loss of the serine group [133,168,194]. However, in a recent study of 
oxidation of PS standards using the Fenton reagent, it was observed that the PS head-group 
can also undergo oxidative modifications leading to the formation of modified polar head-
groups [168,242]. Among these oxidation products, the derivatives with a polar head-group 
containing an acetic acid linked to the phosphate group, called glycerophosphoacetic acid 
(GPAA), were found to be the most abundant [168]. These products showed a distinct 
fragmentation and neutral loss under MS/MS conditions and the typical loss of the serine 
group is absent. This behavior explains why this type of PS oxidation product has been 
overlooked. As yet, PS modified in the serine polar head-group has only been found in 
mitochondria from brain of rats treated with tacrine, which is associated with neurotoxicity 
and oxidative stress conditions [217]. Evaluation of pro-inflammatory activities of PS 
oxidation products with modifications in serine polar head-group was tested through 
cytokine production, and it was found that GPAA had no pro-inflammatory activity [242]. 
Until now, no other efforts have been made to detect these species with oxidative 
modifications on the polar head-group of PS. Nevertheless, it is likely that they can occur 
in vivo, in cells exposed to oxidative conditions. 
To give new insight into this subject, the present work aimed to evaluate the formation 
of GPAA species in keratinocytes (HaCaT cells) after exposure to a radical generator. 
Keratinocytes were selected as a cell model since externalized PS and oxidation of fatty 
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acyl chains in PS were identified in human keratinocytes during oxidative stress  [55,243].  
These cells are frequently used in oxidation studies, because they are susceptible to 
modifications under oxidative stress conditions, such as UV, organic peroxides, or radical 
generators such as AAPH [124,156,244,245]. The immortal human keratinocyte line 
HaCaT is frequently employed for studies of skin keratinocytes in vitro, since they retain 
their differentiation capacity [246]. Keratinocytes were incubated with the water-soluble 
azo-initiator (AAPH), which is frequently used in vitro for oxidation studies. The GPAA 
derivatives were detected in total lipid extracts using a targetted lipidomic approach 
involving neutral loss and precursor ion scanning modes, following optimization of this 
strategy with commercial 1-palmitoyl-2-oleoyl-phosphatidylserine (POPS) as a model 
system. 
 
5.3 Materials and methods 
Materials 
2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH) was from Sigma Aldrich. 
Trypsin and Dulbecco’s Modified Eagle Medium (DMEM) were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Fetal calf serum, streptomycin and penicillin were 
purchased from Invitrogen (Paisley, UK). 1-Palmitoyl-2-oleoyl-phosphatidylserine (POPS) 
was purchased from Avanti Polar Lipids, Inc. (Alabaster, AI, USA). Chloroform 
(Analytical reagent grade), and methanol (HPLC grade) were from Fisher (UK). 
 
Oxidation of phosphatidylserine with AAPH 
Vesicles of POPS were prepared in ammonium bicarbonate buffer 5 mM (pH 7.4). In 
a typical experiment, 250 μg of phospholipid dissolved in chloroform was evaporated to 
dryness, the buffer was added and the mixture was vortexed for 2 min and then sonicated 
for 1 min in a sonicating water bath. The oxidation was performed by addition of 15 μL of 
AAPH to a final concentration of 30 mM and 50 mM in a volume of 250 μL. The mixture 
was incubated at 37 °C in the dark for 24 h. The phospholipid oxidation products were 
extracted using a modification of the Folch method [169] with chloroform–methanol (2:1, 
v/v). 
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Cell culture 
The human keratinocyte cell line HaCaT was obtained from DKFZ (Heidelberg, 
Germany). HaCaT is a spontaneously transformed immortalized human epithelial cell line 
from adult skin that maintains full epidermal differentiation capacity [247]. The cells were 
used after reaching 70–80% confluence, which occurs approximately every 3 days after 
initial plating. Cells beyond passage 45 were discarded. The cells were cultured in 
Dulbecco’s Modified Eagle Medium (high glucose) supplemented with 4 mM glutamine, 
10% heat inactivated fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL 
streptomycin at 37 °C in a humidified atmosphere of 95% air and 5% CO2. 
 
Chemical treatment 
HaCaT cells (15 × 106) were cultured in 150-cm2 flasks and subjected to AAPH 
exposure for 24 h, at 37 °C. The AAPH was dissolved in culture medium to obtain a final 
concentration of 30 mM and 50 mM. Control experiments consisted of untreated cells. 
 
Cell viability/metabolic activity assay 
The effects of AAPH exposure on cell viability/metabolic activity were evaluated by 
the resazurin assay [248]. Briefly, cells were plated in triplicate in a 96 well plate at a 
density of 0.4 × 106 cells/mL, in a final volume of 0.2 mL/well and exposed to 30 mM or 
50 mM AAPH. After 20 h, the cells were washed with PBS and fresh culture medium 
containing 50 μM of resazurin was added to each well. After 4 h (in a total of 24 h AAPH 
treatment) absorbance was read at 570 and 600 nm with a standard spectrophotometer 
(Multiskan GO, Thermo Scientific). Viable and therefore metabolic active cells are able to 
reduce resazurin (a blue dye) into resorufin (pink colored) and, hence, their number 
correlates with the magnitude of dye reduction. 
 
Assessment of cell PS externalization/apoptosis 
PS externalization following AAPH-cell treatment was analyzed by fluorescent 
microscopy using the FITC-Annexin V apoptosis detection kit with 7-AAD from 
Biolegend (San Diego, CA, USA). Briefly, 0.4 × 106 cells were plated in each well of a μ-
Slide 8 well plate (IBIDI GmbH, Germany), in a final culture medium volume of 0.2 mL. 
The cells were then treated with 30 mM or 50 mM AAPH for 24 h, or with 1 μM 
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Staurosporine for 4 h (as a positive control for induction of apoptosis). Cells were washed 
twice with sterile PBS and incubated for 20 min in fresh culture medium containing 2 
μg/ml Hoescht 33258 (Molecular Probes, Invitrogen, Paisley, UK). After this, medium was 
removed and the wells washed twice with PBS, following by 15 min incubation in the dark 
with FITC-Annexin V/7-AAD staining solution. After three washing steps, slides were 
analyzed with a fluorescent microscope (Nikon Corporation, Japan) at 630× magnification. 
Images were captured with a DS-Fi2 High-definition digital camera and analyzed in NIS-
Elements Imaging Software (Nikon Corporation, Japan). 
 
Lipid extraction 
For lipid extraction, untreated cells and AAPH-treated cells (after 24 h stimulation) 
were washed twice with ice-cold phosphate-buffered saline (PBS), scraped into 5 mL of 
ice-cold PBS and the cells pelleted by centrifugation at 200g for 4 min. The pellet was 
resuspended in 1 mL of milli-Q ddH2O. Thereafter, total lipids were extracted using the 
Bligh and Dyer [170]. Lipid extracts were evaporated to dryness under nitrogen and 
resuspended in 500 μL of chloroform. 
 
ESI-MS conditions 
Oxidation products of phosphatidylserine standards and HaCaT total lipid extracts 
were diluted in methanol (1:10, v/v) and detected using a 5500 QTrap mass spectrometer 
(ABSciex, Warrington, UK) operating in negative ion detection mode with direct infusion 
at a flow rate of 5 μL min−1. Mass spectra were acquired over a mass range of 400–1000 
Da. Turbo spray source temperature was set at 150 °C, spray voltage was set at −4.5 kV, 
declustering potential was set at −50 eV and nominal curtain gas flow was set at 20. 
Enhanced mass spectra were acquired at 10,000 Da/s in dynamic fill. Targeted detection of 
GPAA was performed by neutral loss scans (NLS) for 58 Da at a scan speed of 10,000 
Da/s, with collision energy set at −45 eV, Q1 set to low resolution and Q3 set to unit 
resolution. Targeted detection of GPAA by precursor ion scanning (PIS) at m/z 137.1 were 
collected at 1000 Da/s scan speed with step size of 0.5 Da, collision energy at −45 eV and 
with Q1 and Q3 set to unit resolution. Enhanced product ion (EPI) spectra were acquired 
for the ion of interest with collision energy varying between 40 and 50 eV. Dynamic fill 
time was used with a maximum fill time of 250 ms and all other parameters optimized to 
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give maximum signal. There was a small error in the calibration of the instrument, 
resulting in masses slightly higher than the theoretical mass of the lipids by 0.1–0.2 Da, 
especially in targetted scan modes. 
 
5.4 Results and discussion 
To observe whether PS polar head-group oxidation occurred in HaCaT cells after 
AAPH incubation, as observed after radical oxidation of PS by hydroxyl radical [168,236], 
cells were subjected to oxidation with AAPH (30 and 50 mM). The oxidative stimuli used 
were the same as reported in a previous study that mimicked oxidative stress injury in 
keratinocytes as a model of inflammation [156]. AAPH was chosen as it is a water-soluble 
azo-initiator frequently used for oxidation studies, using in in vitro, model systems. AAPH 
after activation lead to alkylperoxyl radicals and akylperoxides that are capable of 
initiating radical lipid peroxidation in liposomes and cells [156]. 
As can be observed in Figure 32A and B, the concentrations of AAPH used 
effectively induce apoptosis in keratinocytes, as demonstrated by PS externalization and a 
marked decrease in cell metabolic activity. Moreover, apoptosis induction was clearly 
dependent on AAPH concentration, as keratinocytes treated with 50 mM were uniformly in 
the late stage of apoptosis, characterized by massive externalization of cell membrane PS 
(in green) and nuclear binding of the 7-AAD probe (in red). These findings support the 
AAPH-treated HaCaT cell model as a suitable one to investigate the oxidation of PS in 
apoptosis. 
 
Detection of phosphatidylserine with a modified polar head group in human keratinocytes exposed to the radical 
generator AAPH 
119 
 
Figure 1  
 
 
 
 
A 
B 
Figure 1: Effect of AAPH on cell metabolic activity and PS externalization. A) Cells were treated with 
30 mM or 50 mM AAPH during 24h and the viability was assessed by resazurin assay. In this assay 
metabolic conversion of resazurin into resorufin will be proportional to cell viability. B) Keratinocytes 
were treated with 30 mM or 50 mM AAPH during 24h, and the apoptosis stage was analyzed by 
fluorescent microscopy using Annexin V, 7-AAD and Hoescht 33258  probes. Intact cells appear with 
just blue nuclei, early apoptotic cells present blue nuclei and green membranes (PS externalization) 
and finally late apoptotic cells present marked green fluorescence and red nuclei. Images 
representative of different fields were acquired with a DS-Fi2 High-definition digital camera coupled 
to a Nikon fluorescent microscope (magnification 630x) and analyzed in NIS-Elements Imaging 
Software (Nikon Corporation, Japan). Bar scale : 10 µm 
  
 
Figure 32: Effect of AAPH on cell metabolic activity and PS externalization. A) Cells were treated 
with 30 mM or 50 mM AAPH during 24h and the viability was assessed by resazurin assay. In this 
assay m tabolic conversion of resazurin into resorufin will be roportional to cell viability. B) 
Keratinocytes were treated with 30 mM or 50 mM AAPH during 24h, and the apoptosis stage was 
analyzed by fluorescent microscopy using Annexin V, 7-AAD and Hoescht 33258  probes. Intact 
cells appear with just blue nuclei, early apoptotic cells present blue nuclei and green membranes 
(PS externalization) and finally late apoptotic cells present marked green fluorescence and red 
nuclei. Images representative of different fields were acquired with a DS-Fi2 High-definition 
digital camera coupled to a Nikon fluorescent microscope (magnification 630x) and analyzed in 
NIS-Elements Imaging Software (Nikon Corporation, Japan). Bar scale : 10 µm 
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The analysis of the lipid extracts obtained from keratinocytes was first undertaken 
using ESI-MS in negative mode (Figure 33). PS species were observed as [M−H]− in low 
abundance since they are minor PL in total extracts, and thus oxidation products were not 
detectable. In order to achieve the sensitivity required to identify PS oxidation species, 
either in the fatty acyl chain or the polar head-group, a targeted shotgun lipidomic 
approach involving neutral loss scanning of 87 Da was performed on control and oxidized 
cell extracts (Figure 34). Loss of 87 Da is a well-known and typical fragmentation of 
phosphatidylserine under MS/MS conditions. The most abundant phosphatidylserine 
species observed were at m/z 788.7, identified as PS-(18:0/18:1), and at m/z 760.7, 
identified as PS-(16:0/18:1). It should be noted that the observed masses of the 
phospholipids were slightly above their theoretical masses (e.g. 788.54 for PS-(18:0/18:1), 
owing to small deviations in the calibration of the instrument. The composition of non-
modified PS species was confirmed by MS/MS. The full list of PS species observed are 
summarized in Table 5; many of these species have been identified previously in 
keratinocytes and cell cultures  [234]. 
 
 
Figure 33: The lipid profile of control HaCaT cells. MS spectrum obtained in negative ion mode 
from total lipid extract of HaCaT cells. 
Table 5: Identification of major PS species identified by NLS of 87 Da in the HaCaT cells lipid 
extract, with the indication of the m/z values of the [M-H] ions observed. 
 
PS species (fatty acyl 
composition) 
NLS of 87Da 
[M-H]- m/z 
16:0/18:1 760.7 
18:0/18:2 786.7 
18:0/18:1 
16:1/20:0 
788.7 
18:0/18:0 790.7 
18:0/20:2 814.7 
18:0/22:6 834.7 
18:0/22:5 836.7 
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Figure 34: The lipid profile of control and cells exposed to AAPH. Spectra of neutral loss of 87 Da 
scanning of lipid extracts of HaCaT cells. (A) Control lipid extracts. (B) Lipid extracts obtained 
from HaCaT cells incubated with 30 mM AAPH. (C) Lipid extracts obtained from HaCaT cells 
incubated with 50 mM AAPH 
Comparing the spectra obtained by NLS of 87 Da from the total lipid extract of 
HaCaT cells treated with AAPH (30 mM and 50 mM) with control HaCat cells, no 
differences between spectra were observed, suggesting that PS modified exclusively in 
fatty acyl chains are not formed or were formed at very low abundance and not detected 
under the experimental conditions used. However, we used direct infusion of a total lipid 
extract and it is possible that ion suppression of oxidized PS with oxygenated acyl chains 
occurred. For complete confidence in the absence of these oxidation products, an LC–MS 
analysis would be required. In contrast, using NLS of 58 Da, which is selective for GPAA 
as a polar head-group, clear evidence for the oxidation of the PS head-group in cells treated 
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with 50 mM AAPH was obtained (Figure 35). The neutral loss of 58 Da is a characteristic 
fragmentation of GPAA, which contains an acetic acid functional group as a polar head-
group (Scheme 11), as described previously [168,236,249]. In GPAA fragmentation the 
neutral loss of 87 Da does not occur. In Figure 35, ions at m/z 731.6, 757.5, 759.5 and 
807.7 were observed and identified as GPAA derivatives, and their identity was confirmed 
by further MS/MS studies. The MS/MS spectrum of the most abundant ion at m/z 759.5 is 
shown as an example in Figure 36. This precursor ion is 29 Da smaller than an un-
modified PS at m/z 788.6, and fragments to yield product ions at m/z 281.3 and 283.3, 
corresponding to the deprotonated oleic acid and stearic acid, respectively, and an ion at 
m/z 419.3 corresponding to lyso-phosphatidic acid, LPA-(18:0). The ion at m/z 253.3 also 
indicates the presence of a GPAA-(16:1/20:0) species. This enabled the identification of 
m/z 759.5 as the product of PS-(18:0/18:1) oxidation in the serine polar head-group. 
 
Figure 35: PS oxidized in the serine headgroup was observed in HaCaT cells after oxidative stress. 
Spectrum of neutral loss scan of 58 Da obtained from HaCaT cells incubated with 50 mM AAPH. 
 
 
Scheme 11: Phosphatidylserine and glycerophosphoacetic acid (GPAA) structures. Specific neutral 
loss of 87 Da from non-modified PS and neutral loss of 58 Da from GPAA. Formation of an ion at 
m/z 137 observed during GPAA fragmentation. 
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Figure 36: Tandem mass spectrometric analysis of GPAA species. MS/MS spectrum of the ion 
[MH] at m/z 759.5 corresponding to the GPAA species formed by PS head group oxidation. 
Interestingly, in all the MS/MS spectra of GPAA derivatives (Figure 36) it was 
possible to observe a product ion at m/z 137.1, which was assigned as HOPO3CH2COO
− 
following fragmentation studies. This product ion is absent in the MS/MS spectra of un-
modified PS and it was not observed in our previous work that identified GPAA 
derivatives for the first time, because those experiments were conducted in a linear ion trap 
mass spectrometer; these instruments have a cut off of 30% of the m/z value of the 
precursor ion, so the ion at m/z 137 could not be detected. This demonstrates the 
advantages of a Q-trap for the identification of novel diagnostic ions for lipid oxidation 
products. To test the value of this diagnostic marker, PIS at m/z 137.1 was used to confirm 
the occurrence of GPAA modifications in cells exposed to AAPH (Figure 37), and lipids 
containing GPAA were clearly observed in samples treated with 30 and 50 mM AAPH. 
These novel results show that PIS for this diagnostic ion is more sensitive than NLS for 58 
Da, which only allows detection of GPAA under the higher stress conditions, but its 
selectivity is not as good, as several ions that did not correspond to the GPAA derivatives 
were also observed, such as ions at m/z 746.9 and 818.8/818.9. The combined information 
from NLS of 58 Da and precursor ion scan (PIS) 137.1 allowed confirmation of the 
presence of species that correspond to the GPAA derivatives in HACT cells. Table 6 
summarizes the ions corresponding to GPAA that were observed in the NLS of 58 and PIS 
m/z 137 spectra obtained from total lipid extract of HaCaT cells incubated with 30 mM and 
50 mM of AAPH. 
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Table 6: The major GPAA species observed in HaCaT cells incubated with 30 mM and 50 mM 
AAPH and the m/z values of the [MH] ions observed in the 58 Da of HaCaT cells incubated with 
50 mM AAPH, and in the PIS at m/z 137.1 for HaCaT cells incubated with 30 mM and 50 mM 
AAPH. 
 NLS of 58 Da PIS m/z 137 
GPAA species 30mM 50mM 30mM 50mM 
16:0/18:1 - 731.6 - 731.7 
18:0/18:2 - 757.5 757.7 757.7 
18:0/18:1 
16:1/20:0 
- 759.6 759.7 759.7 
18:0/18:0 - - - 761.6 
18:0/22:5 - 807.6 - 807.7 
 
 
 
Figure 37: Use of the diagnostic marker at m/z 137.1 to detect oxidized PS in cells exposed to 
AAPH. (A) Spectrum of precursor ion scanning of the ion at m/z 137.1 obtained from control 
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HaCaT cells. (B) Spectrum of precursor ion scanning of the ion at m/z 137.1 obtained from HaCaT 
cells incubated with 30 mM AAPH during 24 h. (C) Spectrum of precursor ion scanning of the ion 
at m/z 137.1 obtained from HaCaT cells after incubation with 50 mM AAPH during 24 h. 
To confirm and corroborate our results from HaCaT cells, further characterization of 
oxidation and fragmentation pathways following AAPH-induced oxidation of a PS 
standard, 1-palmitoyl-2-oleoylphosphatidylserine (POPS (16:0/18:1), was performed. The 
reaction was monitored by ESI-MS and MS/MS in negative ion. POPS was selected since 
PS (18:0/18:1) and PS-(16:0/18:1) are known to be the most abundant species of PS in 
HaCaT cells [234]. Analysis of the ESI-MS spectrum obtained for POPS after treatment 
with AAPH (Figure 38A) allows several deprotonated molecular ions ([M−H]−) to be 
identified, corresponding to the PS oxidation products. The ions at higher m/z than the 
native POPS (m/z 760.6) were found to be oxidation products of the unsaturated fatty acyl 
chain (m/z 776.6, PS+16 Da (hydroxy), 792.6, PS+32 Da (hydroperoxy), m/z 774.6, PS+14 
Da (keto/epoxy derivatives). These are typical oxidation products of PS observed 
previously both in vitro and in vivo [121,122,123,133,168]. Other ions at m/z values 
smaller than the non-modified PS were also detected and were identified as oxidation 
products with modifications in the serine polar head-group. These products were identified 
as PS with a glycerophosphoacetic acid linked to the phosphate group (GPAA), (m/z 
731.6), confirming that the PS modified at the polar head-group can be formed during 
AAPH-induced radical attack, as previously reported during the oxidation of PS induced 
by hydroxyl radical [168]. Oxidation products at the serine polar head-group and the fatty 
acyl chain (m/z 745.6 (GPAA+14 Da), 747.6 (GPAA+16 Da) and 763.6 (GPAA+32 Da) 
were also identified (Figure 38). Tandem mass spectrometry (MS/MS) was used to confirm 
the previous assignments. In the ESI-MS/MS spectra of GPAA in negative ion mode a 
neutral loss of 58 Da was observed, corresponding to the loss of CH3COOH (acetic acid). 
These PS oxidation products are easily differentiated from the native PS and PS oxidized at 
the fatty acyl chains, as the latter show a typical neutral loss of 87 Da (loss of aziridine-2-
carboxylic acid). Also, comparing the ESI-MS/MS spectra of non-modified POPS and 
GPAA, it can be seen that the product ion at m/z 137.1 (assigned as HOPO3CH2COO
−) is 
only present in the GPAA MS/MS spectrum. Figure 38B and C shows that by using neutral 
loss scanning (NL of 87 Da and NL of 58 Da) precursor ion scan (PIS) at m/z 137.1 based 
on these distinct fragmentation profiles of PS oxidation products, it was possible to identify 
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GPAA derivatives in the total lipid extracted obtained from HaCaT cells incubated with 
AAPH. 
 
Figure 38: Mass spectrometric analysis of oxidized POPS by different scanning routines. (A) MS 
spectrum obtained in negative ion mode of an oxidized mixture of POPS showing the [MH] ions. 
Oxidation of POPS was induced after incubation with 30 mM AAPH. (B) Spectrum of neutral loss 
scanning of 87 Da obtained from an oxidized mixture of POPS. (C) Spectrum of neutral loss 
scanning of 58 Da obtained from an oxidized mixture of POPS. (D) Spectrum of precursor ion 
scanning of the ion at m/z 137.1 obtained from an oxidized mixture of POPS. Mass spectra were 
acquired using a 5500 QTrap mass spectrometer. 
AAPH is a water-soluble azo-initiator which generates peroxyl radicals (Scheme 12, 
equation 1) at a constant rate and at a given temperature by thermal decomposition [154] 
and is independent of the cellular metabolism. The AAPH peroxyl radical intermediate is 
the reactive oxygen species responsible for the oxidation of biomolecules such as lipids 
and peptides and proteins. The formation of the GPAA derivatives occurs due to the 
AAPH-induced oxidation at the serine polar head-group, similar to the mechanism that 
occurs in amino acids and peptides [250]. This reaction is proposed to be initiated by the 
AAPH peroxyl radical, which causes the abstraction of the hydrogen linked to the α-
carbon, generating a tertiary radical that is stabilized by the amine nitrogen and carbonyl 
group [154]. This carbon-centered radical reacts with an oxygen molecule and decomposes 
further leading to other oxidation products. Oxidative decarboxylation with formation of an 
additional keto group is usually observed during amino acid oxidation [208]. This occurs 
due to the loss of CO2 from C terminal via β-scission of an alkoxyl radical at the C 
terminal α-carbon (Scheme 12 equations 2 and 3) [209].  
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Scheme 12: Reaction pathways that occurred during PS polar head oxidation by AAPH radical 
generator: Decomposition of AAPH produces molecular nitrogen and two carbon centered radicals. 
The carbon radicals may react with molecular oxygen to give peroxyl radicals (1). There are two 
possible pathways for the formation of GPAA derivatives from PS oxidation. PS polar head group 
may be deaminated and carboxylated to yield an aldehyde one carbon shorter than the original and 
the aldehyde may be oxidized to a carboxylic acid (2). Alternatively PS polar head group may be 
transaminated, resulting in the formation of an a-keto acid which can be oxidatively decarboxylated 
to yield a carboxylic acid one carbon shorter than the original PS polar head (3). 
In spite of the important role of PS oxidation, there is limited knowledge of the 
modifications that can be generated in this phospholipid under oxidative stress, particularly 
in the serine polar head-group. The possibility of formation of several oxidation products 
makes it important to define exactly which are being formed during stress, so that 
biological effects can be correctly linked to the precise products. PS is normally 
maintained in the inner leaflet membrane by the action of aminophospholipid translocase; 
it seems probable that GPAA derivatives in membranes, like PS oxidized at the fatty acyl 
chains, would not be recognized by this enzyme, thus promoting the presence of PS 
modified in polar head-group in outer leaflet membrane and contributing to the recognition 
of apoptotic cells. Interestingly, a recent study evaluated the capacity of GPAA to 
stimulate monocytes and dendritic cells to produce pro-inflammatory cytokines and the 
results showed that GPAA has no pro-inflammatory activity [242]. Nevertheless, the 
specific role of these species in remains to be elucidated and more studies are needed. PS 
oxidized at the polar head-group may also have a significant role in these processes and 
should be explored further in the future. 
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5.5 Conclusions 
This study highlights that oxidation of the serine polar head group, as well as fatty acyl 
chains, in phosphatidylserines in keratinocytes can occur after radical attack by the azo-
initiator AAPH, and is likely to be missed by conventional techniques for identifying PS 
oxidation that depend on detection of the PS head-group. The GPAA derivatives formed 
due to serine head-group modification can be identified using an improved targetted 
lipidomic approach, based on the observation that GPAA oxidative products have a 
specific fragmentation pathway producing a product ion at m/z 137 (HOPO3CH2COOH) 
and a neutral loss of 58 Da. Further studies are needed to investigate the possible formation 
of these species in other cell and tissues. 
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6.1 Abstract 
Extensive exposure to UVA is thought to increase the risk, malignancy and 
progression of human melanoma, the most serious type of skin cancer. Furthermore, it is 
well known that alterations in lipid metabolism represent an early event in carcinogenesis. 
Thus, in this study we aimed to investigate if UVA exposure exerted changes in lipid 
composition in melanoma cell lines. After UV irradiation, the lipid extracts from SK-MEL-
28 cells were analyzed at 0, 2 and 24 hours. The fatty acids analysis were performed by 
GC-MS and the analysis of phospholipids were performed by LC-MS and MS/MS. The 
results showed an increase of mono-unsaturated fatty acid (MUFA), as well as, an increase 
of stearic acid (FA18:0). In contrast, a decrease of palmitic acid (FA16:0) was observed. 
The most significant changes in phospholipids content occurred in phosphatidylcholines 
(PC) and phosphatidylinositol (PI) classes. The results revealed a decrease of PC and an 
increase of PI content in human melanoma cells after UV irradiation. Moreover, LC-MS 
data showed a specific response at the molecular level within each class, with increase of 
MUFA with time, similar with a variation of FA profile. Overall, these data indicate 
membrane lipid changes associated with lipogenesis after UVA exposure which, in turn, is 
usually determinant for cell survival. The absence of cleaved caspase-3 after 2 h and 24 h 
of re-incubation correlates with impairment of apoptosis. The observed alterations in the 
lipid metabolism may be correlated with malignant transformations associated with cancer 
development and progression. Thus, lipids might constitute challenging therapeutic targets 
for the treatment of highly resistant-melanoma. 
 
Keywords: UVA, Phospholipids, fatty acids, melanoma, LC-MS, apoptosis 
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6.2 Introduction 
Solar radiation is considered the most relevant environmental carcinogen causing 
melanoma, a cutaneous cancer with increasing incidence in white populations [251]. The 
toxic effects resultant from sun exposure are primarily mediated by UV radiation, which is 
known to cause mutations in melanocytes and initiate melanoma. Nonetheless, information 
is still lacking regarding the role of UV radiation on melanoma progression and outcome. 
It is generally accepted that UVB is the most aggressive amongst radiations’ wavelengths 
and is capable of initiating melanoma [252]. Both UVB and UVA exposures for long 
periods have deleterious effects and contribute to the onset of the disease, although the 
impact of UVA is less extensive (as reviewed in [253]). The molecular mechanisms that 
underlie UVA toxicity are not fully elucidated. Among the candidates are the formation of 
free radicals and DNA damage, which render cells prone to aging, mutagenesis, and 
carcinogenesis [157,158]. Since UVA is the most prominent component of terrestrial UV 
radiation, contributing in 90-95% in total, its biological effects and impact on photo-
carcinogenesis and tumor progression has been receiving increasing attention 
[160,161,162]. 
Activation of lipid metabolism is an early event in carcinogenesis and a hallmark of 
many types of cancers [254,255]. Therefore, the study of lipidomics is one of the main 
current focus in cancer research. Lipids are key components of cell membranes, providing 
structural support, conditioning fluidity, and regulating permeability and stability of 
biological membranes, as well as, acting as important players in signal transduction 
[254,256,257]. Alterations in the lipid profile have been correlated with cell differentiation 
and malignancy [258]. For instance, phosphoinositides and ceramides are precursors for 
second messengers in signaling pathways that regulate cell growth and proliferation 
[254,259,260,261]. De novo lipid synthesis, particularly of fatty acids (FA), is required for 
carcinogenesis and tumor cell survival, as reported in prostate and breast cancers 
[255,262]. The enhanced metabolism of choline and the increase in the lysophosphatidic 
acid (LPA) content are also observed in many types of cancer [263,264,265,266,267]. 
Moreover, some acidic glycosphingolipids have been reported to be highly expressed in 
melanoma and to promote malignant properties by activating cell growth and adhesion 
UVA exposure induces changes in the lipid profile of human melanoma cells  
133 
 
signals [268,269,270]. The surface exposure of phosphatidylserine (PS) has also been 
described in melanoma cells, which seems paradoxical since PS acts as an apoptotic 
recognition signal for macrophages and tumor cells are able to evade apoptosis [66,271]. 
These and other significant findings have culminated in the identification of lipid 
composition as an additional valuable source of information on disease progression, being 
a potential biomarker for the diagnosis and prognosis of cancer [254]. The analysis of lipid 
profiles have been, nevertheless, difficult due to the presence of the several thousand of 
molecular species that characterize the human lipidome and their structural diversities 
[254]. The emerging mass spectrometry-based lipidomics strategies allow the measurement 
of many lipid species from a complex biological mixture and, thus, have been applied in 
the study of several malignancies [272,273].  
In this study, our primary goal was to obtain a deeper insight into the impact of UVA 
exposure in the dynamics of lipids, and therefore complement the already existing and 
largely explored knowledge on DNA and protein damage [274,275]. Lipidomics-based 
approaches were used to characterize phospholipids and FA profiles of human melanoma 
cells’ membranes. These data were further correlated with cell death.  
6.3 Material and Methods 
Material  
Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 100 U/mL 
penicillin and 100 µg/mL streptomycin solution (Pen/Strep), and 0.25% trypsin/1 mM 
EDTA were purchased from Gibco (Invitrogen, Spain). Phosphate buffered saline (PBS) 
were purchased from Thermo Scientific (Thermo Fisher Scientific, Germany). Caspase-3 
antibody was acquired from GeneTex (Tebu-bio, Portugal). Cleaved caspase-3 was 
purchased from Millipore (Merck Millipore, Germany). Infrared IRDye-labeled anti-rabbit 
antibody specific to Li-Cor’s Odyssey Infrared was acquired from LI-COR Biosciences 
(LI-COR Biosciences, Germany).  
Phospholipid internal standards (1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(dMPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (dMPE), 1,2-dimyristoyl-sn-
glycero-3-phospho-(1′-rac-glycerol) (dMPG) and 1,2-dimyristoyl-sn-glycero-3-phospho-
L-serine (dMPS) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). 
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Acetonitrile, chloroform, methanol and hexane from Fisher scientific (Leicestershire, UK); 
all were of HPLC grade and were used without further purification. All the other reagents 
and chemicals used were of the highest grade of purity commercially available. The water 
was of MilliQ purity filtered through a 0.22-mm filter (Millipore, USA). 
 
Cell culture and exposure to UVA 
SK-MEL-28, a human malignant melanoma cell line, was kindly given by Dr. Ricardo 
Pérez-Tomás (University of Barcelona, Barcelona, Spain). Cells were cultured in DMEM, 
supplemented with 10% FBS and 1% Pen/Strep, and maintained overnight at 37°C in a 5% 
CO2 humidified incubator. Subsequently, medium was removed and cells underwent a 20 
min period of irradiation, the time needed to deliver a total light dose of 60 J/cm2 with a 
ﬂuence rate of 50 mW/cm2 measured with a radiometer Li-COR Model LI-250. The UVA 
source, an Exo Terra Sun Glo A 40W H2104 lamp with a spectrum of emission in the 
UVA range (320–400 nm), was ﬁtted 15 cm above the cells. After irradiation, cells were 
either collected, using trypsin followed by centrifugation (1000 rpm, 3 min) or returned to 
the CO2 incubator for 2 h or 24 h, after which the same method of collection was applied. 
Collected cells were immediately frozen. 
 
Lipid extraction 
Lipids were extracted from SK-MEL-28 cells through the Bligh and Dyer method 
[276]. In brief, 3.75 mL of chloroform–methanol 1:2 (v/v) were added to each sample, 
vortexed, and incubated on ice for 30 min. After the incubation period, 1.25 mL of 
chloroform plus 1.25 mL of doubly distillated water were added, and the samples were 
vortexed and centrifuged at 153xg for 5 min at 22 ºC to obtain a two-phase system 
(aqueous top phase and organic bottom phase) [234,277]. The lipid extracts, recovered 
from the bottom phase, were dried using a nitrogen flow and stored at −20 °C until used.  
 
Characterization of phospholipids profile 
The characterization of individual molecular species of phosphatidylcholine (PC), 
lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphatidylglycerol (PG) and sphingomyelin (SM) classes was 
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achieved by mass spectrometry (MS), using a linear ion trap (LXQ; Thermo Finnigan, San 
Jose, CA, USA) mass spectrometer after separation by liquid chromatography (LC). HPLC 
system (Waters Alliance 2690) was used with a Ascentis®Si column (15 cm × 1 mm, 
3 µm) and a precolumn split (Acurate, LC Packings, USA) in order to obtain a flow rate of 
60 µL min−1. The solvent system consisted of two mobile phases as follows: mobile phase 
A (acetonitrile:methanol:water; 50:25:25 (v/v/v) with 1 mM ammonium acetate) and 
mobile phase B (acetonitrile:methanol 60:40 (v/v) with 1 mM ammonium acetate). 
Initially, 0% of mobile phase A was held isocratically for 8 min followed by linear increase 
to 60% of A within 7 min and maintained for 22 min. The LXQ was operated in the 
negative mode (electrospray voltage −4.7 kV), the capillary temperature was 275 C and the 
sheath gas flow was 8 U. Normalized collision energy™ (CE) ranged between 20 and 27 
(arbitrary units) for MS/MS experiments. Data acquisition was carried out on an Xcalibur 
data system (V2.0) [278]. Relative quantitation of individual phospholipid species was 
determined by the ratio between the area of reconstructed ion chromatogram of a given m/z 
value against the area of the reconstructed ion chromatogram of the respective class [279]. 
 
Fatty acid analysis 
The FA content of the total lipid extracts was assessed by measuring the fatty acid 
methyl esters through gas chromatography (GC), according to a previously described 
method [280]. Briefly, a methanolic solution of potassium hydroxide (2 M) and a saturated 
solution of NaCl were added to lipid extracts (20 μg). The solution was then vortexed and 
centrifuged for 5 min at 613xg to obtain a two-phase system. The FA methyl esters 
recovered from the bottom phase were dried using a nitrogen flow and resuspended in 
hexane. Methyl esters of FA were analyzed by GC-MS on an Agilent Technologies 6890N 
Network (Santa Clara, CA) equipped with a DB-FFAP column with 30 m of length, 0.32 
mm of internal diameter, and 0.25 µm of film thickness (J&W Scientiﬁc, Folsom, CA). 
The GC was connected to an Agilent 5973 Network Mass Selective Detector, operating 
with an electron impact source at 70 eV and the scanning range was m/z 40-500 in a 1 s 
cycle in a full scan mode acquisition. The oven temperature was programmed from an 
initial temperature of 80 ºC, standing at this temperature for 3 min, a linear increase to 160 
ºC at 25 ºC/min, followed by linear increase at 2 ºC/min to 210 ºC, and then at 30 ºC/min 
to 250 ºC remaining at this temperature during 10 min. The injector and detector 
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temperatures were 220 and 280 °C, respectively. Helium was used as carrier gas at a flow 
rate of 1.7 mL/min. 
 
Immunoblot assay 
Total proteins were extracted from cells with boiling 1% sodium dodecyl sulfate. The 
protein content in each sample was determined using the bicinchoninic acid assay [281]. 
Equal amounts of protein (50 μg of protein) were separated on 12% SDS-PAGE and 
transferred onto nitrocellulose membranes. Membranes were then blocked with 5% non-fat 
milk in 1×Tris buffered saline with 0.1% Tween-20 (TBST) for 1 hour at room 
temperature, washed with 1×TBST three times, and incubated with the appropriate primary 
antibody. After being washed three times with 1×TBST, cells were incubated with a proper 
secondary antibody. All antibodies were previously diluted in 3% non-fat milk in 1xTBST. 
Detection of the secondary antibodies was achieved using the Li-Cor’s Odyssey Infrared 
Imaging System (LI-COR Biosciences, Bad Homburg, Germany). Quantitative analysis 
was performed using Quantity One 1-D Analysis Software 4.6.5 (Bio-Rad, Amadora, 
Portugal). 
 
Statistical analysis 
The results were expressed as means and standard error means (mean±SD) for each 
experimental group. To obtain the correlations and similarities between groups a 2-way 
ANOVA independent-measures test followed by the Bonferroni post hoc test where 
differences were considered significant at p < 0.05. Graph pad (version 6.0) was used for 
all comparisons. 
6.4 Results 
In order to assess the effects of UVA exposure on membrane lipids, total lipids were 
extracted from SK-MEL-28 cells at three time points: immediately after UVA exposure (0 
h) and 2 h and 24 h after. Non-irradiated SK-MEL-28 cells were used as control. The 
profiles of FA and phospholipids were determined and apoptosis was analyzed for each 
sample. All experiments were performed in triplicates.  
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6.4.1 GC-MS analysis of FA profile from SK-MEL-28 cells exposed to UVA 
FA are known to influence cell proliferation both in vitro and in vivo. In this study, the 
variation of FA profile in melanoma cells exposed to UVA was determined by GC-MS. 
The relative content of each FA was calculated immediately after UVA exposure (0 h) and 
after 2 h and 24 h, as presented in Table 1. The most abundant FA have 16 and 18 carbons 
length and none or one unsaturation (16:0, 16:1, 18:0, 18:1), followed by FA ranging from 
14:0 to 22:6 (Figure 39, Table 7). Interestingly, distinct variations in the relative content of 
FA were observed in response to UVA exposure: immediately after irradiation we 
observed a decrease of FA18:1, FA20:4 and FA22:6 and an increase of the relative content 
of FA16:0 and FA16:1; after the re-incubation period of 2 h, the relative content of FA16:0 
decreased, whereas the relative content of FA18:0 and FA18:1 increased. We also 
observed an increase of the FA16:1 abundance after 24 h. The FA 20:4 levels 2 h and 24 h 
after UV exposure are similar with the control. The levels of FA 22:6 remain lower than 
the control, R.A.<1,38, throughout the experiment. Additionally, there was also variations 
on the content of saturated (SFAs) (Figure 39A), MUFAs (Figure 39B), and 
polyunsaturated FA (PUFA) (Figure 39C), when comparing control cells versus cells 
exposed to UVA. It was observed that SFA increased immediately after exposure to UVA, 
while PUFA decreased and MUFA registered only a slight increase. However, these 
tendencies revert when analyzing FA after 2 h and 24 h, since SFA and PUFA returned to 
levels similar to the control, and MUFA increased after 24 h incubation. 
 Table 7: The effect of UVA in SK-MEL-28 cell line’s fatty acid content. Relative 
abundance of fatty acids observed in GC-MS chromatogram for lipid extracts from 
melanoma cells control, melanoma cells immediately after irradiation (0 h) and after 2 h 
and after 24 h of exposition. 
 Control 0 h 2 h 24 h 
C14:0 2.82±0.42 3.48±0.12* 2.60±0.12 1.56±0.31**** 
C16:0 26.03±1.41 28.11±0.21**** 23.89±0.55**** 23.94±0.65**** 
C16:1 9.71±0.26 11.57±0.30**** 10.25±0.11 11.36±0.64**** 
C18:0 11.06±0.19 11.85±0.08** 12.91±0.21**** 13.32±0.47**** 
C18:1n9c 26.20±0.54 25.09±0.13*** 27.08±0.39** 28.20±0.31**** 
C18:1n9t 13.10±0.18 13.36±0.23 13.41±0.09 11.81±0.48**** 
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Values are mean ± standard deviation of mean for 3 replicates of each assay. Comparisons were performed 
using two-way ANOVA, with Bonferroni as a posttest for control versus 0 h, 2 h and 24 h. **** P < 0.0001, 
*** P < 0.001, **P < 0.01 and *P < 0.05. 
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Figure 39: Effect of UVA on fatty acid composition of SK-MEL-28 cell line. Effect on saturated 
fatty acids (SFAs) (A), mono-unsaturated fatty acids (MUFAs) (B) and polyunsaturated fatty acids 
(PUFAs) (C) from control cells, cells immediately after UVA exposure, after 2 h and 24 h of 
exposition. 
 
C18:2n9c 1.84±0.07 1.59±0.07 2.16±0.06 2.32±0.28 
C20:0 0.13±0.05 0.31±0.05 0.32±0.06 0.45±0.09 
C20:1n9 0.59±0.31 0.33±0.08 0.50±0.11 0.48±0.05 
C20:3n3 0.54±0.26 0.21±0.07 0.54±0.12 0.45±0.02 
C20:4n6 3.02±0.56 1.54±0.18**** 2.90±0.31 2.77±0.18 
C20:5n3 0.35±0.22 0.07±0.03 0.27±0.09 0.17±0.06 
C22:5 0.91±0.20 0.24±0.01* 0.60±0.13 0.65±0.09 
C22:6 2.63±0.05 0.97±0.05**** 1.38±0.19**** 1.17±0.17**** 
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6.4.2 LC-MS and MS/MS analysis of phospholipid profile from SK-MEL-28 cells 
expose to UVA 
The HILIC-LC-MS approach allowed the determination of the phospholipid profile at 
molecular level of melanoma cells prior and following irradiation. As an example, the 
obtained LC-MS chromatograms of the total lipid extract before irradiation and 24h of the 
incubation after the irradiation are presented in Figure 40A. After 24 h of UVA exposure, 
differences were observed in the relative abundance (RA) of phospholipid classes (Figure 
40B), particularly in PI and PC since the PI content increased while the PC content 
decreased. 
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Figure 40: LC-MS chromatogram for total lipid extracts from SK-MEL-28 cell line, both control 
cells and cells 24 h after UVA exposure (A). Relative abundance of phospholipid classes observed 
in LC-MS chromatogram for lipid extracts from control cells, cells collected immediately after 
irradiation (0 h) and after 2 h and 24 h of exposition (B). Values are expressed as mean ± standard 
deviation of 3 replicates for each assay. Comparisons were performed using two-way ANOVA, 
with Bonferroni as a posttest for control versus 0 h, 2 h and 24 h. ****P < 0.0001, **P < 0.01 
 
Individual phospholipid molecular species were further analyzed and MS data is 
presented by means of RA per phospholipid class. All species were observed in the mass 
spectra obtained in the negative ion mode as [M-H]- ions, in the case of PE, PS and PI, or 
[M+OAc]- ions, in the case of LPC, PC and SM. LC-MS/MS was performed for each ion 
to identify and confirm the respective structures, according to the typical fragmentation 
pathways [7]. Differences in the RA of the molecular species, within classes, were 
observed in the analysis of the cells collected immediately after exposure and after re-
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incubation (2 h and 24 h), in comparison to the control. SM did not evidenced significant 
differences in any moment of the experiment and, thus, were not reported herein. 
Generally, the PC is the most abundant phospholipid class in cell membranes, which 
was also verified for the SK-MEL-28 cell line (Figure 40B). The PC content significantly 
decreased upon UVA exposure (Figure 40B), particularly 24 h after irradiation. The 
molecular analysis of PC class by LC-MS and MS/MS at the distinct time points identified 
the same PC [M+OAc]- ions, but variations in their RA were detected (Figure 41A). The 
PC (16:0/18:1) is the most abundant molecular species in all LC-MS spectra and was 
observed at m/z 818.4, as shown in Figure 41A. Comparison between PC molecular species 
before and after UVA exposure revealed alterations in their RA, with significant 
differences for almost all PC molecular species identified, especially at 24h. The RA of PC 
(16:1/18:1) (m/z 816.4), PC (18:1/18:1) (m/z 844.4), PC (18:0/18:1) (m/z 846.4), PC 
(18:1/20:4) (m/z 866.4) and PC (18:1/22:5) (m/z 892.4) molecular species increased 2 h 
and 24 h after UVA exposure. The levels of the ether linked PC, with mono-saturated fatty 
acid PC (O-16:0/16:1) (m/z 776.4) increased, while saturated PC (O-16:0/16:0) (m/z 776.4) 
decreased. The RA of other molecular species bearing saturated FA, such as PC 
(14:0/16:0) (m/z 764.4) and PC (16:0/16:0) (m/z 792.4) decreased, in accordance to FA 
analysis by GC-MS.  
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Figure 41: Relative abundance of [M+OAc]- ions of PC molecular species (A) and LPC molecular 
species (B) observed in the LC-ESI-MS spectra for lipid extracts from SK-MEL-28 cell line 
(control cells, cells  collected immediately after irradiation (0 h) and after 2 h and 24 h of 
exposition). Values are expressed as mean ± standard deviation of 3 replicates for each assay. In 
inset, the PC and LPC molecular species corresponding to each [M+OAc]- ion are presented. 
Comparisons were performed using two-way ANOVA, with Bonferroni as a posttest for control 
versus 0 h, 2 h and 24 h. ***P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05 
 
Additionally, the LPC molecular species were also affected by UVA exposure (Figure 
41B). LPC were also identified as [M+OAc]- ions. An increase of LPC (14:0) molecular 
species at m/z 526.2 and a decrease of LPC (16:0) molecular species at m/z 554.2 can be 
observed immediately after exposure to UVA. However, upon re-incubation the levels of 
the LPC (14:0) molecular species decreased, while the LPC (18:0) at m/z 582.2 increased. 
Similarly to what was observed in PC and FA, the RA of the species with shorter carbon 
chain length decreased whereas the RA of species with FA 18:0 increased after exposure to 
UVA. 
The LC-MS analysis of the PE classes showed the same molecular species of PE in all 
spectra, but in contrast with PC, the RA of PE molecular species with longer and more 
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unsaturated chains (PE (18:1/18:1)/PE (18:0/18:2), PE (18:1/20:4), PE (18:0/20:4)/PE 
(18:1/20:3), PE (18:0/22:6)/PE (18:1/22:5)) decreased during re-incubation, whereas the 
RA of the molecular specie PE (O-16:1/18:1) at m/z 700.5 increased significantly after 24 
h of re-incubation (Figure 42).  
In the case of PS, the most abundant molecular species is PS (18:0/18:1) at m/z 788.4, 
which was also the only molecular species level exhibiting a significant RA decrease 
immediately after UVA exposure. The RA levels returned to near the control levels after 
24 h re-incubation (Figure 43). 
 
 
Figure 42: Relative abundance of [M-H]- ions of PE molecular species observed in the LC-ESI-MS 
spectra for lipid extracts from SK-MEL-28 cell line (control cells, cells  collected immediately after 
irradiation (0 h) and after 2 h and 24 h of exposition). Values are expressed as mean ± standard 
deviation of 3 replicates for each assay. In inset, the PE molecular species corresponding to each 
[M-H]- ion are presented. Comparisons were performed using two-way ANOVA, with Bonferroni 
as a posttest for control versus 0 h, 2 h and 24 h. ***P < 0.0001, ***P < 0.001, **P < 0.01, *P < 
0.05 
 
 
UVA exposure induces changes in the lipid profile of human melanoma cells  
143 
 
 
Figure 43: Relative abundance of [M-H]- ions of PS molecular species observed in the LC-ESI-MS 
spectra for lipid extracts from SK-MEL-28 cell line (control cells, cells  collected immediately after 
irradiation (0 h) and after 2 h and 24 h of exposition). Values are expressed as mean ± standard 
deviation of 3 replicates for each assay. In inset, the PS molecular species corresponding to each 
[M-H]- ion are presented. Comparisons were performed using two-way ANOVA, with Bonferroni 
as a posttest for control versus 0 h, 2 h and 24 h. ***P < 0.0001, ***P < 0.001, **P < 0.01, *P < 
0.05 
The most abundant PG molecular species in SK-MEL-28 cell line are PG (18:1/22:6) 
(m/z 819.4), PG (16:0/18:1) (m/z 747.4) and PG (18:1/18.1) (m/z 773.4) (Figure 44). 
Immediately after irradiation no significant changes occurred in the PG molecular profile. 
However, after 2 h and particularly after 24 h of UVA exposure, significant changes were 
detected particularly in the RA of molecular species PG (16:0/18:2) and PG (16:1/18:1) at 
m/z 745.4. It was observed an increase of the RA of these two molecular species and there 
was also a significant decrease of the RA of PG (18:1/22:6) (m/z 819.4) molecular species. 
 
 
Figure 44: Relative abundance of [M-H]- ions of PG molecular species observed in the LC-ESI-MS 
spectra for lipid extracts from SK-MEL-28 cell line (control cells, cells  collected immediately after 
irradiation (0 h) and after 2 h and 24 h of exposition). Values are expressed as mean ± standard 
deviation of 3 replicates for each assay. In inset, the PG molecular species corresponding to each 
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[M-H]- ion are presented. Comparisons were performed using two-way ANOVA, with Bonferroni 
as a posttest for control versus 0 h, 2 h and 24 h. ***P < 0.0001, ***P < 0.001, **P < 0.01, *P < 
0.05 
The content of PI class increased 24h after re-incubation, comparing to other 
phospholipids (Figure 40B). A detailed analysis of the molecular species of PI class 
(Figure 45) showed that the RA of PI (18:1/18:1) (m/z 861.5), PI (18:0/18:1) (m/z 863.5) 
and PI (18:0/20:4)/PI (18:1/20:3) (m/z 885.5) increased after UVA exposure. 
 
 
Figure 45: Relative abundance of [M-H]- ions of PI molecular species observed in the LC-ESI-MS 
spectra for lipid extracts from SK-MEL-28 cell line (control cells, cells  collected immediately after 
irradiation (0 h) and after 2 h and 24 h of exposition). Values are expressed as mean ± standard 
deviation of 3 replicates for each assay. In inset, the PI molecular species corresponding to each 
[M-H]- ion are presented. Comparisons were performed using two-way ANOVA, with Bonferroni 
as a posttest for control versus 0 h, 2 h and 24 h. ***P < 0.0001, ***P < 0.001, **P < 0.01, *P < 
0.05 
 
Assessment of apoptosis in SK-MEL-28 extracts 
The impact of UVA exposure in the programed death of SK-MEL-28 cells was also 
investigated by analyses of the activation of caspase-3, resultant from the cleavage of 
procaspase-3 (Figure 46A). Anti-procaspase-3 and anti-caspase-3 antibodies were used to 
determine the expression levels of procaspase-3 and caspase-3, respectively. Ponceau 
staining was used as loading control [282]. As depicted in Figure 46B, the expression 
levels of procaspase-3 decreased after UV exposure (2 h and 24 h), but cleaved caspase-3, 
which exhibits only residual levels in control cells, was not detected 2 h and 24h after 
irradiation 
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Figure 46: Consequences of UVA exposure in apoptosis. A) Apoptosis was assessed through the 
analysis of the expression levels of procaspase-3 and caspase-3 (the active cleaved form), a central 
player in the apoptosis signaling pathway. B) SK-MEL-28 cells were irradiated with UVA for 20 
minutes total light dose of 60 J/cm2 with a ﬂuence rate of 50 mW/cm2. Cells were immediately 
collected (2), or left to collect for 2 h (3) or 24 h (4). Non-irradiated cells (1) were used as control. 
Ponceau staining was used as loading control. 
 
6.5 Discussion  
In the present study, the effect of UVA exposure on the lipid content of SK-MEL-28 cell 
line was investigated in an attempt to correlate changes in the phospholipid bilayer of 
human melanoma cell membranes with the progression of the disease. The content of 
phospholipids and fatty acids was therefore determined after acute exposure to UVA (0 h) 
and after a recovery time (2 h and 24 h after irradiation). Several alterations in the lipid 
metabolism were identified, which may be associated with malignant transformations.  
FA are important contributors to proliferation and survival of the cancer cells and, 
accordingly, several recent studies have reported de novo synthesis of FA in these cells 
(reviewed in [283]). Thus, in this study the effect of UVA exposure on SFAs, MUFA, and 
PUFA was accessed. These classes of FA differ in their susceptibility to peroxidation and 
other structural and physicochemical properties [284]. As depicted in Figure 39, acute 
UVA exposure led to significant decrease of PUFA—the most toxic FA for melanoma 
cells in general [285]—and increase of  SFA and MUFA. UVA is known to generate high 
amounts of reactive oxygen species (ROS) that might be responsible for the degradation of 
PUFAs, which are the most susceptible to lipid peroxidation [23,284]. In mouse melanoma 
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cells, PUFAs were shown to mediate the growth inhibitory effect of transforming growth 
factor β1 [286]. Therefore, the UVA-induced reduction in PUFAs’ content found here and 
the reduced sensitity to their toxic effects, described by L.N. Andrade et al. [285], may 
partially explain the resistant phenotype intrinsic to SK-MEL-28 cells. 
Interestingly, the re-incubation of cells after UVA exposure changed SFAs and PUFAs 
trend, which returned to near control levels, but not MUFAs tendency, which was still 
increasing in a time-dependent way (Figure 39). This behavior favors the formation of 
mono-unsaturated acyl chains and FA elongation, mainly C18, suggesting preponderant 
modifications in lipid metabolism in response to UVA exposure. The increase of C18 and 
the decrease of C16 during the re-incubation period (Table 1) are in agreement with the 
proposed elongation of FAs from palmitic acid (FA 16:0), the only FA described as toxic 
for SK-MEL-28 cells [285], to stearic acid (FA 18:0) via elongation of very long chain 
fatty acids protein 6 (ELOVL6)[287,288]. Furthermore, de novo synthesis of SFAs and 
MUFAs seems to be particularly enriching for the cell membrane of mammalian cells and 
specially for cancer cells, which are able to synthesize up to 95% of SFAs and MUFAs de 
novo due to the enhanced lipogenesis [283]. This is not only crucial for tumor cell survival 
but may also contribute to the resistance of cancer cells to therapy [284]. Overall, the 
UVA-induced alterations in the FA profile of SK-MEL-28 cells may contribute to a more 
resistant phenotype, since MUFAs are less prone to lipid peroxidation and, therefore, 
prevent cells from ROS attack and increase cancer cell survival [284].  
The increase of the species FA 18:0 and MUFA has been observed in phospholipid 
molecular species and is being associated with tumor lipogenesis as a metabolic response 
to cell survival and proliferation of tumor cells [283]. Remodeling of the phospholipid 
content of the cell membrane has important biological impacts. The detailed analysis of 
phospholipid classes described in this work showed that different classes of phospholipids 
have distinct responses to UVA exposure. Moreover, within each class, there are molecular 
specie-specific responses. PC is a major constituent of eukaryotic cell membranes and, not 
surprisingly, it is the most abundant class of phospholipids in SK-MEL-28 cells. Overall, 
PC decreased in response to UVA exposure, in a time-dependent manner (Figure 40). This 
observation is largely attributed to a decrease of saturated species, whereas the RA of 
mono- and poly-unsaturated species increased.  
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When comparing with other phospholipids, the PC content significantly decreased 
after 24 h of irradiation, and although not as significant, the LPC content showed a 
tendency to increase. Balogh et al suggested in their work with B16-F10 mouse melanoma 
cells, the action of PLA2 enzyme to explain the reduction of PC species with rise of the 
correspondent LPC species after the treatment with heat and benzoyl alcohol [289]. The 
same study also showed a decrease of PI content as a consequence of the decrease of 
unsaturated species. In contrast, in our study, PUFA decreased immediately after UVA 
exposure returning to the control levels after 24 h. At 24h it was also observed the decrease 
of PC and an increase of PI content. In addition, after 24 h of UVA exposure, we observed 
a rise of the LPC (18:0) molecular species, as well as the elevation of PC and PI molecular 
species with long chains, reinforcing the idea that FA elongases action may occurred. 
Another study explored the metabolic response to Hsp90 inhibition in human melanoma 
cells. The authors associated Hsp90 inhibition with an increase of PC content, showing the 
importance of metabolic changes as potentially biomarkers of anti-cancer with Hsp90 
drugs in malignant melanoma [290]. In this study, the authors came to the conclusion that 
the UVA exposure lead to augment of melanoma progression (Figure 47). The decrease of 
PC abundance and an increase of PI abundance can be perhaps an important signal of this 
progression, as well as a signal of FA remodelation in order to promote tumor cell survival. 
Higher levels of PI and alterations in its profile have been observed by different authors in 
breast cancer cells [273,291,292]. In fact, PI is an important structural phospholipid that is 
regulated by reversible phosphorylation. The phosphorylated derivatives of PI, called 
phosphoinositides, are mediators of carcinogenesis: they bind signaling proteins, thus 
regulating numerous cellular responses (e.g. cell growth and proliferation) [257], and they 
are critical second messenger molecules of signaling pathways involved in the control of 
cytoskeletal re-organization and membrane trafficking [293]. Alterations in the remaining 
phospholipid classes were less evident. PE, which exhibited a slight time-dependent 
decrease after irradiation, was shown to have anti-tumor effects on mice melanoma cells, 
both by inducing apoptosis and inhibiting cell proliferation [294]. Thus, a decrease of PE 
could also be an adaptive response of tumor cell survival.  
The alterations in the lipid metabolism observed in this study pointed to the increased 
ability of SK-MEL-28 cells to evade apoptosis and sustain survival after UVA exposure. 
To further investigate this hypothesis we analyzed the expression of procaspase-3 and its 
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cleaved active form (caspase-3), a central player in both extrinsic and intrinsic pathways of 
apoptosis (Figure 46A). Caspase-3 is endogenously expressed as an inactive proenzyme 
(procaspase-3) which has to be cleaved into two active fragments (17 and 12 kDa) that, in 
turn, are capable of regulate downstream targets essential to induce cell death. With this 
experiment we have showed that UVA exposure clearly downregulated procaspase-3; 
however, this event did not result its an enhanced concentration of the active form (Figure 
46B). Actually, active caspase-3 was undetectable after UVA exposure, in spite of the 
already scarce levels in control cells (Figure 46B). Downregulation of procaspase-3 was 
previously demonstrated in poorly differentiated tumors in head and neck squamous cell 
carcinoma [295], and correlated with poor prognosis in resected nonsmall-cell lung cancer 
[296] and increased resistance to methotrexate- and doxorubicin-induced apoptosis in 
osteosarcoma cells [297]. Caspase-3 activation could be prevented via interaction between 
procaspase-3 and p21, a cell cycle regulator whose expression was shown to be induced by 
UV radiation [298]. On the other hand, active caspase-3 could be inactivated by IAP 
family members. Interestingly, melanoma inhibitor of apoptosis protein (ML-IAP) is 
highly expressed in melanoma and is particularly effective in inhibiting caspase-3 [299]. 
 
Figure 47: Scheme of the major findings the study of UVA-induced lipid membrane alterations in 
SK-MEL-28 cell line in order to prevent cell death 
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6.6 Conclusion  
The data obtained from human melanoma cells after UVA exposure evidenced 
membrane lipid changes associated with lipogenesis and, consequently, cell survival. The 
UVA exposure resulted in increased PI and reduced PC content in human melanoma cells. 
These results together with an increase of MUFA and FA18:0 in opposition to the decrease 
of FA16:0 after 24 h of the UVA exposure indicate de novo synthesis of MUFA and SFA. 
The absence of cleaved caspase-3 after to 2 h and 24 h of UVA exposure, supports the 
hypothesis that UVA alters the phospholipidome in human melanoma cell line in order to 
prevent cell death. These results gave further insights on the harmful effect of the UVA, 
and the consequent adaptations of lipid metabolism, that must underlie cell survival and 
proliferation, associated with carcinogenesis, tumor development and malignancy.
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7.1 Abstract 
 
Recent evidence suggests that phosphatidylserine (PS) and its oxidized species drive 
the clearance of apoptotic and necrotic cells by macrophages with putative inflammatory 
and immune response modulation. However, currently it is not clear whether PS and 
oxidized PS differentially modulate the functional responses of macrophages. The purpose 
of this paper is to deeply explore this question by evaluating the influence of PS oxidation 
products on the macrophages inflammatory status. Thus, we determined the effects of 
oxidized 1-palmitoyl-2-linoleoyl-phosphatidylserine (oxPLPS) and PLPS on the 
production of the pro-inflammatory mediator nitric oxide (NO) and the inducible NO 
synthase (iNos) and IL1 mRNA transcription levels, in RAW 264.7 macrophages, 
cultured in the absence or in the presence of the Toll-like 4 receptor agonist 
lipopolysaccharide (LPS). Additionally, a range of inflammation-associated signaling 
pathways, such as nuclear factor (NF)-B and mitogen-activated protein kinases (MAPKs) 
were also disclosed.  
The results obtained showed that both PLPS and oxPLPS species are deprived of 
intrinsic pro-inflammatory activity. Exquisitely, only oxidized PLPS were found to 
significantly inhibit NO production and iNos and IL1 genes transcription induced by LPS. 
At a molecular level, these effects were partially due to attenuation of LPS-induced c-Jun-
N-terminal kinase (JNK) phosphorylation and p65 NF-B nuclear translocation. Overall 
our data suggest that oxPLPS, but not native PLPS, mitigates pro-inflammatory signaling 
in macrophages, contributing to containment of inflammation during apoptotic cell 
engulfment. 
 
Keywords: phospholipids, oxidation, inflammation, macrophages  
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7.2 Introduction 
Clearance of apoptotic cells by phagocytes is a crucial homeostatic function in several 
cellular processes such as embryonic development, tissue remodeling and resolution of 
inflammation [300,301]. The removal of dying cells prior to the loss of plasma membrane 
integrity prevents the release of toxic or immunogenic intracellular contents, limiting the 
establishment of a deleterious inflammatory cascade and autoimmune responses.  
The role of macrophages as the main cells involved in apoptotic cell removal is 
well‐established. However, the nature of the “eat-me” signals and receptors that lead to cell 
recognition and engulfment are still in debate. Several receptors on the surface of 
macrophages such as CD14 [302], CD91 [303] and scavenge receptors [304] have been 
implicated in the recognition of apoptotic cells. The constitutive expression of the 
scavenge receptor CD36 on macrophages and dendritic cells was shown to be crucial for 
their capacity to recognize and engulf dying cells. Furthermore, ectopic expression of the 
receptor on non-professional phagocytes such as fibroblasts and melanoma cells confers 
them phagocytic activity over cells undergoing apoptosis [305,306]. 
Regarding eat-me signals, the translocation of phosphatidylserine (PS) to the outer leaf 
of cytoplasmic membrane is the central phagocytosis-associated event occurring in 
apoptotic cells [87,88,100,103]. In fact, masking PS exposure in dying cells was shown to 
inhibit their engulfment in vitro and in vivo [307,308]. However, the exact nature of the PS 
species that drive this strong eat-me signal is not totally disclosed. Greenberg and co-
workers in an elegant study about macrophage recognition of apoptotic cells via CD36 
have shown that recognition occurs via membrane associated oxidized PS (oxPS) and, to a 
lesser extent, oxidized phosphatidylcholine (oxPC), but not by non-oxidized phospholipid 
species [104].  It is well known that PS is susceptible to alterations under oxidative stress 
conditions and that these modifications occur before their externalization. During 
apoptosis, the asymmetric transbilayer distribution of PS is lost, bringing PS to the surface. 
The appearance of PS in outer monolayer of the plasma membrane could be related to its 
oxidation in membrane of apoptotic cells, and that oxidized PS may fail to be recognized 
by aminophospholipid translocases (APT), preventing the translocation to the inner leaflet 
of plasma membrane [95,96]. Oxidized PS has already been detected in apoptotic cells 
[98,241]. Besides this role in tagging apoptotic cells for engulfment, it is plausible that 
Anti-inflammatory effect of oxidized 1-palmitoyl-2-linoleoyl phosphatidylserine in activated macrophages 
155 
 
oxPS may also contribute to modulate intracellular signaling pathways in phagocytes in 
order to limit their activation. However, the role of oxidized phospholipids (oxPLs) in 
inflammatory response is unclear, and it is reported that oxPLs can present anti- or pro-
inflammatory properties [309]. The research to date has tended to focus on the effect of 
oxPC in the inflammatory response rather than oxPS. Regarding oxPS role in 
inflammation, it was demonstrated that it has pro-inflammatory properties in several cases 
including endothelial cells [114,310] and species of oxPLs were identified in some cases of 
chronic inflammation as in the case of atherosclerosis [311]. However, other studies 
suggest that some phospholipids exert anti-inflammatory actions and that this ability is 
improved upon their oxidation [312]. Accordingly, it was reported that PS is able to 
suppress the formation and release of pro-inflammatory mediators while inducing the 
production and release of anti-inflammatory cytokines (transforming growth factor β 
(TGFβ) and interleukin 10 (IL-10)) in activated macrophages [84,85,106,313]. Moreover, 
PS liposomes were shown to reduce the LPS-induced release of NO in microglial cultures 
from neonatal rat brain [108,109] and in apoptotic PC12 cells [110]. Similarly, it was 
reported that PS inhibited the production of the inflammatory mediators IL-6, IL-8, 
vascular endothelial growth factor and prostaglandin E2 in IL-1β-stimulated fibroblast-like 
synoviocytes from rheumatoid arthritis patients via modulation of NF-B and JNK/p38 
MAPK signaling pathways [314]. Despite these evidences for PS involvement in the 
modulation of inflammatory responses, knowledge regarding the influence of PS oxidation 
products is scarce.  
Therefore, in the present study, we have evaluated the influence of PS oxidation 
products in the modulation of pro-inflammatory events in macrophages. We have 
compared the effects of 1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS) 
and oxidized PLPS (oxPLPS) on LPS-stimulated RAW 264.7 macrophages. We found that 
both PLPS and oxPLPS are deprived of intrinsic pro-inflammatory activity, but that 
oxPLPS may contribute to restrain inflammatory events in macrophages during apoptotic 
cell recognition and engulfment. 
 
 
 
Anti-inflammatory effect of oxidized 1-palmitoyl-2-linoleoyl phosphatidylserine in activated macrophages 
156 
 
7.3 Material and methods 
Material 
PLPS was obtained from Avanti polar lipids, Inc. and used without further 
purification. FeCl2, EDTA and H2O2 (30%, w/w) were acquired from Merck. 
Triethylamine (Acros organics), chloroform (HPLC grade), methanol (HPLC grade) and 
ethanol absolute (Panreac) were used without further purification. TLC silica gel 60 plates 
with concentrating zone (2.5x20cm) were purchased from Merck. Dulbecco’s Modified 
Eagle Medium (DMEM), penicillin, streptomycin, resazurin and LPS from Escherichia 
coli (serotype 026:B6) were obtained from Sigma–Aldrich Química (St Louis, MO, USA). 
Fetal calf serum and trypsin were purchased from Invitrogen (Paisley, UK). The protease 
and phosphatase inhibitor cocktails, cOmplete Mini Protease Inhibitor and PhosSTOP 
respectively, were obtained from Roche (Mannheim, Germany). Antibodies against 
phospho-p44/p42 MAPK (ERK1/ERK2), phospho-p38 MAPK, phospho-SAPK/JNK, and 
anti-NF-kB p65 were from Cell Signaling Technologies (Danvers, MA, USA). Antibodies 
anti-actin and anti-lamin were from Millipore (Bedford, MA, USA) and Calbiochem 
(Darmstadt, Germany), respectively. The alkaline phosphatase-linked secondary antibodies 
and the enhanced chemifluorescence (ECF) reagent were obtained from GE Healthcare 
(Chalfont St. Giles, UK), and the polyvinylidene difluoride (PVDF) membranes were from 
Millipore Corporation (Bedford, MA). TRIzol® reagent was purchased from Invitrogen 
(Barcelona, Spain). The iScript Select cDNA Synthesis Kit and SYBR green were obtained 
from BioRad (Hercules, CA, USA). Primers were from MWG Biotech (Ebersberg, 
Germany). Unless otherwise stated, all other reagents were from Sigma Chemical Co. (St. 
Louis, MO, USA) or from Merck (Darmstadt, Germany). 
 
 
Oxidation of phosphatidylserine by Fenton reaction  
Ammonium hydrogen carbonate buffer (5 mM, pH 7.4) was added to 1 mg of 
phospholipid and the solution was vortex-mixed and sonicated for the formation of 
vesicles. Oxidative treatments using Fe (II) and H2O2, were carried out by adding 40 μM 
FeCl2 and 10 mM of H2O2 to total a volume of 500 μL of solution. The mixture was left to 
react at 37°C in the dark for several hours with agitation [168,236,249]. 
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Cell culture 
Raw 264.7, a mouse leukaemic monocyte macrophage cell line from American Type 
Culture Collection (ATCC number: TIB-71), was cultured in DMEM supplemented with 
10% non-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin 
at 37 ºC in a humidified atmosphere of 95% air and 5% CO2. Along the experiments, cells 
were monitored by microscope observation in order to detect any morphological change. 
 
Determination of cell viability by resazurin assay 
Assessment of metabolically active cells was performed using 7-hydroxy-3H-
phenoxazin-3-one-10-oxide sodium salt (resazurin) colorimetric assay as previously 
reported [248]. Briefly, Raw 264.7 cells (60×105 cells/well) were plated and allowed to 
stabilize for 12h in 200 µl medium in 96 well plates. Following this period, cells were 
either maintained in culture medium (control) or incubated with 5 different concentrations 
of the lipids to be tested. After 20h, a resazurin stock solution (500µM in phosphate 
buffered saline) was added to a final concentration of 50 µM and cells further incubated at 
37 ºC for 4h, in a humidified atmosphere of 95% air and 5% CO2. The bioreduction of the 
dye was quantified by absorbance measurement at 570 nm, with a reference wavelength of 
620 nm in an automated plate reader (Multiskan 60, Thermo Scientific). 
 
Measurement of nitrite production by the Griess reagent 
The production of nitric oxide (NO) was measured by the accumulation of nitrite in 
the culture supernatants, using a colorimetric reaction with the Griess reagent [195]. 
Briefly, 170 μl of culture supernatants were diluted with equal volumes of the Griess 
reagent [0.1% (w/v) N-(1-naphthyl)-ethylenediamine dihydrochloride and 1% (w/v) 
sulphanilamide containing 5% (w/v) H3PO4] and maintained during 30 min, in the dark. 
Culture medium was used as blank and nitrite concentration was determined from a 
regression analysis using serial dilutions of sodium nitrite as standard. The absorbance at 
550 nm was measured in an automated plate reader (Multiskan 60, Thermo Scientific).  
 
RNA extraction 
Raw cells were plated at 2x106 cells/well in 6-well microplates in a final volume of 2 
ml and treated during 24 h with PLPS (30 µg/mL) or oxPLPS (30 µg/mL). When testing 
Anti-inflammatory effect of oxidized 1-palmitoyl-2-linoleoyl phosphatidylserine in activated macrophages 
158 
 
the effect of lipids over LPS stimulation, the cells were exposed to the lipid during 1h prior 
to the addition of 1µg/ml of LPS. Total RNA was isolated from cells with the TRIzol® 
reagent according to the manufacturer's instructions. Briefly, cells were washed with ice-
cold PBS harvested and homogenized in 1 ml of Trizol by pipetting vigorously. After 
addition of 200 μl of chloroform the samples were vortexed, incubated for 2 min at room 
temperature and centrifuged at 12,000×g, for 15 min, at 4ºC. The aqueous phase containing 
RNA was transferred to a new tube and RNA precipitated with 500 µl of isopropanol for at 
least 10 min at room temperature. Following a 10 min centrifugation at 12,000g, the pellet 
was washed with 1 ml 75% ethanol and resuspended in 100 μl 60 ºC heated RNA Storage 
Solution (Ambion, Foster City, CA, USA) . The RNA concentration was determined by 
OD260 measurement using a Nanodrop spectrophotometer (Wilmington, DE, USA) and 
quality was inspected for absence of degradation or genomic DNA contamination, using 
the Experion RNA StdSens Chips in the ExperionTM automated microfluidic 
electrophoresis system (BioRad Hercules, CA, USA). RNA was stored at -80ºC until use. 
 
Real-time RT-PCR 
One microgram of total RNA was reverse transcribed using the iScript Select cDNA 
Synthesis Kit. Briefly, 2 µl of random primers and the necessary volume of RNase-free 
water to complete 15 µl, were added to each RNA sample. The samples were heated at 65 
ºC, for 5 mim, and snap-chilled on ice for 1 min. After this, 5µl of a Master Mix containing 
1 µl of iScript reverse transcriptase and 4 µl of 5x Reaction Buffer were added to each 
sample. A protocol for cDNA synthesis was run on all samples (5 min at 25 ºC, 30 min at 
42 ºC, 5 min at 85ºC and then put on hold at 4 ºC). After the cDNA synthesis, the samples 
were diluted with RNase-free water up to a volume of 100 µl. Real-time PCR was 
performed in a 20 µl volume containing 5 µl cDNA (50 ng), 10 µl 2x Syber Green 
Supermix, 2 µl of each primer (250 nM) and 1 µl H2O PCR grade. Samples were denatured 
at 95ºC during 3 min. Subsequently, 40 cycles were run for 10 sec at 95 ºC for 
denaturation, 30 sec at the appropriate annealing temperature and 30 sec at 72 ºC for 
elongation. Real-time RT-PCR reactions were run in duplicate for each sample on a Bio-
Rad My Cycler iQ5. Primers were designed using Beacon Designer® Software v7.2, from 
Premier Biosoft International and thoroughly tested. Primer sequences are given in Table 
8. 
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Table 8: Oligonucleotide primer pairs used for real-time RT- PCR. 
PRIMER 
5’-3’ SEQUENCE 
F: FORWARD; R; REVERSE 
REFSEQ ID 
HPRT1 
F: GTTGAAGATATAATTGACACTG 
R: GGCATATCCAACAACAAAC 
NM_013556 
IL-1 Β 
F: ACCTGTCCTGTGTAATGAAAG 
R: GCTTGTGCTCTGCTTGTG 
NM_008361 
INOS 
F: GCTGTTAGAGACACTTCTGAG 
R: 
CACTTTGGTAGGATTTGACTTTG 
NM_010927 
 
Amplification reactions were monitored using a SYBR-Green assay. Gene expression 
changes were analyzed using the built-in iQ5 Optical system software v2. The software 
enables analyzing the results with the Pfaffl method [304], a variation of ΔΔCT method 
corrected for gene-specific efficiencies, and to report gene expression changes as relative 
fold changes compared to control samples. The results were normalized using a reference 
gene, HPRT-1, determined with Genex® software (MultiD Analyses AB) as the most stable 
for the treatment conditions used.  
 
Western Blot 
Total cell lysates were prepared using the RIPA buffer [50 mM Tris–HCl (pH 8.0), 1% 
Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS and 2 mM EDTA] 
freshly supplemented with 1 mM DTT, protease and phosphatase inhibitor cocktails. 
Cytoplasmic and nuclear extracts were obtained by a commercial nuclear extract kit 
(Active Motif, Rixensart, Belgium), according to the manufactor instructions. Protein 
concentration of cell lysates was determined by the bicinchoninic acid protein assay. Cell 
lysates were denaturated at 95 ºC, for 10 min, in sample buffer [0.125 mM Tris (pH 6.8), 
2% (w/v) SDS, 100 mM DTT, 10% glycerol and bromophenol blue]. 
Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis transferred to 
polyvinylidene fluoride membranes and specific antibodies against phospho- or total forms 
of ERK1/2, JNK, p38 MAPKs and against NF-kB p65 were used. The immune complexes 
were detected using the enhanced chemifluorescence reagent on the Typhoon FLA 9000 
(GE Healthcare, Chalfont St. Giles, UK) and analyzed with the software ImageQuant TL® 
(GE Healthcare, Chalfont St. Giles, UK). To demonstrate equivalent protein loading, 
membranes were stripped and reprobed with antibodies against actin or lamin. 
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Statistical analysis 
The results were expressed as means and standard error means (mean±SD) for each 
experimental group. To obtain the correlations and similarities between groups a 1-way 
ANOVA independent-measures test followed by the Dunnett’s test was used and 
differences were considered significant at p < 0.05. Graph pad (version 6.0) was used for 
all comparisons. 
 
7.4 Results 
7.4.1 PLPS and oxPLPS do not modulate the inflammatory status of macrophages  
Production of NO by RAW 264.7 macrophages incubated with PLPS and oxPLPS was 
evaluated and no significant differences were observed between samples and control 
(unstimulated cells) (Figure 48A). NO is produced under inflammatory conditions by 
inducible NO synthase (Nos2 or iNos) in activated inflammatory cells, including 
macrophages. Therefore, we analyzed the effects of PLPS and oxPLPS on the expression 
levels of iNos. The results show that oxPLPS did not significantly affected (p>0.05) the 
expression of iNos. In contrast, PLPS slightly induced transcription of this gene (p<0.05) 
(Figure 48B) which, however, is not reflected in a significant variation in NO production 
(Figure 48A). Overall oxPLPS and PLPS did not show significant pro inflammatory 
properties in macrophages, in the conditions tested in this study. 
 
A B
 
Figure 48: Effect of PLPS and oxPLPS on NO production and iNos gene expression in 
macrophages. RAW 264.7 macrophages were maintained in culture medium (control) or treated 
either with non- and oxidized PLPS (30 µg/mL) for 24h. (A) Nitrite levels in the culture 
supernatants were evaluated by the Griess reaction as described in material and methods. Nitrite 
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concentration was determined from a sodium nitrite standard curve and the results are expressed as 
concentration (μM) of nitrite in culture medium. Each value represents the mean±SD from at least 
3 experiments. (B) The total RNA was extracted and retro-transcribed as described in the material 
and methods. The mRNA levels of iNos gene are depicted as normalized fold expression relatively 
to control. The relative expression of iNos gene was normalized using HPRT1 as reference gene. 
Each value represents the mean±SD from at least 3 experiments. (* P<0.05). 
 
7.4.2 OxPLPS, but not PLPS, showed anti-inflammatory properties in LPS-triggered 
activation of macrophages  
Macrophages were incubated with PLPS and oxPLPS in the presence of the TLR4 
agonist and pro-inflammatory agent LPS in order to evaluate their anti-inflammatory 
properties. First, the variation in NO production induced by LPS was assessed and the 
results obtained in this assay showed that the non-oxidized PLPS had no inhibitory effect 
on the LPS-evoked NO production (p>0.05) (Figure 49A). In contrast, oxPLPS inhibits 
NO production triggered by LPS in a dose-dependent way (p<0.01 for 15 g/mL and 
p<0.0001 for 30, 45 and 60 g/mL of oxPLPS) (Figure 49A and 49B). In a second 
approach we analyzed the effects of PLPS and oxPLPS on the expression of iNos gene 
(Figure 49C) induced by LPS. Data showed a decrease in iNos expression in macrophages 
treated with oxPLPS (30 µg/mL) (p<0.05), which corroborates the results previously 
obtained for NO quantification (Figure 49A). Interestingly, Arg-1, which participates in the 
regulation of iNos activity by competing for the common substrate L-arginine, is 
overexpressed in macrophages treated with oxPLPS (p<0.05) but not in macrophages 
treated with PLPS (p>0.05) (Figure 49D).  
Additionally the analysis of the IL1 gene expression was also performed and no 
significant changes were induced by either PLPS or oxPLPS (Figure 49E) in the absence of 
LPS (p>0.05), confirming the lack of intrinsic pro-inflammatory activity of these lipids. 
LPS strongly induces the expression of IL1  and, when cells were simultaneously exposed 
to LPS and oxPLPS, LPS-induced expression of IL1 was significantly decreased (p<0.05) 
while no significant alterations were observed when PLPS was used (p>0.05) (Figure 49F). 
These results confirm the anti-inflammatory properties of oxPLPS, previously revealed by 
the reduction of LPS-induced NO production (Figure 49A and 49B). 
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Figure 49: Influence of PLPS and oxPLPS on LPS-induced macrophage pro-inflammatory status. 
Raw 264.7 cells were incubated with culture medium alone (Control; C), with LPS (1µg/mL) and 
with non-oxidized (PLPS) or oxidized PLPS (oxPLPS; 30µg/mL except in (B) where 
concentrations are indicated) for 24h (A and B). Nitrite levels in the culture supernatants were 
evaluated by the Griess reaction as described in material and methods. Nitrite concentration was 
determined from a sodium nitrite standard curve and the results are expressed as concentration 
(μM) of nitrite in culture medium. The total RNA was extracted and retro-transcribed as described 
in the material and methods. The mRNA levels of iNos (C) Arg1 (D) and IL1β (E, F) genes are 
Anti-inflammatory effect of oxidized 1-palmitoyl-2-linoleoyl phosphatidylserine in activated macrophages 
163 
 
depicted as normalized fold expression relatively to control. The relative expression of the 
indicated genes was normalized using HPRT1 as reference gene. Each value represents the 
mean±SD from at least 3 experiments. (* P<0.05, **P<0.01, *** P<0.001, **** P<0.0001) 
 
7.4.3 OxPLPS but not PLPS inhibited JNK phosphorylation triggered by LPS in 
macrophages  
The expression of pro-inflammatory molecules is tightly regulated by several 
transcription factors and signaling pathways. Among these pathways, mitogen- activated 
proteins kinases (MAPKs) and the transcription factor NF-B are signaling molecules that 
play critical roles in the regulation of cell survival/apoptosis and cellular response to 
cytokines and stress. To elucidate the mechanisms underlying inhibition of LPS-induced 
macrophages activation upon oxPLPS stimulation, the effect on the activation of the pro-
inflammatory signaling pathways MAPKs and NF-B were examined. Three groups of 
MAPKs were studied: extracellular signal-regulated kinases (ERK), c-Jun NH2-terminal 
kinase (JNK) and p38 MAPK.  
In macrophages stimulated with oxPLPS and PLPS in the absence of LPS no 
activation (evaluated by protein phosphorylation) was detected for ERK1/2, JNK and p38 
MAPK relatively to control cells (p>0.05) (Figure 50). Interestingly, oxPLPS partially 
inhibited JNK p46 and JNK p54 (p<0.01) activation triggered by LPS, but no inhibition 
was detected for ERK1/2 or p38 MAPKs (p>0.05). No significant effect was observed in 
PLPS-treated cells (p>0.05) (Figure 51). 
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Figure 50: Influence of PLPS and oxPLPS on MAPKs activation in macrophages. Total cell 
extracts were analyzed by Western blot using antibodies against (A) phospho-JNK p54/p46, (B) 
phospho-ERK 1/2 and (C) p38MAPK. The results are expressed as percentage of immunoreactivity 
in control cells and protein loading was controlled using antibodies against total (A) JNK, (B) ERK 
and (C) p38 MAPKs. A representative blot and the mean±SD from at least 3 experiments are 
shown. 
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Figure 51: Influence of PLPS and oxPLPS on MAPKs activation triggered by LPS in macrophages. 
Total cell extracts were analyzed by Western blot using antibodies against (A) phospho-JNK 
p54/p46, (B) phospho-ERK 1/2 and (C) p38MAPK. The results are expressed as percentage of 
immunoreactivity in LPS-treated cells and protein loading was controlled using antibodies against 
total (A) JNK, (B) ERK and (C) p38 MAPKs. A representative blot and the mean±SD from at least 
3 experiments are shown. **P<0.01 
7.4.4 Inhibition of p65 nuclear translocation by oxPLPS on LPS-stimulated 
macrophages 
The NF-κB transcription factor regulates the expression of many genes involved in 
immune and inflammatory responses, including iNos. To elucidate whether oxPLPS and 
PLPS modulate the nuclear translocation of NF-B p65 in macrophages treated in the 
absence or in the presence of LPS Western blot analysis was performed to quantify the 
cytosolic and nuclear p65. In macrophages stimulated with oxPLPS and PLPS in the 
absence of LPS no effect was observed in the protein levels of both cytosolic and nuclear 
p65 relatively to control (p>0.05) (Figure 52A). In contrast, oxPLPS increases the levels of 
cytosolic p65 in macrophages treated concomitantly with LPS (p<0.05) (Figure 52A). As 
opposed, no effect was observed in cytosolic p65 after macrophages treatment with PLPS 
(p>0.05). Concerning nuclear p65, no significant effect was observed in both PLPS- and 
OxPLPS treated cells (p>0.05), although in the presence of oxPLPS nuclear levels of p65 
are slightly decreased relatively to LPS-stimulated cells. Taken together these data suggest 
that oxPLPS selectively decreases the nuclear translocation of p65 NF-B. 
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Figure 52: Effect of PLPS and oxPLPS on cytosolic (A) and nuclear (B) p65 protein levels of 
macrophages cultured in the absence (left) or in the presence (right) of LPS. The migration of NF-
B p65 to the nucleus was analyzed using an antibody against NF-B p65 in cytoplasmic (A) and 
nuclear (B) protein extracts. Equal protein loading was controlled using antibodies against actin 
and lamin in cytosolic and nuclear extracts respectively. A representative blot and the mean±SD 
from at least 3 experiments are shown. * P<0.05. 
 
7.5 Discussion 
Cellular apoptosis and subsequent 'silent' removal represents an important check-point 
for the resolution of inflammation. Failure in apoptotic cells clearance resulting in 
secondary necrosis-driven tissue damage has been implicated in conditions of chronic 
inflammation and autoimmunity. Apoptotic cells undergo profound biophysical changes, 
such as PS externalization, that warrant their efficient recognition and uptake by 
macrophages before fading to secondary necrosis. However, the nature of the “eat-me” 
signals and receptors that lead to cell recognition, engulfment and concomitantly silence a 
pro-inflammatory pathological condition are still under discussion. In this study, we 
evaluated the influence of PS oxidation products in the modulation of pro-inflammatory 
events in macrophages. Therefore, we have compared the effects of PLPS and oxPLPS on 
LPS-stimulated RAW 264.7 macrophages. We found that both PLPS and oxPLPS are 
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deprived of intrinsic pro-inflammatory activity. Exquisitely, oxPLPS may contribute to 
restrain inflammatory events in macrophages during apoptotic cell recognition and 
engulfment. More specifically oxPLPS, in contrast to PLPS, inhibits NO production and 
iNos expression in LPS-stimulated macrophages (Figure 49A, B and C). The results 
obtained from IL1 analysis also confirm the absence of activated (M1) macrophages, 
(Figure 49F) thus highlighting a putative role of oxPLPS in tempering inflammation. 
Corroborating these results, we also disclosed that oxPLPS, but not native PLPS, mitigate 
pro-inflammatory signaling in macrophages, thus reinforcing the contribution of oxPLPS 
to containment of inflammation during apoptosis. The results obtained in this work for 
non-oxidized PLPS are somewhat in disagreement with previous  published work that 
ascribed to PS an inhibitory role on LPS-induced NO production [315,316,317]. However, 
Greenberg et al also reported that oxPS, but not non-oxidized PS, participates in 
macrophages recognition of apoptotic cells via CD36 [104]. These contradictory results 
may be partially explained by different experimental conditions used, namely the 
concentrations of PS utilized as well as its oxidation levels are certainly important. The 
dissimilar performance of non-oxidized versus oxPLs species has also been observed for 
PC species. Friedl and co-workers, demonstrated that oxPC, but not native PC, inhibits 
iNOS expression in macrophages [318]. 
It is well-known that oxidation of phospholipids can generate a plethora of oxidation 
products with different structural features and also different properties [22,114]. PS, upon 
oxidation, can also generate not only distinct products with oxygenated fatty acyl chain, 
but also products resulting from PS polar head oxidation [168]. Recently, it was reported 
that several isolated oxidation products of 1-palmitoyl-2-oleoyl-PS did not induce cytokine 
production in monocytes, while PS oxidation products with a terminal 
hydroperoxyacetaldehyde in the polar head showed pro-inflammatory properties, 
promoting an increase in pro-inflammatory cytokines (IL-1β, IL-6, IL-8, MIP-1β and TNF-α) 
production [242]. Bochkov and colleagues showed the crucial role of oxidized 
phospholipids as biological active compounds (as reviewed in [114]). Seyerl et al have also 
verified that oxidized phospholipids, including PS, but not their native forms, are specific 
regulators of T cell activation [319]. Furthermore, it was also demonstrated that the polar 
groups of oxidized phospholipids affected the dysfunction of endothelial cells induced by 
LPS in vitro and in vivo, leading to attenuated RHO GTPases activation [320]. Further 
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studies taking into account the oxidation of the polar group are highly needed and will be 
of outmost importance to clarify their role in the inflammatory response modulation 
evoked during apoptotic cell recognition and engulfment. 
The modulation of intracellular signaling pathways by PLPS and oxPLPS was also 
examined. The inhibitory effect of oxPLPS in NO production can be partially associated 
with NF-B and MAPKs modulation since activation of macrophages by LPS involves the 
simultaneous activation of all classes of MAPK (JNK, ERK and p38) and NF-B. These 
findings suggest that down-regulation of iNos and IL1 genes results from an inhibitory 
effect of oxPLPS on NF-B signaling pathway, through an impairment of p65 
translocation into the nucleus (Figure 52). Additionally, JNK also assumes a protagonist 
role in the anti-inflammatory potential of oxPLPS (Figure 51). Indeed, it is well known that 
iNOS expression is controlled by several signaling pathways, among them NF-kB and 
MAPK [321,322].  
In conclusion, and in addition to their role in the promotion of phagocytosis of 
apoptotic cells by macrophages, oxPLPS appears to exert signalling characteristics 
important for tempering inflammation. Given that “silent” clearance of apoptotic cells is 
critical for restoration of tissue function, we hypothesize that oxPLPS play a key role in 
promoting timely resolution of inflammation. However, the biological relevance of these 
findings needs to be deeply explored and validated in in vivo models. 
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Phospholipids are structural components in cell membranes and lipoproteins and have 
been recognized as important signalling molecules, crucial for homeostasis and also 
associated with the development of diseases. Among phospholipids, phosphatidylserines, 
which are ubiquitously distributed in all cells, although in minor abundance, participate in 
important signalling events, including in blood clotting, apoptosis and in tumours. Some 
evidences show that oxidized PS molecular species are more active than non-oxidized PS 
species, as the case of apoptosis [104]. 
The present work was conducted to address the problem of the identification of the 
products generated during oxidation PS using different oxidation systems, namely the 
hydroxyl radical and a radical generator, the AAPH. It is known from studies of other 
phospholipid classes, that different oxidation systems can generate different oxidation 
products, that can have distinct biological significance and that possess different 
identification problems. In this work, we have studied several model PS species bearing 
different combinations of fatty acyl chains, namely with palmitic acid in sn-1 and sn-2 
(DPPS) and with palmitic acid linked to sn-1 and unsaturated fatty acids, oleic acid, 
linoleic acid and arachidonic acid linked to sn-2 designated respectively as POPS, PLPS 
and PAPS. The different PS model compounds were used to evaluate the influence of fatty 
acid composition in the oxidation process at the molecular level. New PS oxidation 
products were identified during oxidation of each PS molecular species and these species 
were characterized by off-line TLC-MS and on-line LC-MS and MS/MS. The identified 
PS oxidation products included long chain products, which preserved the phospholipid 
skeleton (hydroxy, peroxy, and keto derivatives). These species were identified during 
oxidation of POPS, PLPS and PAPS. Short chain products, formed by cleavage of the 
unsaturated fatty acyl chains, giving rise to shortened fatty acyl chain with a terminal 
aldehyde or carboxylic groups, were only identified during oxidation of PLPS and PAPS. 
Products with cleavage in the polar head group were also identified during oxidation of 
DPPS, POPS, PLPS and PAPS. The glycerophosphoacetic acid derivatives (GPAA) 
products, resulting from oxidative cleavage of the serine polar head group, were identified 
for the first time in the present work, as well as other products with polar head groups, 
assigned as acetamide and hydroperoxyacetaldehyde terminal, observed in the DPPS and 
POPS. The results of our work allowed identifying for the first time new oxidation 
products of PS, due to oxidative cleaved of serine moiety. 
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The hydroxyl radical was used also to induce the oxidation of glycated POPS and 
PAPS, mimicking the oxidation in hyperglycemia conditions. The results obtained revealed 
that glycated PS oxidized earlier than non glycated PS, leading to more abundant oxidation 
products. The glycoxidation products observed, when glycated PAPS was used as a model 
compound, included products from oxidation in fatty acyl chain and products with a 
terminal formamide in polar head group formed from a cleavage in the glucose moiety 
(cleavage in C1-C2 bond). Interestingly, in these studies it was also possible to identify 
molecular species arising from oxidative cleavage in glycated polar head and also new 
products arising from oxidative cleavage of the glucose moiety between C1-C2 bond with 
formation of formamide terminal. Products arising from oxidative cleavage of the glucose 
moiety between the C2-C3 bond with acetic acid attached to amine group and between the 
C3-C4 bond with formation of hydroxypropanone terminal in polar head group were also 
identified. The identification of these PS-AGES arising from glycated POPS oxidation 
gave new insights on the glycation PS mechanisms, opening new perspectives for the 
detection of these products in complex biological matrices. PS is an amino phospholipid, 
similarly to PE, and thus most probably with similar propensity to be glycated: However, 
although glycated PE has been identified and quantified in plasma of diabetic patients [24], 
glycated PS was only reported to be formed in vitro, but it has never been identified in vivo 
[27]. This fact may be to the result of the in vivo low abundance of these species or due to 
their easy degradation under oxidative conditions. Glycation of biomolecules is a well-
known reaction that occurs in vivo, particularly in hyperglycemia. Glycation of proteins 
has been extensively studied and is recognized as an important event that occurs in 
diabetes mellitus patients [230]. It is also recognized that glycated biomolecules and their 
degradation products trigger an increase of oxidative stress and an inflammatory response, 
which is responsible for different diabetic complications, such as micro and macrovascular 
complications, atherosclerosis and others. In spite of the recognition of the importance of 
protein glycation as important biomarkers of uncontrolled hyperglycemia, glycation of 
other biomolecules, including phosphatidylserines, is still an unexplored field. Since 
diabetes is associated with an increase of the oxidative stress status, the modifications 
occurring in glycated PS species were assessed in this work by LC-MS and MS/MS, but 
further work is needed to understand the biological effects of combined glycation and 
oxidative induced PS modifications. 
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PS is present in biological matrices in low amounts comparing with other 
phospholipid classes such as PC and PE. In oxidative stress conditions, only a small 
percentage of PS is oxidized and several products are generated during this oxidative 
process, difficulting their identification. Most of the PS oxidation products already 
identified in complex samples were hydroperoxide (PS-OOH) or hydroxide (PS-OH) 
derivatives, since they are the primary and the most abundant products formed. However, 
more sensitive approaches are required to overcome the challenge of the detection and 
quantification of PS oxidation products in biological systems, suggesting that targeted 
analytical approaches, based on mass spectrometry, are needed. The fragmentation 
pathways identified in this work, which are specific of the PS oxidation products with 
modified in serine polar head (the GPAA derivatives), were used to develop a target 
lipidomic strategies to screen the formation of these species in cells after an oxidative 
stimuli. The approach that we have developed involved the neutral loss and precursor ion 
scanning modes, which was optimized previously with oxidized POPS. Keratinocytes were 
selected as a cell model, since externalized PS and oxidation of fatty acyl chains in PS 
were previously identified in these cells during oxidative stress [55, 243]. Using this 
targeted lipidomic approach, GPAA derivatives were successfully detected from total lipid 
extracts. The positive identification of serine head oxidation products in cells under 
controlled oxidative conditions opens new perspectives and justifies further studies in other 
cellular systems in order to understand fully the role of PS polar head group oxidation in 
cell homeostasis and disease.  
The extracellular exposure of PS has been associated with several physiopathological 
situations, including apoptosis and in tumor cells. The biological significance of the PS 
externalization in tumor cells has not been fully elucidated, since tumor cells are not 
recognized by macrophages receptors. Thus, this process of externalization does not seem 
to promote any signaling event, at least in order to facilitate the elimination of these cells. 
Several reports have shown the increased exposure of PS on the outer leaflet of the plasma 
membrane in several tumor cell lines such as melanoma and melanoma metastases, gastric 
carcinoma, leukemia, tumor blood vessels [62, 66-69]. PS externalization seems to be 
correlated with malignancy, suggesting that PS can be a uniform marker of tumor cells and 
metastases and a potential target for the further development of cationic antitumor peptide 
drugs [62, 65, 72]. In this work, human melanoma cells were exposed to UVA radiation in 
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an attempt to give some insight in a possible correlation of PS, oxidation, apoptosis and 
tumor malignancy, since UVA exposition has been considered to be associated with the 
onset and progression of the disease. Interestingly, the results from the lipidomic analysis 
showed only a few modifications in PS species, like the decrease of PS-18:0/18:1 in the 
moment of irradiation, and no oxidation product were detected. The results also showed 
the occurrence of the remodeling of the phospholipid profile, confirmed with fatty acids 
analysis by GC-MS. The changes were correlated with lipogenesis and de novo synthesis 
of saturated and mono-saturated fatty acids, presumably to promote the cell survival. In 
fact, the increase of the ratio of mono-unsaturated fatty acid/polyunsaturated fatty acid 
makes the phospholipid membrane less susceptible to be oxidized. The absence of cleaved 
caspase-3 after 2h and 24h of re-incubation correlates with the impairment of apoptosis. 
The observed alterations in the lipid metabolism may be correlated with malignant 
transformations associated with cancer development and progression. Thus, lipids might 
constitute challenging therapeutic targets for the treatment of highly resistant-melanoma. 
The biological effects of the PLPS and oxPLPS were evaluated in Raw 264.7, a mouse 
leukaemic monocyte macrophage cell line; the results showed that oxPS but not native PS 
has anti-inflammatory activity due to its ability to inhibit the LPS-induced NO production 
and Nos2 and il1b gene transcription. At the molecular level, this was shown to be the 
result of attenuation of LPS-induced JNK phosphorylation and p65 NF-kB nuclear 
translocation. These data suggest that oxPLPS, but not native PLPS, mitigates pro-
inflammatory signaling in macrophages, contributing to containment of inflammation 
during apoptotic cell engulfment. 
 
The results described in this work gave new insights on the modifications of PS and 
showed the importance of oxPS versus non-oxidized PS in response of macrophages to 
pro-inflammatory stimulus. Nonetheless, for more detailed understanding of the 
mechanisms that rule the safe removal of apoptotic cells, which might be significant for the 
design of novel therapeutic strategies, it is important to determine whether the exposure on 
the surface of apoptotic cells of different oxidation products of PS differentially modulates 
the functional responses of macrophages. Despite the contribution of this work for the 
identification of oxidation products of PS, this field of research is far from being 
General conclusions  
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completely explored, although it is essential for the understanding of the relation between 
the PS oxidation products formed and the specific biological activity. 
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